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Peptidomimetic foldamers, oligomers that can fold into a well defined conformation
in solution, can control functions that would not be possible in nature. Their spe-
cific conformation can mimic peptides and therefore control a variety of biological
function via protein-protein interactions in absence of proteolysis, which is a typical
feature of peptidomimetics.
This thesis describes the synthesis of γ-amino acid precursors as building blocks





















dented mechanistic rearrangement observed during a 6-endo-trig cyclisation assisted
by organocatalysis was performed. Then, a novel enantio- and diastereoselective syn-
thesis of 5-membered ring cis-γ-amino acid precursor was developed. The targeted
product was obtained in 72% yield, 9:1 cis/trans ratio and 92% ee. A mechanistic
discussion of the studied 5-exo-trig cyclisation is presented. NMR and computa-
tional studies suggested that two joint catalytic cycles characterise the synthesis of


















oselectivity degradation may be due to the epimerisation of the cis-product to the
trans-product leading to a change of enantioselectivity with time. Control of this
process is crucial to isolate efficiently the cis-product.
The synthesised 5-membered ring cis-γ-precursor was then incorporated in a
γ/α-oligomer. The synthesised peptide proved to populate a 10/12-helical struc-
ture in spite of the smallest ζ angle yet observed for a helix of this type, therefore
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The control of stereochemistry is one of the main pursuits in organic chemistry
because of the different reactivity that the two resulting enantiomers might have
in a chiral environment. This was sadly demonstrated in the 1960’s in the case
of thalidomide; a drug administered to pregnant women to alleviate nausea and
morning sickness. Shortly after the drug was released, it was discovered that the
two enantiomers of this drug had different effects. The (R)-enantiomer produced
















Figure 1.1: The two enantiomeric forms of thalidomide.
first, it was believed that the administration of a single enantiomer would have solved
the problem, however they found out that the (R)-thalidomide would epimerise
to the (S)-enantiomer in the body after administration, which meant that even
giving the pure enantiomer would have been unsuitable. The negative effect of
thalidomide led to more rigorous drug regulations and highlighted the importance
of stereoselective synthesis of compounds and in particular of medication.1
At first, enantioselective molecules were achieved via different routes such as
chiral resolution or using chiral auxiliaries. For chiral resolution, a racemic mixture
is coupled with a chiral molecule forming diastereomers that can be separated in
an achiral environment (e.g. chromatography or crystallisation). The two separate
compounds can be then converted to the targeted enantiomers but the maximum
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achievable yield is 50%. As a result, this is an inefficient method for targeting a single
enantiomer. Chiral auxiliaries induce chirality to new forming bonds, however the
atom economy is penalised by the presence of the auxiliary. The auxiliary has to
be removed after the reaction making this technique undesirable. An alternative
method to achieve enantiopure compounds is through use of chiral catalysts. This
method is more efficient, enables higher yields and provides a greater atom economy.
1.1 Asymmetric Catalysis
There are three main categories of catalysts that are used for asymmetric synthesis:
biocatalysis, metal catalysis and organocatalysis.2 Biocatalysis uses enzymes that
are already used by nature for the synthesis of enantiomerically pure compounds. An







R=H, CH3, OC2H5, I, PhCH2, CH(OH)CH3, COCH3, 
CH=CH2, CH2=CHCH2, CH3CH=CH, HCC, Si(CH3)3
1 2
Scheme 1.1: Biocatalysed dihydroxylation of arenes.3
extremely well with specific substrates. However, often they require cofactors and
specific conditions, making this category incompatible with a variety of substrates
and conditions.
Transition metal catalysis originated in the 1950’s,3 and the discovery of
tris(triphenylphosphine)rhodium chloride as a catalyst by Wilkinsons and co-workers
essentially marks the beginning of the development of asymmetric catalysis. The
substitution of phosphines with chiral ligands led to first advances in asymmetric hy-
drogenation.4 An example of asymmetric hydrogenation is presented in Scheme 1.2,
where compound 4 is obtained in quantitative yield and with 95% ee. Following the
discovery of Wilkinson’s catalyst, transition metal catalysis has been widely used
due to low catalyst loading, which has led to high efficiency and good malleability of
reactions with a variety of substrates. However, there are growing concerns around
metal catalysts due to their costs and sustainability issues. Owing to their toxic-
ity and persistence in the environment, transition metals require a specific disposal























Scheme 1.2: Asymmetric hydrogenation catalysed by the Wilkinson’s catalyst.
method. Additionally, the risk of heavy metal residue contamination in medical
preparations can make transition metals unsuitable for use by pharmaceutical com-
panies.
Asymmetric organocatalysis is a proficient method to obtain directly only one
enantiomer and can be employed to accelerate chemical reactions using organic
molecules without the aid of any metal atoms.5 Compared with metal catalysts,
organocatalysis produces less toxic waste and material, are less expensive and more
readily available. Organocatalysts tend to be air and water stable, requiring less
harsh conditions than metals and they have a wider substrate scope than biocata-
lysts.2 There are several classes of organocatalysts and two of the most commonly
used involve the use of compounds that act as (i) covalently bonded reagents,5 and
(ii) via hydrogen bonding and ion paring.6
1.1.1 Covalent organocatalysis
1.1.1.1 Enamine catalysis
Secondary amine catalysis is part of the first class of catalysts. The use of these
catalysts in the absence of any metal was first reported in 1971 independently by
Hajos and Parrish7,8 and by Eder, Sauer and Wiechart.9 Hajos and Parrish cyclised
the triketone 5 to compound 7 using (S)-proline 6 (3 mol%) as catalyst in anhydrous
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Scheme 1.3: Hajos-Parrish asymmetric aldol reaction catalysed by (S)-proline.
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and then dehydration was performed to give the optically pure compound 8 in 95%
yield and 88% ee.
At the same time, Eder, Sauer and Weicher first tested several chiral primary
and secondary amines in order to steroselectively cyclise optically active steroids,
before finding that natural amino acids achieved better results.9 They studied the
same reaction using a higher catalyst loading and a solution of perchloric acid in
acetonitrile at 80 °C, and after 22 hours product 8 was obtained in 87% yield and











22 h, 80 °C
O
O
87% yield, 84% ee5
6
8
Scheme 1.4: Eder-Sauer-Wiechert aldol reaction catalysed by (S)-proline
After several proposed mechanisms for proline catalysed reactions, in 2004 Houk
and co-workers10 demonstrated, via a computational study, that the catalytic reac-
tion involves a proline enamine intermediate. At the same time, List and co-workers
reported experimental evidence on the same proposal performing the reaction in
18O enriched water and found that the side chain carbonyl was labelled.11 This
proved the proposed enamine mechanism and it was followed by further 1H NMR
studies, which led to the identification of reaction intermediates. These studies led
to the currently accepted mechanism of a proline catalysed reaction where the car-
boxylic acid of proline coordinates to the carbonyl of the electrophile promoting the





Figure 1.2: Catalytic intermediate proposed by Houk and reported experimentally by
List.10
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In general, secondary amines are Lewis bases and their catalytic mechanism
might proceed via enamine or iminium mechanism.11,12 In the first case, the catalyst
activates carbonyl compounds (11) and generates an enamine intermediate (12) that
can react with several electrophiles, forming a new bond in α-position (13).13 For
an α,β-unsaturated compound, the reactivity will be different and the iminium-form
intermediate will react with a nucleophile in the β position (Scheme 1.5).
It was not until the 2000’s that, secondary amines became more popular as cat-
alysts.14 In 2001, List and his research group, studied several proline-catalysed reac-
tions, such as intermolecular aldol, Mannich and Michael reactions (Scheme 1.6).14
Proline was one of the first catalysts in this category. Proline’s efficacy derives from
its bifunctionality due to the carboxylic acid group that acts as Brønsted acid to-
gether with the secondary amine group which performs as a Lewis Base.5,15 The
bifunctional catalyst can activate both nucleophile and electrophile.16–19 In particu-
lar, the catalyst controls the enantioselectivity of the product through the formation
of a H-bond between the electrophile and the carboxylic acid. However, proline pre-
sented solubility issues therefore alternative catalysts were designed.
To overcome difficulties encountered with poor H-bonding electrophiles, proline-


















































Scheme 1.5: Enamine catalysis and iminium catalysis.










































Scheme 1.6: List’s proline (6) catalysed reactions: (a) intermolecular aldol reaction, (b)
first highly enantioselective three-component Mannich reaction and (c) enam-
ine catalysed Michael reaction.
tetrazole 29 as a valid alternative to proline.20–22 Torii and co-workers reported an
asymmetric direct aldol reaction assisted by water (Scheme 1.7).21 They concluded
that the tetrazole catalyst can give highly efficient results if the conditions are ad-
justed specifically for the reaction. Shortly after, Ley and co-workers reported an
asymmetric Mannich-type reaction catalysed by 29, which gave the targeted prod-
uct in good yields, excellent dr and excellent ee (Scheme 1.8).22 They proposed a
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Scheme 1.7: Asymmetric direct aldol reaction assisted by water and catalysed by 29 per-
formed by Torii and co-workers.21





























Scheme 1.8: Asymmetric Mannich-type reaction catalysed by 29 performed by Ley and
co-workers.22
and Bahmanyar (Scheme 1.8).17,18,23,24 Hartikka and co-workers compared the reac-
tivity of tetrazole catalyst 29 with proline 6 for asymmetric aldol reactions.25 They
observed that the tetrazole catalyst 29 had a higher turnover number than proline
6. Notably, in the presence of substrates with a lower reactivity, the consumption
of starting material occurs at a higher rate with 29. They suggested that the high
efficiency of 29 compared to 6 might derive from the higher lipophilicity of 29,
which provides compatibility with a wider range of solvents due to the presence of
the tetrazolic group (Scheme 1.9). The hydrogen bond between the acidic proton
of the tetrazole and the carbonylic group of the substrate might be stabilised by































Scheme 1.9: Catalytic cycle proposed by Hartikka and co-workers.25
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List defined the observed bicyclic oxazolidinone by-product as a parasitic in-
termediate in reactions carried out in DMSO whereas Blackmond and co-workers
thought it was crucial for the reactivity of proline and suggested that it might in-






































Scheme 1.10: Blackmond and co-workers observation of hemiaminal species as catalytic
intermediates in the reaction.27
In 2005, Hartikka and co-workers used NMR spectroscopy to rationalise the
greater reactivity of the tetrazole catalyst compared to proline.25 They showed that
proline generates parasitic bicyclic oxazolidinone compounds reducing the efficiency
of the catalyst, whereas 29 does not.25 In 2005, Ley and co-workers presented an-
other study where they compared proline derivatives with the proline catalyst for
asymmetric Mannich, nitro-Michael and aldol reactions. They found that 29 gener-
ated better results than proline in all cases (Scheme 1.11).29 They suggested that the
improvement in enantioselectivity of the tetrazole catalyst 29 over proline 6 might
derive from the size difference between the tetrazole and the carboxylic acid which
might affect the facial preference of the substrate or possibly different transition
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Scheme 1.11: Nitro-Michael addition catalysed by 29 performed by Ley and co-workers.29



















Scheme 1.12: Diarylprolinol silyl ether geometric control.
One of the major exponents of proline-derivative catalysts was Jørgensen, who
designed pyrrolidine derivatives with high enantioselectivity due to greater geometry
control and efficient face shielding (Scheme 1.12).30 Several new enamine catalysts
were developed (1.3(a)), including the free alcohol 51, which presented a high stereo-
control, but surprisingly a low turn-over number. They ascribed this problem to the






























































Figure 1.3: (a) Pyrrolidine derivative enamine catalysts; (b) Pyrrolidine derivative cat-
alytic cycle with catalyst 51 showing the hemiaminal side product formation
43 and 44.
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A simple protection of the hydroxyl group (53, diphenylprolinol silyl ether)
solved the problem, resulting in considerably increased catalytic turnover number.
In parallel, Hayashi and co-workers studied the reactivity of the same system 53 in
the preparation of nitroalkanes from nitroolefins and aldehydes (Figure 1.3).32 After
a catalyst screen of a test reaction, they showed that catalyst 53 was giving superior
results compared to other catalysts. Stirring the reaction at 0 °C for 27 hours gave
compound 60 in 80% yield, 99% ee, and a ratio of diastereoisomers syn/anti of

















Scheme 1.13: Michael reaction performed by Hayashi and co-workers.
with a transition state model proposed by Seebach and Golinski (Figure 1.4).33
They showed that the double bond of the enamine is oriented away from the bulky
diphenylsiloxymethyl group and the enamine will then react selectively with the









Figure 1.4: Transition state model proposed by Seebach and Golinski.
In the past ten years, several studies have been conducted to investigate the
mechanism of action of nitro-Michael additions using organocatalysis. In particular,
nitro-Michael reactions mediated by the Hayashi-Jørgensen catalyst have been in-
vestigated. Seebach and Hayashi presented a study where they identified a cyclobu-
tane species (CB, 69) as intermediates of the reaction via 1H NMR spectroscopy
(Scheme 1.14).34 Aldehyde 62 condenses into the secondary amine organocatalyst
61. The enamine formed 63 then reacts with nitroolefin 64 to form the interme-
diate 65, which is in equilibrium with a CB species 69. Hydrolysis leads to the
protonation of the nitronate and finally release of the targeted product 67.34 They





















































Scheme 1.14: Proposed catalytic cycle by Seebach and Hayashi in 2011.34
investigated the addition of different acid co-catalysts to understand why this addi-
tive is essential in order to perform more efficient reactions. They confirmed that
acid additives (i) accelerate the generation of the enamine, (ii) promote the addition
of the enamine to the nitro olefin, (iii) aid the conversion of the CB intermediate
69 with H2O to Michael addition products, and (iv) affect diastereoselectivity and
epimerisation at the α-carbonyl position to the final product. They postulated that
the CB intermediate is a "parasitic" species that inhibits the product formation.34
However, in a parallel work, Blackmond and co-workers found that the formation of
these species maintain high stereoselectivity (Scheme 1.15).27,28 They observed that
the formation of the CB intermediate 74 is inversely proportional to the presence of
the product enamine which would otherwise lead to a degradation of diastereoselec-
tivity. They monitored reactions in situ to observe the effect of water in the reaction











































Scheme 1.15: Organocatalytic cycle of a nitro-Michael addition proposed by Blackmond
and co-workers in 2012.35,36
and have found that there were not substantial changes with or without addition
of water and, therefore, conclude is unlikely that the protonation step would be the
rate determining step.
In 2012, Pihko and Pápai presented a model where they combined experimental
and computational experiments. They suggested that the rate determining step is
related to the protonation step of a dihydrooxazine oxide (OO) intermediate 75,
which was fully characterised via NMR spectroscopy.37 They compared the reactiv-
ity of α-alkyl substituted and unsubstituted nitro olefins and rationalise the lower
reactivity of substituted substrates over unsubstituted. As previous mechanistic
studies proved that the rate determining step of this type of reaction was expected
after the formation of the intermediate CB, they assumed that the low reactivity
of α-alkyl substitued nitro olefins was not an intrinsic problem of the substrate.
Instead, they thought it was rather related to the intermediate stability, considering
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the slow protonation step in the presence of a substitutent in α-position to the nitro
group. The addition of an acid co-catalyst favoured this protonation step allowing
the release of the product in high yields, high enantioselectivity and high diastere-
oselectivity. With this study, Pihko, Papai and co-workers highlight the importance
of intermediates stability to predict reactions reactivity.37
Pfalz, Wennemers and co-workers via an ESI-MS spectroscopic technique anal-
ysed the back-reaction of the nitro Michael addition to compare forward and back-
ward reactions and thus identifying the rate determining step. They concluded that
in the presence of non-acidic catalysts, such as the Hayashi-Jørgensen catalyst, the
rate determining step cannot be the C-C bond formation. This finding would be in
line with other mechanistic studies that propose the protonation step that follows
the C-C bond formation as the turnover-limiting and stereoselectivity-determining
step.37–39
However, in 2017 Pápai and co-workers presented a computational study where
they observe that nitro-Michael reactions catalysed by Hayashi-Jørgensen catalyst
do not meet Curtin-Hammett conditions as previously stated in literature (Fig-
ure 1.5).35,36,39 The Curtin-Hammett principle states that two intermediates or
reactants that are rapidly interconverting between each other will generate two
irreversible different products. The product ratio is related to the energy of the
two conformers and to the energy barrier from each of the isomers to the respec-
tive products. They found that the transition state of the protonation occurs at
a lower energy compared to C-C bond formation transition states. This outcome
would be in contrast with Curtin-Hammett stereoselectivity control since the fast
interconversion between the two intermediates would be unfeasible. They explained
that even if the rate determining step of this reaction is the protonation step, the
stereoselectivity is determined by the C-C bond formation transition states (Fig-
ure 1.5(b)). Pápai and co-workers presented a computed free energy profile where
the two enantioselective paths are analysed together. The proposed mechanistic
discussion concluded that the methodology used by Wennemers and co-workers is
valid for most reactions that are characterised by the same turnover-limiting and
stereoselectivity-determining step, however in this case the two steps are not co-
inciding and therefore they suggest that the validity of this method is reduced.38
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In summary, enamine organocatalysis has been widely studied, however questions









































Figure 1.5: (a) Nitro-Michael reaction that was computationally and experimentally stud-
ied by Pápai and co-workers. (b) Computed free energy profile of nitro-michael
addition catalysed by 53 and performed by Pápai and co-workers.40
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1.1.1.2 Iminium catalysis
The second type of mechanism in Scheme 1.5 envisages the generation of an iminium
ion, formed by the reaction of the catalyst with carbonyl compounds, which then
reacts with nucleophiles. For instance, this type of catalysis is utilised to activate
α,β-unsaturated compounds generating a new bond in β-position (Scheme 1.16).



















Scheme 1.16: Example of nucleophilic addition to α,β-unsaturated compounds.
tioselective Diels-Alder reaction via iminium ion catalysis.41 The reaction of α,β-
unsaturated aldehyde 86 with an enantiopure secondary amine as the catalyst led
to the formation of an iminium ion able to react with diene 87 in order to obtain
compounds 88 (Scheme 1.17). They tested several secondary amine catalyst but
they found that using compound 85 as catalyst product 88 was achieved in 99%
yield and only after 8 hours. The ratio between the exo- and the endo-product was
respectively 1.3:1 and the (2S)-exo-aldehyde was obtained with a 93% ee.41 In 2002,
Macmillan and co-workers investigated the enantioselective 1,4-addition of aniline
rings 89 to α,β-unsatured aldehydes 90. They found that in only 20 minutes with




























Scheme 1.17: First highly enantioselective amine catalytic Diels-Alder.



















Scheme 1.18: Enantioselective 1,4-addition of aniline rings to α,β-unsaturated aldehydes.
1.1.2 Non-covalent organocatalysis
1.1.2.1 Brønsted base/brønsted acid bifunctional catalysis
In 1923, a Brønsted acid was defined as a proton donor according to the Brønsted-
Lowry theory, whereas a Brønsted base was considered a proton acceptor.43,44 In
the same year, Lewis acids were described as substances able to accept a pair of
non-bonding electrons and Lewis bases as electron-pair donor.45 In 1884, Friedel
and Crafts used for the first time aluminium chloride as a Lewis acid which was able
to catalyse electrophilic aromatic substitutions.46 Brønsted acids have been known
as catalysts since 1942, when Wassermann and co-workers presented a Brønsted acid
catalysed Diels-Alder (Scheme 1.19).47 The ability of a strong acid to catalyse reac-
tions was already known, however they proved difficult to use because of their lack
of regioselectivity.48 Chemists observing natural enzymatic systems began to study
systems with weak interactions or H-bonding in order to design new catalysts.49
The usage of H-bonding to direct molecules’ assembly became more prevalent at
the end of the 20th century. In 1990, Etter and co-workers set the basis for the
following studies on achiral thiourea based H-bond donor catalysts.50,51 They stud-
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Scheme 1.19: First catalytic Diels-Alder reaction.





















Scheme 1.20: Catalytic Claisen rearrangement.
ied the molecular recognition properties of diarenylureas co-crystallized with Lewis
bases.50,51 In 1994, Curran and Kuo proved that urea derivatives were efficacious
organic catalysts.52 In 1995, they studied a Claisen rearrangement (Scheme 1.20)
showing an eminent acceleration of the reaction in the presence of this new cata-
lyst.53
In 1998, Sigman and Jacobsen presented their results obtained experimentally
using thioureas catalysts in an asymmetric Strecker reaction.54 Four years later,
Jacobsen together with Vachal, presented a structure-based mechanistic analysis
which demonstrated the accountability of the thiourea dual H-bond interaction for

































Scheme 1.21: Organocatalysed Strecker reaction.









Figure 1.6: Bifunctional thiourea catalyst.
They found via isotope shift experiments that the imine substrate exclusively
interacts with the urea hydrogens.55 The thiourea enhances the electrophilicity of the
substrate via hydrogen bonding activation and the tertiary amino group activates
the nucleophile (Figure 1.6).13,56
The first enantioselective Aza-Henry reaction catalysed by a bifunctional




























Scheme 1.22: First Aza-Henry reaction catalysed by bifunctional thiourea organocatalyst.
The bifunctionality of this catalyst enables this reaction because it deprotonates
the nitro group to give the nitronate enhancing the electrophilicity of the substrate
(Scheme 1.23).57,58



























Scheme 1.23: Deprotonation of the nitroalkane to the corresponding nitronate.
1.1.2.2 Phase-transfer catalysts
An example of ion pairing catalysis is phase-transfer catalysis, which involves a sys-
tem with two different phases, an aqueous and an organic layer, where the anion
acts as base or nucleophile. The catalysis is due to the ability of cations to transfer
anions in the organic phase in order to react with the substrate.59,60 An interesting
example was reported by Corey et al. in 1997. They present the mechanism and
the geometrical factors responsible for the enantioselectivity of phase-transfer cata-
lysts based on cinchona alkaloid molecules (Scheme 1.24).61 They believed that the
quaternary bridgehead nitrogen of the cinchona alkaloid 108, which is the centre
of a tetrahedron, should have steric hinderance to three of the faces, leaving the
fourth one accessible enough to the counterion of the substrate. They found that
the bulkier group R1 is, the higher the enantioselectivity of these catalysts.61,62 An




























Scheme 1.24: Ion pairing catalysis through cinchona alkaloids.
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and excellent ee (up to 99% ee) in the presence of catalyst 108.
A multitude of reactions have been made possible with these catalysts (e.g.
asymmetric aldol, Mannich, Michael and Diels-Alder reactions)63 including the
catalysis of reactions with nitro compounds. An example of asymmetric aza-

























Scheme 1.25: Asymmetric aza-Henry reaction under phase-transfer catalysis.
They demonstrated through experimental and theoretical studies that the cat-
alyst 111 forms hydrogen bonds with the nitro group of the substrate 114. This
interaction leads to a more rigid structure, which is one of the reasons of high enan-
tioselectivity. They obtained 114 in good yield and with excellent enantiomeric
excess of syn product (up to 99% ee).11
1.2 Intramolecular Nitro-Michael Additions
The combination of organocatalysis and nitro olefins opened the way to the gener-























Scheme 1.26: Secondary amine catalysed addition of nitronates to α,β-unsatured aldehy-
des, achieving γ-amino acid precursors.
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examples of nitro-Michael additions have already been described in this chapter be-
cause of the high utility of the respective products. The use of organocatalysis for
nitro-Michael addition gives way to the synthesis of a variety of γ-amino acid pre-
cursors that can be easily achieved by oxidising the carboxylic group and reducing
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Scheme 1.27: Enantioselective Michael addition performed by Cobb and co-workers for
the synthesis of a γ-amino acid precursor.
Intermolecular Michael additions have been widely studied and reported in lit-
erature.29,32,34 Intramolecular nitro-Michael additions assisted by organocatalysts
are reported in the literature but to a lesser extent. An example of enantioselective
Michael additions of nitronates onto conjugated esters is described in Scheme 1.27.
Cobb and co-workers obtained compound 121 in 87% yield, with excellent dr (>19:1)
and 95% ee.65 In 2013, an intramolecular Michael addition was reported for the final
synthesis of atropurpuran A-ring 124 (Scheme 1.28). After reaction optimisation
they obtained moderate dr (24:24:11:41) and moderate ee of the four diastereomers
(28,67, 70, 36 %).
In summary, organocatalysis is a valid method to obtain enantioselective
molecules via a more environmentally friendly procedure compared to metals. Nitro-
Michael addition assisted by organocatalysts can lead to γ-amino acid precursors.
However, only a few examples of intramolecular nitro-Michael additions assisted by
organocatalysis have been reported in the literature to date. Cyclic γ-amino acids
can be used as building blocks for the synthesis of constrained oligomers and this
field is still under investigation.























Scheme 1.28: Intramolecular Michael addition performed by Chen and co-workers.66
1.3 Peptidomimetic Foldamers
1.3.1 Peptides and peptidomimetics
Peptides are essential to the human body as they control many vital functions.
They are responsible for cell-cell communication and they regulate the interaction
of ligands with receptors.67 Peptides and proteins are sequences of amino acids and
they are characterised by primary, secondary, tertiary and quaternary structures.68
Figure 1.7: The hierarchical structure of proteins.69
A primary structure can be defined as a sequence of amino acids linked together
through peptide bonds. These types of bonds have a planar structure caused by
resonance of the nitrogen lone pair through the carbonyl (n → π*). The formed
double bond prevents rotation of the peptide bond itself, letting free rotation only
of fragments connected to the double-ended peptide.
Peptides have two different conformations: a trans conformation, which is the
most favoured, and a cis conformation, which presents a sterically hindered section
between the residues (Figure 1.8).
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Figure 1.8: Trans and cis peptide configurations.70
The latter conformation is usually seen with proline, forming conformations














Figure 1.9: Natural Pro-Gly-β-turn as an example of cis conformation of a peptide bond.
The folding of the amino acids sequence can be described as secondary structure,
which is mainly due to hydrogen bonds between non-adjacent atoms in the main
chain. The three major secondary structures are α-helices, β-sheets and β-turns.
α-Helices are formed through hydrogen bond interactions between moieties from
the same sequence. Side chains are positioned outside the helix in order to reduce
steric hinderance. β-Sheet rearrangements are defined as adjacent strands that are
joined together through hydrogen bonds, the side chains are arranged at right angles
to the sheet to minimise steric issues. The tertiary structure is caused by globular
folding of proteins due to polar peptidic interactions with water and apolar side
chains’ tendency to aggregate minimising contact with polar compounds. Finally,
the arrangement of multiple folded proteins is called quaternary structure.68
In the last few decades, scientific interest in peptide-based drugs has increased
considerably and several therapies have been developed.71 Peptides exhibit some
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problems related to their poor oral bioavailability due to metabolic degradation,
their difficulty crossing the blood-brain-barrier and undesired effects caused by the
interaction of conformationally flexible peptides with receptors.67 The introduction
of peptidomimetics in drug discovery presented beneficial results in view of the fact
that peptidomimetics were able to overcome most of the peptide-based drugs’ issues,
thus becoming a very interesting tool for drug discovery.72 A peptidomimetic can
be considered as a molecule that can mimic or inhibit a specific biological function
of a peptide. They also present some additional advantages compared to peptides:
their specific conformational restrictions can minimise undesired interaction with
non-targeted receptors, and the presence of extra hydrophobic groups and isosters
that substitute the peptide bond enables a better transfer of the peptidomimetic
through the cell. All these features lead peptidomimetics to develop resistance to
proteases, revealing higher activity than peptides.67,72
1.3.2 Peptidomimetic foldamers
In the 1990’s, the synthesis of unnatural oligomers that can mimic proteins secondary
structure was explored, but it was not until 1998 that a clear definition of foldamers
was provided by Gellman. A foldamer was defined as any oligomer that can fold into
a well-defined conformation in solution.73 Foldamers usually have a high molecular
weight and, when in solution, they prefer a globular structure due to noncovalent
interactions between nonadjacent monomer moieties.74 They can be categorised in
two different classes: bio-inspired foldamers and abiotic foldamers. Bio-inspired
foldamers refer to those oligomers that resemble bio-macromolecules such as proteins
and nucleic acids, whereas abiotic foldamers describe all the remaining foldamers
that do not.75
The present study focuses on peptidomimetic foldamers which can mimic pep-
tide substrates of enzymes or peptide ligands of protein receptors which regulate
several biological functions. β-peptides were the first foldamers to be extensively
studied and it was found that this type of foldamer presented antimicrobial proper-
ties.76 Their amphiphilicity allowed these compounds to penetrate bacterial mem-
branes and disrupt them without leading to bacterial resistance, an effect readily
seen with other antibiotics.76 Following this discovery, the use of foldamers has
increased, and they have been adapted for various applications including: (i) molec-
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ular recognition opening a new route for receptor design,77–79 (ii) sensors ("foldamers
switching"),80–84 (iii) enzyme-like catalysts85,86 and (iv) they could open up the way
to the development of new materials, due to their interesting properties.87,88
1.3.2.1 Foldamers based on γ-residues
In the last 20 years, the interest towards the study of foldamers based on unnatural
amino acids increased as well as the use of γ-amino acids as residues in foldamer
synthesis. Hanessian's89,90 and Seebach's91,92 groups were the first ones to present
γ-peptides with one, two or three substituents that are prone to form specific helical
conformations. In 1998, Seebach and co-workers presented a pivotal study, where















Figure 1.10: Oligomer synthesised by Seebach and co-workers which folds into a right
handed helix.92
They discovered that the stability of the helical conformation increased upon
homologation of the residues. Indeed, the synthesised γ-hexapeptide 125, compared
to the α and β peptides, formed 14-membered H-bonding rings between the carbonyl
of residue i and the amide proton of residue i+3 leading to the formation of a right
handed helix (Figure 1.10).92
At the same time, Hanessian and co-workers were working on the synthesis of γ-
peptides derived by homologation of l-Ala and l-Val and they observed that despite
the short length of the peptide, it was already displaying a helical structure. They
also reported that α-substitution of γ-residues can stabilise the helical structure even
further on the condition that the orientation of the α-group is not disrupting the
secondary structure of the main peptide backbone (Figure 1.11).90











































Figure 1.11: Oligomers synthesised by Hanessian and co-workers.90
In 2003, ab initio MO theory was performed to identify the most stable sec-
ondary structures for homogenous oligomers based on γ-amino acids. Hofmann and
co-workers found that periodic structures with 14- and 9-membered ring pseudocy-
cles were the most stable and these results were in agreement with the experimental































Figure 1.12: Possible hydrogen bonding patterns for helices of γ-peptides studied by Hof-
mann and co-workers.93
1.3.2.2 Foldamers based on vinylogous amino acids
Vinylogous amino acids are rigid systems that could be useful for the synthesis of
foldamers. The first synthesis of vinylogous peptides in order to study the secondary



















Figure 1.13: Oligomer synthesised by Hagihara and co-workers that presents features typ-
ical of a secondary structure.94
structure was presented by Hagihara and co-workers in 1992.94 They observed that
vinylogous peptide 132 exhibits important characteristics of well defined secondary
structures (Figure 1.13). Another example of vinylogous peptides was reported in
1997 by Coutrot and co-workers (Figure 1.14).95 They found that trans CH=CMe
groups lead to an open conformer, whereas cis CH=CMe groups induced the forma-
tion of an intramolecualar 9-membered pseudocycle.95
Several further theoretical studies were carried out by Hofmann and co-workers.
In 2003 they performed ab initio MO theory on vinylogous γ-amino acids comparing
them to saturated γ-peptides (Figure 1.15 and Figure 1.16).93 They found that the
introduction of a E double bond into the backbone aids the generation of larger
Figure 1.14: Crystal molecular structures of E and Z oligomers synthesised by Coutrot
and co-workers obtaining intramolecular 9-membered ring pseudocycles for
Z -oligomers.95





















Figure 1.15: E and Z vinylogous oligomers (n = 1, 6) studied by Hofmann and co-
workers.96
H-bonded pseudocycles, such as 19- and 22-membered ring pseudocycles compared
to Z vinylogous γ-peptides which are more stable with 7- and 9-membered ring
pseudocycles (Figure 1.15).96
Indeed, in 2013 Maillard and co-workers synthesized oligomers based on 5-
membered ring constrained γ-amino acids substituted in the γ-position.97 This new
family of ring constrained γ-amino acids exhibited a right-handed 9-helix structure
(so named because of the H-bonds occur in 9-atom pseudocycles, Figure 1.17). These
γ-peptides proved to be stable in organic and in aqueous media, which is a valuable
characteristic for medicinal chemistry applications. Oligomers 136 and 137 were
found to form a tight 9-helix secondary structure in organic solvents. Oligomers


































Figure 1.16: Possible hydrogen bonding patterns for helices of E-133 (ζ = 180°) and
Z -134 (ζ = 0°) vinylogous γ-peptides with the hydrogen bonds formed in
forward and backward direction along the sequence.96




































Figure 1.17: γ-peptides synthesised by Malliard and co-workers that have been found to
form a 9-helix secondary structure.97
solvents and they presented similar NOEs signals confirming that the secondary
structure is maintained even in aqueous media.97
1.3.2.3 α/γ-peptides
Foldamers can control functions that would not be possible in nature.74 The syn-
thesis of this type of unnatural peptides can be designed according to the type of
secondary structure required. γ-Amino acids were chosen as building blocks for the
synthesis of foldamers because lengthening the amino acid backbone chain, the num-
ber of H-bonds that can form within a few residues increases. Oligomers based on a
single monomeric unit have homogeneous backbones and all the examples cited to
date belong to this category. Oligomers with heterogeneous backbones are based on
different monomeric units which alternate (Figure 1.18).
Homogeneous backbones Heterogeneous backbones
Figure 1.18: Simplistic example of homogeneous and heterogeneous backbones.98
This second class of foldamers has proven to be necessary in order to widen
the foldamer repertoire and facilitate their design. In 2005, Anada and co-workers,
synthesised hybrid peptide sequences containing α-, β- and γ-residues. α/γ-peptides
were found to have a 12-helix conformation (Figure 1.19).99

















Figure 1.19: (a) Oligomer synthesised by Anada and co-workers.99
In 2006, Hofmann and co-workers reported that α/γ-peptides present stable
secondary structures and if the hydrogen bonding alternates in forward and back-
ward direction along the sequence the conformation is even further stabilised. The



















Figure 1.20: (a) α/γ-peptides studied by Baldauf and co-workers. (b) Most stable helices
of α/γ-octamers predicted with ab initio MO theory by Hofmann et al.100
Sharma, Kunwar101 and co-workers presented the first study of α/γ-peptides
based on acyclic γ-residues and they reported that these unnatural peptides present
a H12/10-helix conformation. 12/10-helical structures are characterised by alter-
nation of 12- and 10-membered rings H-bonds with different directionality of the
pseudocycles (relative positions of interacting amino acids γ1→ α2/γ1← α4). They
report the first example that confirmed the Hofmann group’s predictions100 of the
secondary structure in α/γ-peptides was correct (Figure 1.21).



























n = 1, 3 n = 2, 3144 145
Figure 1.21: Oligomers synthesised by Sharma, Kunwar and co-workers that fold into
12/10-helices.101
In 2016, Ganesh Kumar and co-workers reported an example of α/γ-hybrid















































































































Figure 1.22: Oligomers synthesised by Ganesh Kumar and co-workers that fold into 12-
helices.
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Single-crystal and solution conformation showed a 12-helix secondary struc-
ture conformation for the designed peptides which contained a Z -vinylogous residue
(Figure 1.23).
Figure 1.23: A) Solution conformations of the α/γ-hybrid peptides 146 and 150, from
left to right. B) An overlay of the X-ray and NMR structures of 150. C) The
X-ray structure of peptide 146, illustrating the non-planarity of the C=C
and C=O bonds (Cβ-Cα-C-O=103°) in the Z -vinylogous residues.102
They found that the calculated dihedral angles of the α/γ-peptides containing
Z -C-C double bond do not match to the theoretical and experimental dihedral angles
of saturated α/γ-peptides proposed by Hofmann and co-workers (Table 1.1).100
Table 1.1: Comparison of the backbone dihedral angles of the Z -vinylogous γ-amino acids
synthesised by Ganesh Kumar and co-workers102 with the theoretical model
presented by Hofmann and co-workers for α/γ-hybrid peptides.100
α/γ-hybrid
12-Helix
φ θ ζ ψ
Theoretical
model
−122±2° 52±2° 62±2° −125±4°
Z -γ-residues −119±4° 100±5° 0±3° −78±4°
α/γ-Vinylogous-peptides are therefore considered a new class of peptides and
to date the study reported by Ganesh Kumar and co-workers is the only example of
heterogeneous peptides containing cyclic vinylogous cis-γ-residues that can be found
in literature.
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1.4 Aims of the Study
Foldamers can fold into specific conformations and they could control several biolog-
ical functions. The general aim of this work was the identification of new unnatural
peptides with specific secondary structures.
The first goal of this thesis was to synthesise novel cyclic γ-amino acid precursors
as valuable building blocks for pharmaceutical purposes and for the synthesis of







Figure 1.24: Generic γ-amino acid precursor.
The aim was to achieve these pharmaceutical tools enantioselectively via
organocatalysis. Then, investigation of the mechanism of studied organocatalytic















Scheme 1.29: Planned intramolecular nitro-Micheal addition reactions.
The last goal was to synthesise and characterise foldamers based on con-
















Organocatalytic Addition for the
Synthesis of γ-Amino Acid Precursors
2.1 Background
Cyclic γ-amino acids have many advantages over acyclic γ-amino acids, they both
mimic the neurotransmitter γ-aminobutyric acid (GABA), however cyclic γ-amino
acids are characterised by a rigid backbone that can be easily functionalised by a
variety of groups. For these reasons they are of interest for use in pharmaceuticals
and for the synthesis of unnatural peptides as described later. Owing to their in-
triguing structure, cyclic γ-amino acids have been of interest to our research group
for some years. Of particular recent interest has been the synthesis of the γ-amino
acid precursor 3-nitrocyclohexane-1-carbaldehyde 151, which would allow access to
the respective γ-amino acid 152 (Scheme 2.1).
Syntheses of 3-aminocyclohexanecarboxylic acids 152 have been reported since















Scheme 2.2: Catalytic hydrogenation to obtain 152 performed by Greenstein and co-
workers.
via hydrogenation of the alkenes 153 using platinum oxide catalyst.103 However, it
was not until 1977 that Johnston and co-workers repeated the synthesis of γ-amino
acids with full stereochemical characterisation.104
In 1981, Allan and co-workers presented an alternative synthetic pathway to
access both cis-optical isomers.105 An allylic bromination of 154 was undertaken
to generate 155. Reaction of this crude product with potassium phtalimide in N -
methylpyrrolidinone yielded 156 as a mixture of isomers, which was then followed by
acid hydrolysis to achieve 157. l or d-othreinine was used to form crystalline salts,
of which 157 gave the resolved phtalimido acids 159 and 161. The targeted enan-
tiomers of 152 were then obtained via a catalytic reduction followed by deprotection











































































> 97% ee162 163 164 165
Scheme 2.4: Synthetic procedure presented by Granja and co-workers for the enantiose-
lective synthesis of 165.
More recently, in 2003, Granja and co-workers presented the synthesis of 165
in three steps.106,107 First, simultaneous reduction of the aromatic ring and the ni-
tro group was performed under H2 atmosphere with Raney Nickel under pressure
at 150 °C. The reaction yielded a selectively specific diastereomer cis, in racemic
form. The amine was then protected with di-tert-butyl dicarbonate in the pres-
ence of N,N -diisopropylethylamine and was recrystallised several times with (R)-
phenylethanamine in order to obtain the protected product 165 in high enantiose-
lectivity (>97% ee, Scheme 2.4).106
In 2006, Hu and co-workers presented an alternative synthesis of cis-152 and
significantly, access to the enantiomerically pure trans-152 (Scheme 2.5).108 Finally,
in the last decade, Newman and co-workers and Karlsson presented an optimised










































Scheme 2.5: Enantiomeric synthesis of trans-152 developed by Hu and co-workers.
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tion using mild and selective conditions which are both important aspects when
considering scale-up preparation.109,110
To date, the synthesis of the nitroaldehyde γ-amino acid precursor 151 has
not been reported in the literature, and thus the development of an organocatalytic
route to afford the γ-amino acid was appealing. Therefore, the initial purpose of
this study was to define an enantio- and diastereoselective synthesis of 151 using
secondary amine catalysts based on work that was started by a previous member
of the group.111 Surprisingly, however, the constitutionally isomeric 5-membered















>19:1 dr, 70% ee
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Scheme 2.6: Aim of the study and observation of the unexpected 5-membered ring as side
product in previous work by the group
A possible reaction mechanism was initially proposed by the group, and is
described in Scheme 2.7.111 According to this hypothesised mechanism, aldehyde
171 condenses with the catalyst to form enamine 176 via the iminium ion. Next,
the initially targeted 6-membered ring 177 is generated. A further tautomerisation
of the iminium ion to the enamine leads to the synthesis of bicyclic compound 181
through the displacement of the nitro group (Favorskii-like rearrangement). Then, a
plausible scenario is that the nitro group nucleophilically attacks the least hindered
position of 181, through the nitrogen lone pair to give intermediate 183 (Path A,
Scheme 2.7). A possible alternative route could be that the oxygen atom of the
ambident nitrite could react with the iminium ion to form intermediate 182, which
































































































Scheme 2.7: Proposed organocatalytic cycle for the synthesis of 173 from terminal nitro
olefin 171.
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cyclopropanes, to produce compound 183 (Path B, Scheme 2.7). Intermediate 183
can then tautomerise to 184, followed by a final hydrolysis that yields product 173
and releases catalyst 172. It was believed that the proposed mechanism was more
likely to occur compared to the [2+2]-mechanism proposed by Blackmond and co-
workers (in red),35,36 owing to the steric demands of 178 and 179. However, there
was no literature precedent for this reaction pathway.
2.2 Aims and Objectives
The aim of this chapter was to investigate the envisaged unprecedented mechanistic
rearrangement observed during a 6-endo-trig organocatalytic intramolecular Michael
addition. This chapter first describes the attempts to reproduce the organocatalytic
synthesis of the 6-membered ring 151, which previously generated the 5-membered
ring 173 as the only observed product (Scheme 2.8). Then, in an attempt to under-
stand the reaction mechanism, synthesis of intermediates, along with in situ NMR






















Scheme 2.8: 6-endo-trig cyclisation assisted by diarylprolinol silyl ether organocatalyst for
the formation of 151 and 173 as a result of a rearrangement.
2.3 Results and Discussion
2.3.1 Synthesis of the terminal nitro olefin substrate
The first synthetic approach to obtain the cyclic 6-membered ring γ-amino acid
precursor involved synthesis of the terminal olefin 171 (Scheme 2.9). This procedure
began with a nucleophilic substitution of ethyl 6-bromohexanoate 185 with sodium
nitrite in 71% yield, followed by reduction of ester 186 to aldehyde 187 in 72% yield.
The aldehyde was then protected to form the acetal 188, which underwent a Henry
reaction to give compound 189 in 78% yield. Elimination of the mesylated primary
alcohol gave the corresponding nitro olefin 190 in 61% yield. A final deprotection
2.3. Results and Discussion 59
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Scheme 2.9: Synthesis of the α-nitro olefin 171
The multiple synthetic steps, combined with the instability of 171 towards silica
made this synthetic route poorly reproducible and, therefore, undesirable, leading
to the design of a new synthetic route.112,113
The second procedure began with the reduction of ethyl 5-bromovalerate 191 to
the aldehyde 192, which was promptly protected to give the acetal 193. However,
the next steps proved more problematic. It was hoped that selenide 197 could
be synthesised from a nucleophilic substitution of bromine with compound 196,
followed by an oxidation with hydrogen peroxide, a concomitant elimination and a
final deprotection of the aldehyde to achieve product 171 (Scheme 2.10).114
The substitution was attempted with three different reaction conditions: (i) in








































Scheme 2.10: Second synthetic procedure to achieve the α-nitro olefin substrate.(i) a)
nBuLi, -78 °C; b) LDA, -78 °C to rt; c) DBU (10 mol%) at rt.
the presence of nBuLi at -78 °C, (ii) with LDA raising the temperature from -78
°C to rt and (iii) with DBU (10 mol%) at rt. In all instances, the reaction failed to
form any product and this might be due to the steric hinderance of the nucleophile.
Due to the more significant issues encountered during the second outlined syn-
thetic plan, the first procedure described in Scheme 2.9 was selected for the synthesis
of the terminal nitro olefin 171.
2.3.2 Organocatalytic 6-endo-trig cyclisation
As already discussed, a previous group member synthesised the terminal nitro olefin
171 with the intention of performing a 6-endo-trig cyclisation, when intriguingly,
the 5-membered ring 173 was the observed product instead of the expected 6-
membered ring 151 (Scheme 2.6).111 Therefore, this organocatalytic Michael addi-
tion was initially repeated here, however, contradictorily to the previous findings, the
6-membered ring 151 was the main product, and only 1% yield of the 5-membered
ring 173 was isolated (Scheme 2.8).
In the presence of the Hayashi-Jørgensen catalyst 53, compound 171 cyclises
to the 6-membered ring with 45% yield and a dr calculated after purification via
flash chromatography of 1:4.5 cis/trans ratio. The diastereomer trans presented
a ee of 6%, whereas the enantioselectivity of the cis diastereomer was not calcu-
lated because of the small amount of isolated material. The low yield compared to
















Scheme 2.11: Intramolecular Michael addition of nitro olefin 171 in the presence of the
Hayashi-Jørgensencatalyst 172
Scheme 2.6 could be due to the formation of compounds between the nitro olefin
171 and the catalyst 172 that did not hydrolyse to the final product, inhibiting
the regeneration of the catalyst. The obtained side products were isolated via flash
chromatography, however, characterisation was not possible due to the presence of
other impurities. The organocatalytic reaction was not optimised because the focus
of the study was the understanding of the observed rearrangement and the isola-
tion of the more appealing 5-membered ring γ-amino acid precursor 173 as will be
discussed in chapter 3.
2.3.3 Identification of rearrangement intermediates
Although we managed to synthesise the 6-membered ring 151, the reaction mech-
anism was still unclear, and therefore required further investigation. Synthesis of
intermediate 151 was undertaken in an attempt to validate the proposed mecha-
nism. The exposure of 151 to the same previous reaction conditions (20 mol% of
Hayashi-Jørgensen catalyst 172, 10 mol% of 3-nitrobenzoic acid and CH2Cl2) would
have validated the proposed mechanism (Scheme 2.8). If the reaction yielded the
5-membered ring 173 as previously found, that would suggest that compound 151
could plausibly be part of the catalytic cycle.
An alternative synthetic strategy to the organocatalytic 6-endo-trig cyclisation
was designed in order to achieve 151 on a larger scale. The first synthetic procedure
is described in Scheme 2.12. Nucleophilic substitution of the bromine in ethyl 4-
bromobutyrate with a nitro group was achieved to afford 199 in 49% yield, followed
by reduction of the ester to the aldehyde 200 in 88% yield. The nucleophilic addition
of compound 201 to the aldehyde 200 yielded 202 in 61% yield, as a mixture of
two different diastereoisomers. Protection of the alcohol of both compounds was
then performed, followed by an oxidation with hydrogen peroxide in order to obtain
compound 204 in 91% yield. The use of caesium carbonate as a base enabled the
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Scheme 2.12: First proposed synthetic pathway for the synthesis of compound 151.
closure of the ring in 76% yield. The reduction of the alkene gave nitroester 206.
This step was found to be problematic, where several methods were attempted, but
only hydrogenation of the alkene 205 catalysed by Pd/C (10 wt%) was found to
be successful leading to the desired product 151 in a 37% yield (Table 2.1). The
reason for these difficulties can be attributed to (i) the conjugation of the double
bond with the electron withdrawing ester, which deactivates the double bond, (ii)
the hinderance of the trisubstituted alkene which keeps the structure very rigid, and
is thus sterically difficult to reach for the reduction, and (iii) the presence of the nitro
group which is also prone to reduction. Due to the difficulties encountered with the
reduction of the α,β-unsaturated ester, an alternative route for this specific reduction
was established (Scheme 2.13). The reduction of the α,β-unsaturated ester 205
with DIBAL-H directly obtained the allylic alcohol 207,115 which was subsequently
oxidised to the aldehyde 208. The organocatalytic reaction was carried out directly
with 208 in the presence of a Hantzch Ester, which was chosen as an in situ reducing
agent of the alkene. Aldehyde 208 was expected to condense with the secondary
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Entry Reagents Solvent T [°C] Time [h] Yieldi [%]
1 H2, Pd/Cii MeOH rt 3 37
2 NaBH(OAc)3 CH3CNiii 0 4.5 0
3 NaBH4 MeOH iii 0 – rt 2.5 0
4 H2, Rh(PPh3)3Cliv THF iii rt 4 d 0





rt - 35 7 d 0
6 Rh(PPh3)3Cl)v ,
PhMe2SiH
THFiii rt - 50 3 d 0
7 Rh(PPh3)3Clvi,
PhMe2SiH
Tolueneiii 80 5 0
(i) Isolated yield. (ii) 10 wt%. (iii) Anhydrous solvent. (iv) 4 mol%. (v) 10 mol%. (vi) 1
mol%.
amine catalyst 172, followed by an in situ reduction of the alkene performed by
the Hantzch ester. The reduced imminium intermediate 177 would then be able to
rearrange to 173. Hantzch esters have been observed to be particularly successful as
reducing agents for example in the presence of Macmillan catalysts.116,117 However,
under the ascribed conditions, the targeted rearranged product 173 was not obtained
(Scheme 2.13).118 The unsuccessful outcome of this experiment can be attributed to
either: (i) inability of the reaction to occur via intermediate 177 or (ii) inefficient
reduction of the alkene by the Hantzch ester having prevented the formation of
151, and therefore prevented the occurrence of the proposed rearrangement. The
bulky group of the Hayashi-Jørgensen catalyst 172 might have hindered the alkene,
preventing the reduction, therefore, it is not possible to determine between the two
possible reasons.
Due to the encountered issue with the Hantzsch ester in situ reduction, a new
synthetic procedure that bypasses the α/β-unsaturated aldehyde reduction was de-
veloped (Scheme 2.14). The new designed strategy involved a lower number of steps
to achieve the nitroaldehyde 151, compared to the one described in Scheme 2.12. A
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Scheme 2.13: In situ reduction of the α,β-unsaturated ester to pursue the targeted
organocatalytic reaction.
single nucleophilic substitution of 1,4-dibromo butane with the organoselenide 201
yielded the bromo-organoselenide 211 in 19% yield. The low yield can be accounted
for the poor selectivity of the reaction due to the presence of the two bromine atoms
of 210, and thus, formation of side products. The oxidation of the organoselenium
compound produced 212 in 55% yield and it was followed by a nucleophilic substi-
tution with sodium nitrite which afforded 213 in 57% yield. Cyclisation was then
performed with caesium fluoride to afford 206 in 56% yield and final ester reduction
with DIBAL-H led to the synthesis of the targeted 6-membered ring 151 in 96%
yield (Scheme 2.14). After the successful synthesis of 151, it was then reacted un-
der the organocatalytic reaction conditions where previously the 5-membered ring
173 was first observed (20 mol% of Hayashi-Jørgensen catalyst 172, 10 mol% of
3-nitrobenzoic acid and CH2Cl2, entry 1 of Table 2.2). Under reaction conditions







































Scheme 2.14: Successful synthetic procedure for the synthesis of compound 151.
where a mixture of both cis and trans of 151, along with 20 or 50 mol% cata-
lyst loading, also varying the co-catalyst loading from 10-25 mol%, no formation
of 173 was observed. The reaction was also attempted with a single diastereomer.
First the cis diastereomer was reacted under the same reaction conditions (20 mol%
Hayashi-Jørgensen catalyst 172, 10 mol% 3-nitrobenzoic acid, CH2Cl2), then the
trans diastereomer was reacted in DMF instead of dichloromethane (Table 2.2). In
both cases, the targeted product 173 was not detected and a mixture of cis and
trans of starting material 151 was recovered. As a result, with the intermediate,
synthesised and unsuccessfully reacted in equivalent reaction conditions, it is still
unclear whether the 6-membered ring 151 is an intermediate of the reaction and
further investigation is needed to address this issue.
2.3.4 1,2-nitro shift
As discussed previously, the proposed catalytic cycle could not be confirmed via
the synthesis of the hypothesised intermediate 151. The subsequent generation of
the 5-membered ring 173 as product of an intended 6-endo-trig cyclisation was
still ambiguous. Several test reactions were attempted to reproduce the observed
rearrangement and to understand the reasons behind the 5-membered ring 173 for-
mation (Table 2.3). The terminal nitro olefin 171 was reacted with 20 mol% of
Hayashi-Jørgensen catalyst 172, 10 mol% 3-nitrobenzoic acid, in CH2Cl2 to deter-
mine the yield of the 5-membered ring 173. The formation of 173 was compared
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to the percentage of internal nitro olefin 214 present in the starting material and it
was found that, even in absence of impurities, the 5-membered ring 173 was formed
(Entry 6 and 7 of Table 2.3), suggesting that the initially proposed catalytic cycle
was plausible (Scheme 2.7).
Interestingly, a 5-exo-trig reaction with the internal nitro olefin 214 under the
same adopted conditions (20 mol% of Hayashi-Jørgensen catalyst 172, 10 mol% 3-
nitrobenzoic acid, in CH2Cl2) led to prompt formation of the 5-membered ring 173.
This suggested that a 1,2-nitro shift of the substrate from the terminal nitro olefin
171 to the internal nitro olefin 214 might occur. The formation of the internal nitro
olefin 214 was hypothesised to derive from the mesylation and elimination step of













Scheme 2.15: Mesylation of the alcohol 189 to the nitro olefin 190.
study was performed and the internal nitro olefin was not identified.
This suggests that a 1,2-nitro shift probably occurred during work up and pu-



























20 10 CH2Cl2 0
2 cis and
trans
50 25 CH2Cl2 0
3 cis 20 10 CH2Cl2 0
4iv trans 20 10 DMF 0
(i) Hayashi-Jørgensen catalyst 172. (ii) 3-nitrobenzoic acid. (iii) Determined by 1H NMR
spectroscopy. (iv) In the presence of H2O (100 mol%).
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1 rt 280 min 18 4
2 rt 10 days 2 <5iii
3 rt 70 min 18 10
4 0 5 days 18 10
5 rt 60 min 18 22
6 rt 180 min 0 <5%iii
7 rt 90 min 0 <5%iii
(i) Percentage of terminal olefin 214 calculated via 1H NMR spectroscopy as side product.
(ii) Isolated yield. (iii) Yield determined by crude 1H NMR spectra. (iv) Yield determined by
1H NMR spectra of fractions containing a mixture of 6-membered ring 151 and 5-membered
ring 173.
rification over silica gel of the crude nitro olefin 190 leading to a mixture of terminal
nitro olefin 171 and internal nitro olefin 214 that were difficult to separate via flash
chromatography. Table 2.3 presents syntheses of the 5-membered ring 173 under
various reaction conditions, with differing quantities of the internal nitro olefin 214
as starting material impurity during the intramolecular cyclisation of the terminal
nitro olefin 171. Despite higher yields of the 5-membered ring 173 being obtained
when the starting material contained a higher percentage of the internal nitro olefin
214, the nitroalkane 173 was also identified when the starting material was pure
(Table 2.3).
In an attempt to rationalise the formation of the 5-membered ring 173 from pure
starting material 171, further 1H NMR studies were performed. The 1,2-nitro shift
was not observed when the terminal nitro olefin 171 was left in CDCl3 or in CH2Cl2
and 3-nitrobenzoic acid (10 mol%) in absence of the Hayashi-Jørgensen catalyst
172. A 1H NMR study of protected terminal nitro olefin 215 in the presence of
the Hayashi-Jørgensen catalyst 172 (20 mol%) and 3-nitrobenzoic acid (10 mol%)
in CD2Cl2 was then performed (Figure 2.1). Figure 2.1(b) displays the increase
2.3. Results and Discussion 68
in concentration of the protected internal nitro olefin 216 over time. Figure 2.1(c)
shows the overlap of 1H NMR spectra of the monitored reactions. The characteristic
peak of the internal alkene proton is shown and increases with time. 3% of nitro
olefin 216 is formed in 3 days at room temperature, despite the protection of the
aldehyde.

































Figure 2.1: (a) 1,2-nitro shift of 215 to 216 occurring in the presence of catalyst 172. (b)
Plot of the integral, which is proportional to the concentration, of the inserted
nitro olefin 214 with time. (c) In situ monitored reaction 1H NMR spectra
overlap. The spectra are zoomed in on the dt of the characteristic alkene
proton which is highlighted in red.
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A mechanism has already been proposed for this specific rearrangement.119–123
Prochazka and co-workers reported in 1971 the mechanism of isomerisation of nitro
olefins, where they use triethylamine as base.119–121 The latter can abstract the β-
proton from the nitro olefin, forming the 3-membered ring intermediate, and the
conjugated acid. The formation of the internal nitro olefin is then followed and a


















Scheme 2.16: Leseticky and co-workers mechanistic proposal for the isomerisation of nitro
olefins.
Of particular note, only 3% of the internal olefin 216 is formed after 3 days
when the aldehyde is protected. This suggests that in the presence of the catalyst the
aldehyde plays a significant mechanistic role, possibly condensing into the secondary
amine, and a concerted mechanism might occur promoting the 1,2-nitro shift. This
would explain the previously observed much faster formation of the 5-membered
ring 173 when the aldehyde is unprotected.
2.4 Conclusion
In this chapter, the synthesis of the terminal nitro olefin 171 has been optimised
with a 17% yield over 6 steps. A preliminary study of a 6-endo-trig cyclisation for
the final synthesis of γ-amino acid precursor 151 containing a 6-membered ring in
45% yield, has been reported. Interestingly, the 5-membered ring γ-amino acid pre-
cursor 173 was observed only as a side product (<5% yield) during a 6-endo-trig
cyclisation (Scheme 2.17). A preliminary mechanistic study to understand the rear-
rangement observed during a organocatalytic 6-endo-trig cyclisation of nitro olefins
was performed (Scheme 2.8). Synthesis of a possible 6-membered ring intermediate
151 was accomplished and was tested under the same reaction conditions where
the rearrangement was observed. However, the expected rearrangement to the 5-
membered ring 173 was not observed under the catalytic conditions, therefore was























Scheme 2.17: 6-endo-trig cyclisation assisted by diarylprolinol silyl ether organocatalyst
for the formation of 151 and 173 as a result of a rearrangement.
nitro olefin 214 cyclised promptly to the 5-membered ring 173, therefore a 1,2-nitro
shift of the terminal nitro olefin 171 to the internal nitro olefin 214 was then pro-




Figure 2.2: Internal nitro olefin 214.
173 was also obtained from pure nitro olefin 171, therefore a 1H NMR study was
performed and it was found that a 1,2-nitro shift of the protected terminal nitro
olefin 215 to the protected internal nitro olefin 216 was observed. Only 3% of the
protected internal nitro olefin 216 was formed in 3 days suggesting the importance of
the free aldehyde in the rearrangement (Figure 2.1). To conclude, a concerted mech-
anism of the secondary amine catalyst 53 with the nitro olefin substrate 171 could
be hypothesised to rationalise the formation of the 5-membered ring 173 during the
initally expected 6-endo-trig cyclisation.
2.4.1 Future work
Further studies would be necessary to demonstrate if a concerted rearrangement of
the terminal nitro olefin 171 to the afforded 5-membered ring 173 is part of the
catalytic cycle. Computational and further NMR studies could give a preliminary
understanding of a possible concerted mechanism. An optimisation of the envisaged
enantio- and diastereoselective 6-endo-trig reaction should be performed to develop
an organocatytic route to the novel 6-membered ring nitro-aldehyde 151.
Chapter 3
Organocatalytic access to
cis-5-membered ring γ-amino acid
precursors via a 5-exo-trig
Intramolecular Michael Addition
3.1 Background
During the study of 6-endo-trig cyclisation, it was observed the generation of the
5-membered ring 173 that might have resulted from a rearrangement of the terminal










Scheme 3.1: Nitro olefin 171 and 5-exo-trig cyclisation of nitro olefin 214 to the γ-amino
acid precursor 173.
felt it was important to investigate the 5-exo-trig intramolecular Michael addition
of nitro olefin 214 assisted by organocatalysis.
Synthesis of cyclic γ-amino acid precursors is extremely interesting for phar-
maceutical purposes and as building blocks for the synthesis of foldamers (chapter
1). Particularly interesting is the synthesis of cis-173 since it has proven difficult
in the past. To date, only Ley and co-workers reported in 2002 the synthesis of an












-10 °C to rt
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Scheme 3.2: Synthesis of the 5-membered ring cis-γ-amino acid 174 developed by Ley and
co-workers. PLE = pig liver esterase
only 10% ee (Scheme 3.2).124 In this study, a desymmetrisation of the meso-diester
219 with polymer-supported pig liver esterase on Eupergit® was performed.
In 2008, Enders and co-workers presented an organocatalytic asymmetric
domino reaction to achieve the 5-membered ring α-substituted γ-amino acid pre-
cursors.125 From the substrate scope, it was apparent that the smaller the R group,
the greater the diastereoselectivity towards the trans diastereomer and vice versa
with larger substituents, albeit with lower yields (Table 3.1).
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Table 3.1: Substrate scope of an organocatalytic domino reaction of aldehydes 223 and

















(a-e) (a-e)223 224 225




225a Me 2 62 66:34 94, 96
225b Et 4 59 13:87 60, 97
225c iPr 7 40 1:99 -, 93
225d nPr 4 45 10:90 59,97
225e nBu 4 41iii 11:89 -, 97vi
(i) Reaction conditions: 2 mmol 224, 5 eq. aldehyde 223, 20 mol% catalyst, and 100
mol% PhCO2H at rt in 4.0 mL DMSO. (ii) Combined yield of separable diastereomers. (iii)
Determined by GC analysis. (iv) Determined by HPLC analysis on a chiral stationary phase
on the corresponding aldehyde 225 except 225e. (v) Yield after reduction of the aldehyde
to the alcohol (NaBH4, MeOH, 0 °C). (vi) Determined by HPLC analysis of alcohol 225e
on a chiral stationary phase.
In 2013, Gellman and co-workers reported an asymmetric synthesis of the
5-membered ring 226.126 A Michael addition of nitromethane to cyclopentene-1-
carboxaldehyde aided by the Hayashi-Jørgensen catalyst 53 was performed to af-
ford the trans diastereoisomer in >19:1 dr, high yields and high enantioselectivity
(Scheme 3.3).





















    40 psi H2
    MeOH, rt
2. Boc2O, 
   iPr2EtN
   CH2Cl2, rt
3. H2Cr2O7
    acetone





Scheme 3.3: Synthesis of trans-5-membered ring γ-amino acid precursors performed by
Gellman and co-workers.
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membered ring γ-amino acid precursors.127 A modified procedure inspired by Gell-
man and co-workers was created with the aim of using it in manufacturing. Catalyst
loading as low as 1 mol% was used maintaining high enantioselectivity.
3.2 Aims and Objectives
The aim of the study was to design an enantio- and diastereoselective synthesis of
cis-γ-amino acid precursor 226 and their analogues assisted by organocatalysis. This
chapter first describes the optimisation of the targeted 5-exo-trig cyclisation, which
is then followed by a mechanistic investigation. In situ NMR studies, identification
of kinetic profiles, enantioselective and computational studies were performed and











Scheme 3.4: 5-exo-trig cyclisation for the final synthesis of 174.
3.3 Results and Discussion
The present work focused on the optimisation of a 5-exo-trig cyclisation assisted by
organocatalysis to achieve the desired 5-membered ring γ-amino acid precursor 173.
Synthetic routes to obtain nitro olefin 214 were designed in order to perform the








Scheme 3.5: 5-exo-trig cyclisation for the synthesis of the aldehyde 173.
3.3.1 Synthesis of the internal nitro olefin 214.
Two different procedures were explored for the synthesis of nitro olefin 214. The
first procedure began with the nitration of the double bond of ethyl 6-heptenoate
228 via a radical process followed by the reduction of the ester to the aldehyde 214
with DIBAL-H.128 This synthetic procedure lead to the targeted product with a
















Scheme 3.6: First synthetic procedure for the synthesis of nitro olefin 214.
22% yield over two steps (Scheme 3.6).
In order to achieve the internal nitro olefin 214 with less impurities a different
procedure was designed. First, an oxidation of cyclohexene 230 was performed with
ozone at -78 °C, followed by a methylenation. A nitration of the double bond of
232 and deprotection of the acetal 233 achieved the final product 214 in 13% yield
over the four steps. The second procedure avoided the synthesis of impurities and
racemic cyclised product which were difficult to separate from the nitro olefin 214.
It was speculated that these were obtained as a result of the DIBAL-H reaction and
purification on silica. However, the first procedure presented a higher overall yield






























Scheme 3.7: Second synthetic procedure for the synthesis of nitro olefin 214.
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3.3.2 Preliminary optimisation for the synthesis of the γ-amino acid
precursor 173.
Once the substrate was synthesised a catalyst screen at room temperature was per-
formed. At first, the investigation was carried out at room temperature without any
further reduction as a provisional study. This method led to the synthesis of the
trans diastereomer 173 as main product of the reaction.






































































Figure 3.1: Selected catalysts to perform a preliminary screen at rt.
Diastereoselectivity and enantioselectivity were not reported where yields were
considerably low and the obtained results were not significant for the optimisation
of the reaction. Bifunctional catalysts 238, 239 and 240 were synthesised according
to literature procedures.129,130 A preliminary catalytic screen was performed with
the reaction catalysed by the Hayashi-Jørgensen catalyst 53 reaching completion in
20 minutes, in 62% yield, with a 1:4 cis/trans diastereoselectivity and a –59% ee of
the major diastereomer. The cis diastereomer and was confirmed later in the study

















Figure 3.2: (a) Synthesis of the ester 241 to identify relative stereochemistry. (b) X-ray
crystal structure of 241 (CCDC: 1947228).
with a crystal structure (Figure 3.2).
The same reaction was performed in the presence of an acid co-catalyst (3-nitro
benzoic acid) at rt and at 0 °C. In both cases, yields, diastereoselectivity and enan-
tioselectivity improved to 94% and 98% yield with a 1:9 and 1:13 dr and –62% and
–71% ee respectively (Entry 2 and 3 of Table 3.2). The yield was improved further
with the use of bifunctional catalyst 29 and this is probably due to a lower amount
of impurities forming (Table 3.2). As with catalyst 53, repeating the reaction at 0
°C with tetrazole catalyst 29 the dr improved to 1:7, which suggests that at lower
temperature the cis diastereomer is more likely to be isolated. Several other sec-
ondary amine catalysts and bifunctional catalysts were tested (Table 3.2), however
all with limited success in terms of ee and dr.
Interestingly, Hayashi-Jørgensen-CF3 catalyst 234 produced a 1:2 dr in favour
of the trans product with mismatched enantioselectivity between the cis and trans
diastereomers. This indicates that the formation of the two diastereomeric products
may occur via different intermediates and a more in depth study of the mechanism
is discussed later in this chapter.
Primary amine catalyst 235 was screened alongside benzoic acid as co-catalyst
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1 53 0.3 rt 62 1:4 -59
2 53iv 0.5 rt 94 1:9 -62
3 53iv 0.5 0 98 1:13 -71
4 29 1.5 rt 91 1:8 72
5 29 9.5 0 74 1:7 79
6 51 2.5 rt 67 1:2 6
7 6 0.7 rt 67 1:9 -7
8 234 120 rt 67 1:2 15v
9 85 2.5 rt 54 1:7 -59
10 237 72 rt 26 1:1 ND
11 235vi 144 rt 11 1:2 -22
12 236 18 rt 51 1:5 85
13 238 16 rt 50 1:3 63
14 239 19 rt 70 1:3 61
15 240 96 rt 41vii 1:6 88
(i) Combinatorial isolated yield of separable diastereomers. (ii) Determined by crude 1H
NMR. (iii) Determined by HPLC analysis on a chiral stationary phase. (iv) In the presence
of 3-nitrobenzoic acid (10 mol%) as co-catalyst. (v) -70% ee for cis diastereomer. (vi) In the
presence of benzoic acid (10 mol%) as co-catalyst. (vii) Yield of single trans diastereomer
because the cis diastereomer was not separable from impurities.
to aid the enamine formation and hydrolysis as reported in literature (Table 3.2).131
However, the reaction presented 1:2 dr and –22% ee of trans-173 and only 11% yield
after 6 days, which is probably due to the slow rate of hydrolysis of the iminium
intermediate impeding the catalytic cycle to complete (Entry 11, Table 3.2).
Catalysts 238 and 239 gave moderate to good yields, moderate enantioselectiv-
ities (entry 13 and 14 of Table 3.2) and 1:3 dr. The inclusion of a primary amine and
thiourea moiety within the same catalyst (236 and 240) led to high enantioselec-
tivity (entries 12 and 15 of Table 3.2). The reaction catalysed by 240 achieved the
best results from the catalyst screen and was used for further optimisation studies.
Mild and strong acids were tested as additives to the reaction, however all led
to a reduction in diastereoselectivity and enantioselectivity (Table 3.3).
A different strategy was therefore outlined to optimise the enantioselective syn-
3.3. Results and Discussion 80




















1 - 96 41iv 1:6 88
2 Benzoic
acidv
7 47vi 1:4 57









5 43vi 1:2 45
6 TFA 7 23vii 1:1.5 40
7 3-NBA 6 44 1:1.5 37
(i) Combinatorial isolated yield of separable diastereomers. (ii) Determined by crude 1H
NMR. (iii) Determined by HPLC analysis on a chiral stationary phase. (iv) ) Yield of
single trans diastereomer. (v) Co-catalyst loading of 10 mol%. (vi) Yield of single trans
diastereomer because product cis was obtained together with not easily separable impurities.
(vii) The reaction did not go to completion.
thesis of the 5-membered ring 173. This initial study was valuable to deepen our
understanding of the targeted reaction and to select the best catalysts for further
investigations. The enantioselectivity of cis-173 was not recorded during this first
preliminary study apart from entry 9 of Table 3.2 because it was obtained as minor
diastereomer (cis-173) with poor yields. Having focused on the synthesis of the
trans diastereomer in the first part of the study, the project moved on to target the
synthesis of the cis diastereomer.
3.3.3 Asymmetric synthesis of cis-γ-amino acid precursor 226.
In the past, cis-γ-amino acid precursors have proven to be difficult to synthesise
enantioselectively and only one example has been reported in literature as previously
mentioned (Scheme 3.2).124 The study of the 5-exo-trig cyclisation at rt led to the
identification of the best catalysts for further optimisation of the cis-nitroalcohol 226
synthesis. Five catalysts out of the catalyst screen performed at rt were selected to
test at lower temperature followed by an in situ reduction in order to isolate cis-226
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OH1. Catalyst (20 mol%), 0 °C
2. NaBH4, MeOH, 0 °C
214 226




1 53 1 57 1:1 87iv , -27
2 29 14 62 2:1 -83iv , 71
3 51 96 5v 1:1 ND, ND
4 85 72 42 1:6 -68, -74
5 240vi 104 6 1:1.5 -95, ND
(i) Combinatorial isolated yield of separable diastereomers. (ii) Determined by crude 1H
NMR. (iii) Determined by HPLC analysis on a chiral stationary phase. (iv) Determined by
AD-H HPLC chiral column. (v) The reaction did not go to completion.(vi) The reaction
was carried out at rt.
(Table 3.4). The reactions were carried out at 0 °C except from the reaction catalysed
by 240, which was performed at rt due to slow reactivity (Table 3.4). Catalyst 240
gave the highest ee for cis-226 albeit with a long reaction time, low yield and dr.
Catalyst 53 and 29 produced the best results in terms of yields, diastereoselectivity
and enantioselectivity and therefore were selected for further investigation.
Interestingly, opposite enantiomers can be selectively obtained using either the
Hayashi-Jørgensen catalyst 53 or the 5-pyrrolidin-2-yltetrazole catalyst 29 (entry 1
and 2 of Table 3.4). The reason behind this outcome can be associated to the differ-
ent mechanism of reaction of the two catalysts. The Hayashi-Jørgensen catalyst 53
controls the enantioselectivity of the reaction via the steric hinderance of the bulky
TMS group. Although more in depth mechanistic studies conducted independently
by Blackmond, Seebach, Hayashi, Pápai and Pihko revealed that intermediates of
the reaction might influence the stereoselectivity (chapter 1).34,35,37,40,132–137 In con-
trast, the tetrazole catalyst 29 behaves as a bifunctional catalyst and the actrac-
tive nature of the tetrazole group, rather than the repulsive hinderance, affects the
enanantioselectivity.25,138,139
Temperature control of the reaction was unsurprisingly an important aspect of
diastereoselecitivity. Temperature plays an important role as cis-226 is the kinetic
product and can only be isolated at low temperature after in situ reduction to the
corresponding alcohol, since the cis diastereomer tends to convert to the more sta-
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OH1. Catalyst (20 mol%)
2. NaBH4, MeOH
214 226






1 53 -20 5 20iv 1:1 36, 53
2 53 -10 3 64 1:1 -86, -26
3 29 -20 22 62 3:1 82, 22
4 29 -10 22 68 1:1 83, 67
(i) Combinatorial isolated yield of separable diastereomers. (ii) Determined by crude 1H
NMR. (iii) Determined by HPLC analysis on a chiral stationary phase. (iv) The reaction
did not go to completion.
ble thermodynamic product trans in the presence of the secondary amine catalyst.
Each diastereomer may be formed from different mechanisms which may explain the
different enantioselectivities of the two diastereomers. A more in depth mechanism
discussion is presented later in this chapter. The organocatalytic reaction was tested
at 0, -10 and -20°C with catalysts 53 and 29 (Table 3.4 and Table 3.5). The use of
tetrazole catalyst 29 at -20°C achieved the highest dr ; a solvent screen was therefore
performed with this catalyst. The intramolecular Michael addition was tested with
different solvents, but only chlorinated solvents led to good diastereoselectivity and
excellent enantioselectivity (Table 3.6). Protic and polar solvents such as methanol
and THF (entry 4 and 6, Table 3.6) were found to have a detrimental effect on yield
and enantioselectivity of the reaction and this can be associated to the coordination
of the solvent to the tetrazole moiety interfering with the protonation step which
might be crucial for the reactivity and the selectivity of the reaction. Interestingly,
performing the reaction in dichloroethane gave the best results in terms of dr and ee
(entry 7, Table 3.6). Dichloroethane might reduce the rate of the reaction by stabil-
ising one of the two competing transition states for the cis and trans diastereomers.
This process can lead to the selective synthesis of the cis diastereomer, considerably
shifting the dr towards the synthesis of the intended cis diastereomer.140,141
The solvent screen was then followed by another co-catalyst screen. In the pres-
ence of an acidic co-catalyst, such as entry 1 and entry 2 of Table 3.7, the diastere-
oselectivity shifted towards the synthesis of trans-226 as the main diastereomer.
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1 CH2Cl2 22 62 3:1 82, 22
2 Toluene 24 57 3:1 70, 32
3 CH3CN 25 54 1:1 65, 56
4 THF 24 52 1:1 50, 38
5 CHCl3 20 68 3:1 79, 48
6 MeOH 26 11 1.5:1 -10, ND
7 DCE 50 53 7:1 85, 54
(i) Combinatorial isolated yield of separable diastereomers. (ii) Determined by crude 1H
NMR. (iii) Determined by HPLC analysis on a chiral stationary phase.
Basic co-catalysts on the other hand favoured the production of cis-226 albeit in
low yields (Table 3.7). This type of co-catalyst might promote the formation of side
products, reducing the efficiency of the reaction. The next step for the optimisation
of the 5-exo-trig intramolecular Michael addition was the concentration screen. As


























48 53 1:2 78, 80
2 3-NBA 48 68 1:5 70, 82
3 Acetic acid 77 54 2:1 86, 62
4 Catechol 48 47 N.A.v 74, 41
5 TEA 20 25 4:1 -26, ND
6 Dimethyl-
piperazine
48 18 2.5:1 7, 5
(i) Combinatorial isolated yield of separable diastereomers. (ii) Determined by crude 1H
NMR. (iii) Determined by HPLC analysis on a chiral stationary phase. (iv) The reaction
did not go to completion.(v) The dr cannot be calculated via NMR.
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Table 3.8: Concentration screen of the 5-exo-trig cyclisation.




1 0.2iv 42 58 6:1 83, -
2 0.05 168 74 8.5:1 93, -
3 0.1 48 66 6:1 89, -
4 0.2 50 60 5.5:1 88, -
5v 0.1 72 60 5.5:1 91, -
6vi 0.05 168 51 4:1 85, 45
(i) Combinatorial isolated yield of separable diastereomers. (ii) Determined by crude 1H
NMR. (iii) Determined by HPLC analysis on a chiral stationary phase. (iv) The reaction
was carried out with anhydrous solvents. (v) The reaction was reduced with DIBAL-H. (vi)
Cold addition of a solution of substrate (2m in DCE) to the reaction mixture.
expected, yield improved considerably from 58% to 78% when diluting the reaction
from 0.2m to 0.05m and this is possibly due to the suppression of side reactions, like
nitro olefin polymerisation, which might occur at higher concentrations.142,143 The
diastereoselectivity also increased which can be explained by the fact that at lower
concentrations the epimerisation of the product cis-226 to the trans-226 occurs at
a lower rate of the reaction. Interestingly, we can also notice an improvement of the
enantioselectivity for cis-226 probably due to a reduced self-aggregation phenomena
of the catalyst which can lower the efficiency of the catalyst.144,145
A catalyst loading screen was performed to complete the reaction optimisation
and it was found that the reaction maintains comparable results when using cata-
lyst loading as low as 5 mol% (Table 3.9). Low catalyst loading is an important
achievement for organocatalysis and it is likely that the reaction catalysed by 2
mol% catalyst would give higher yield if the reaction was carried out in larger scale
due to encountered solubility issues (entry 5, Table 3.9).












1 0.1 10 70 64 7:1 89, 26
2 0.1 5 168 52 11.5:1 88, 0
3 0.05 10 24 74 9:1 92, 34
4 0.05 5 168 75 10:1 89, -56
5 0.05 2 168 43 10:1 92, -11
(i) Combinatorial isolated yield of separable diastereomers. (ii) Determined by crude 1H
NMR. (iii) Determined by HPLC analysis on a chiral stationary phase.
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3.3.3.1 Scale up of the reaction
The optimisation of the 5-exo-trig cyclisation assisted by the bifunctional tetrazole
catalyst 29 produced the desired cis-nitroalcohol 226 in high yield, good diastereos-
electivity and excellent enantioselectivity. The reaction was then successfully scaled
up to 7 mmol and it was stopped after 99 hours instead of 168 hours producing
analogous results (Table 3.10). It is believed that the amount of starting material
left in solution is not reacting as fast as in the first 4 days and this might be due to
the high concentration of the competing product 173 formed that tends to condense
again with the catalyst in order to convert to the more stable trans-173. A more
in depth discussion about the diastereoselectivity degradation is presented later in
this chapter.






























1 0.64 20 168 74 8:1 93
2 0.64 5 168 75 10:1 89
3 7.0 5 99 74 9:1 92
(i) Combinatorial isolated yield of separable diastereomers. (ii) Determined by crude 1H
NMR. (iii) Determined by HPLC analysis on a chiral stationary phase.
3.3.3.2 Substrate scope
The optimised conditions were tested with different substrates to prove the generality
of the reaction for the synthesis of the desired cis-5-membered ring nitroalcohols.
First, several α-substituted nitro olefins were synthesised according to Scheme 3.8.
The synthesis was performed in 4 steps. An oxidation of cyclohexene was performed
with ozone to form the aldehyde 231 in quantitative yield. A Henry reaction was
carried out to synthesise the nitro alcohol 242, which was followed by an elimination
to achieve the corresponding nitro olefin 243. The acetal deprotection was the final
step to achieve the aimed nitro olefins. α-Substituted nitro olefins 244a-e were


















































Scheme 3.8: Synthetic procedure to afford α-substituted nitro olefins.
achieved in yields between 15-23% over four steps. Henry reactions are known to
produce low yields and instability of acetals in silica gel might have caused even
lower yields. The main problem during the synthesis of α-substituted nitro olefins
was the uncontrolled deprotection of the aldehyde during the purification on flash
chromatography on silica gel and the immediate cyclisation of part of the nitro
olefin to the racemic 5-memberered ring 245.112,113 The synthesised substrates were
tested with the optimised organocatalytic conditions for the synthesis of the cis-5-
membered ring 245 (Scheme 3.8). The reactions were not as successful as expected
O
HO2N
1. Catalyst               (20 mol%)












Scheme 3.9: α-substituted nitro olefins synthesised for the substrate scope of the 5-exo-trig
cyclisation.
















a R=Me 33% yield
b R=Et 28% yield
c R=Pro 27% yield







Scheme 3.10: Synthesis of ketones 249a, 249b and 249c.
as no product was isolated. Therefore, the reactions were repeated at 0 °C and at
rt, but comparable results were reported. The reason for this outcome might be
explained because of the substitution on the α-position to the nitro group.
Ketones have also been tested. Methyl, ethyl and propyl ketones were syn-
thesised in 3 steps following the procedure described in Scheme 3.10. First, ethyl
6-hexenoate 246 was converted to the Weinreb amide 247, followed by a Grignard
reaction to obtain the respective ketones in quantitative yields. Then, the olefin was
oxidised to a nitro olefin with a radical nitration reaction obtaining ketones 249a,
249b and 249c in 33%, 28% and 27% yield over the three steps. The intramolec-
ular cyclisation was performed with all three ketones at -20 °C and in the absence

























9%, 1:2 dr 
cis 87% ee
trans -55% ee








Scheme 3.11: Ketones substrate scope.


































DCE, 70 °C HCl (1N) 




Scheme 3.12: Synthesis of substrate 255.
reaction was repeated at rt with the addition of an acidic co-catalyst to facilitate
the condensation of the catalyst into the substrate. The rate of the reaction was
still low and the reaction was stopped after 7 days for the methyl ketone 249a and
8 days for the ethyl and propyl ketones 249b and 249c (Scheme 3.11). Methyl
ketone 250a was the only one that produced a moderate yield of 56% and 1:1 dr,
whereas substrates 250b and 250c presented a much lower yield and 1:2 dr with a
higher formation of the trans diastereomer. The reason for lower yield and diastere-
oselectivity in favour of trans diastereomer for ethyl and propyl ketones 250b and
250c can be accounted for the steric hinderance of the substitutents reducing the
bifunctionality of the catalyst.
A substrate with a nitrogen embedded in the substrate structure was also syn-
thesised in four steps as shown in Scheme 3.12. A nuclephilic substitution of di-
ethoxyethylamine to 4-bromobut-1-en 251 in the presence of potassium carbonate
at 65 °C was carried out in order to achieve the amine 252 in 68% yield. The

















Scheme 3.13: Nitrogen embedded substrate organocatalysis.
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taining 253 in 81% yield. Then, a nitration of the olefin was performed achieving
254 in 54% yield, which was then followed by an aldehyde deprotection with acetic
acid and 1m HCl at 0 °C to achieve the targeted substrate 255 in 40% yield. The
reason of the low yield of the deprotection might be due to a high reactivity of this
substrate and to the instability of this compound on silica as the acetal can depro-
tect and induce a racemic intramolecular cyclisation which could be aided by the
mild acidic conditions of the silica. The reaction was carried out under the same
optimised reaction conditions for nitro olefin 214. The reaction presented 1:1 dr
and 48% yield. The ee of the 5-membered ring cis-256 is -77% whereas the ee of
trans-256 is 14% (Scheme 3.13). This can be explained by the fact that the reac-
tion should undergo the same mechanism described for substrate 214, leading to a
high enantioselective cis-product and a less enantioselective trans-product. A full
discussion of the mechanism is presented later in this chapter.
A substrate containing an aromatic ring was synthesised to finally achieve an
enantioselective indane derivative. The dihydrobenzyofuran 259 was first enantio-


















4-nitrobenzoic acid (10 mol%)











Scheme 3.14: Enantio- and diastereoselective synthesis of the dihydrobenzofuran 259 per-
formed by Tang and co-workers.
In contrast to the literature precedent, the current work presents the synthe-
sis of a bicyclic compound in absence of any heteroatom adopting the optimised
methodology for the selective synthesis of cis diastereomers.
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Substrate 265 was synthesised via a 5-step route (Scheme 3.15). The first step
was an oxidation of 1,2-dihydronaphthalene (260) with ozone, followed by an in
situ reduction to compound 261. The benzylic alcohol was than selectively oxidised
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Scheme 3.15: Synthesis of the indane derivative precursor.
to the aldehyde 262 in order to perform a Wittig reaction to achieve the olefin
263. The alcohol moiety is then oxidised to the aldehyde 264, followed by the
final nitration of the olefin with silver nitrite and TEMPO. The designed synthesis
of the nitro olefin 265 was achieved with an overall yield of 29% over the 5 steps
(Scheme 3.15). The organocatalytic intramolecular Michael addition was performed
using optimised conditions. The indane derivative 266 was achieved in 72% yield,
with 1:1 dr, 90% ee for cis-266 and 52% ee for trans-266 (Scheme 3.16).
Assignment of diastereomers of the synthesised substrates was performed by
comparison of 1H NMR splitting patterns of protons on the methyl next to the
nitro group (ABX systems). It is possible to observe a regular pattern between
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Scheme 3.16: Organocatalytic reaction for the synthesis of the indane derivative 266.
3.3. Results and Discussion 91
in resonance frequencies then the trans δνABcis » δνABtrans as shown in Figure 3.3.
The difference of δνAB is related to the magnetic field generated by the electrons
moving in their orbitals caused in the first place by the external field. The different
orientation of the groups generates a magnetic field that shields the external field
in different ways therefore it is possible to discriminate between the two isomers
without further degenerative derivatization.147–149
Figure 3.3: Stacked 1H NMR spectra showing the peaks of the protons highlighted in blue
of the respective substrates and the different δν for cis- and trans-products.
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3.3.4 Mechanistic study of the 5-exo-trig cyclisation
The optimisation of the 5-exo-trig cyclisation assisted by the secondary amine tetra-
zole catalyst 29 was previously described. Owing to the observed diastereoselectivity
degradation, a mechanistic study was performed to understand and optimise further
the target 5-exo-trig reaction.
3.3.4.1 Kinetic study
A kinetic study was carried out in order to investigate the progress of the reaction
and to have a better understanding of the mechanism of the reaction (Scheme 3.17).
The optimised 5-exo-trig organocatalytic reaction was carried out in a NMR tube
in a 0.1m solution of the substrate in CD2Cl2 and in the presence of 5 mol% of 5-

















Scheme 3.17: 5-exo-trig organocatalytic cyclisation studied via in situ NMR spectroscopy.
at -20 °C and then at 0 °C, but in both cases the reaction rate was still very low and
the catalyst was not soluble enough in solution without stirring. Therefore, temper-
ature was raised to 25 °C in order to study the kinetic profile of the reaction. As
already discussed, increase in temperature influenced the cis:trans ratio conversion,
however in situ monitoring of the reaction provided a general understanding of the
kinetic profile of the reaction for further optimisation. Figure 3.4 shows the kinetic
profile of the studied 5-exo-trig cyclisation until full consumption of the starting
material 214. The concentration of starting material (in blue) decreases whereas
the concentration of cis-173 and trans-173 increases (respectively in red and green)
with different reaction rates. The reaction was analysed in the first 2 hours of the
reaction to interpolate the functions of the different lines in order to determine the
initial rate of the reaction for the two diastereomers (1.4 x 10−2 mol L−1 s−1 for the
cis and 3.0 x 10−3 mol L−1 s−1 for the trans, Figure 3.5). The rate of the reaction
for the synthesis of the cis diastereomer was significantly faster than the reaction
rate for the trans diastereomer.
After 7 h with complete conversion of the starting material, the formation of cis
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Figure 3.4: Progress of reaction until consumption of starting material.
diastereomer decreases, whereas an increase of the trans concentration is observed
(Figure 3.6(a)). The reason for this outcome can be accounted for the stability of
cis and trans diastereomers in presence of the catalyst once the starting material
has been all consumed. The cis is the kinetic product and therefore less stable than
the trans, which is the thermodynamic product. With time, diastereoselectivity
degradation occurs and figure 3.6(a) displays the reduction of the cis concentration
and a rise of the trans concentration. In particular, in figure 3.6(b) it is possible to
observe that once the concentration of the starting material is low, the concentration























[S] : y = 0.1223 - 0.03415 x 
R2 = 0.9857
[cis] : y = - 0.006763 + 0.01434 x 
R2 = 0.9923
[trans] : y = - 0.001037 + 0.002976 x 
R2 = 0.9818
Figure 3.5: Progress of the reaction up to 1.84 hours in order to define the rate of the
reaction.
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of material observed in Figure 3.6(b) can be accounted for intermediate species and
impurities probably due to the polymerisation of the nitro olefin 214 that were not
identified.















































Figure 3.6: (a) Plot of concentration of cis- and trans-173 with time once the starting ma-
terial was completely consumed.(b) Plot of concentration of starting material,
cis- and trans-173 normalised to 0.1.
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The ratio cis/trans was analysed together with the concentration of the start-
ing material normalised to 100 so that the ratio of the two diastereomers is easily
comparable to the progress of the reaction and at the concentration of the starting






























Figure 3.7: Plot of [cis]/([cis]+[trans])vs time to study the ratio of formation of cis-173
and trans-173 in comparison with the progress of the reaction. The concen-
tration of the starting material was normalised to 100 in order to compare the
different species during the progress of the reaction.
At first, both diastereomers are formed even if the concentration of the cis is
still higher then the trans. Then, there is an increase on the production of cis-173
up to a maximum at 2.62 h. The decline in the rate of formation of cis-product
is likely to be linked to the decrease in the concentration of substrate present. In
contrast to the beginning of the reaction, the catalyst at this point could condense
into both product 173 or substrate 214 thus slowing down the formation of the
cis-product.
In conclusion, the preliminary kinetic profile of the 5-exo-trig cyclisation catal-
ysed by 29 highlights the fact that to isolate the product with the hightest ratio of
cis diastereomer, the reaction must be stopped before full consumption of starting
material and a decrease of temperature might reduce diastereoselectivity degrada-
tion that accelerates as soon as the concentration of product is higher than the
concentration of starting material.
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3.3.4.2 Kinetic profiles of reactions catalysed by MacMillan and Hayashi-
Jørgensen catalysts
The determination of the kinetic profile of the 5-exo-trig cyclisation catalysed by the
bifunctional tetrazole catalyst 29 led to a general understanding of the reaction. The
comparison of the obtained results with kinetic profiles of the same intramolecular
reaction catalysed by other catalysts could provide significant information about the
efficacy of the chosen tetrazole catalyst 29 for the synthesis of the cis-5-membered
ring 226. A preliminary kinetic study of the 5-exo-trig cyclisation was performed
with Macmillan and Hayashi-Jørgensen catalysts. A 0.1m solution of substrate 214
in CD2Cl2 was reacted respectively with 5 mol% of catalyst 85 and 53 and the
reaction was monitored in situ at 25 °C to achieve cis- and trans-173 (Scheme 3.18).
The reaction was also performed in larger scale at rt and at 0 °C and the results were






















Scheme 3.18: Kinetic study performed at 25 °C and monitored in situ by 1H NMR spec-
troscopy.
performed in the presence of Macmillan catalyst 85 did not go to completion in 12
hours. The highest concentration of the cis diastereomer was formed during the first
hour of the reaction and then it slightly decreased over time. The trans was the main
product of this reaction and the initial reaction rates are 3.4 x 10−3 mol L−1 s−1 for
the cis formation and 4.4 x 10−3 mol L−1 s−1 for the trans formation (Figure 3.8).
The reaction catalysed by Hayashi-Jørgensen catalyst 53 went to completion
in 4 hours (Figure 3.9). The concentration of the starting material decreases in
a linear way, which could be associated to a 0th order of the reaction. However,
at 60.3 minutes the concentration of substrate is shifted from the expected linear
trend and this could be related to the autocatalytic effect of the product formed.














































cis: y = 0.003352 x + 0.001493
R2 = 0.7948





Figure 3.8: Kinetic profile of the 5-exo-trig cyclisation catalysed by Macmillan catalyst
85.
The concentration of the nitro alkane formed is at this point of the reaction high
enough that the acidic protons in α-position to the nitro group could behave as
acidic co-catalyst, accelerating the reaction as reported by Burés and co-workers for
a similar nitro-Michael addition.132 Diastereoselectivity degradation is also observed
in the presence of the Hayashi-Jørgensen catalyst 53 at a much higher rate than for
catalysts 29 and 85, especially once the concentration of the substrate is lower than
the concentration of the products (Figure 3.9). The rate of the reaction for cis- and
trans-173 formation are respectively 3.4 x 10−4 mol L−1 s−1 and 2.5 x 10−4 mol
L−1 s−1.
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[S] : y = 0.1006 - 0.0006268 x 
R2 = 0.9802
[cis] : y = 0.0001422 + 0.0003383 x 
R2 = 0.9936






Figure 3.9: Kinetic profile of the 5-exo-trig cyclisation catalysed by Hayashi-Jørgensen
catalyst 53.
In summary, the kinetic profiles of the same reaction catalysed by different sec-
ondary amine catalysts (29, 85 and 53) exhibit different reactivity between the three
cases. All studied reactions presented a higher concentration of cis diastereomer at
the beginning of the reaction but only the reaction catalysed by 5-(pyrrolidin-2-yl)-
1H-tetrazole (29) maintains a high concentration nearly to the end of the reaction.
The reaction catalysed by the Hayashi-Jørgensen catalyst 53 shows a similar rate
of cis and trans production, however a drastic diastereoselectivity degradation is
observed as soon as the starting material concentration is lower than the concentra-
tion of the cis and trans product, whereas the reaction catalysed by the Macmillan
catalyst 85 presents a fast conversion of the cis diastereomer to the most stable
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trans.
3.3.4.3 Enantioselective study
An investigation on diastereoselectivity degradation was performed. One of the
reasons that could lead to the conversion of cis- to trans-product could be assigned

















Scheme 3.19: epimerisationmechanism from cis to trans diastereomer.
In this case the proton α to the carbonyl has a pka of ∼ 15 and it is likely
that once the product is formed and the concentration of the substrate is lower than
the concentration of the product, the catalyst can condense again into the formed
cyclic aldehyde and promote the epimerisationto the more stable trans-product.
A retro-Michael reaction could also hypothetically occur because of the acidity of
the protons in the α-position to the nitro group, promoting the opening of the cycle
again. The following cyclisation could lead to the more stable thermodynamic trans-
product 273, however the opening of the cycle to 272 would make accessible all four
enantiomers (Scheme 3.20).
In order to gain a better understanding of the mechanism of the reaction, an
enantioselective study was performed (Table 3.11). The reaction was carried out
under the same reaction conditions used for the NMR kinetic study at rt in CH2Cl2






























270 271 272 273
Scheme 3.20: Retro-Michael reaction mechanism leading to the conversion of the cis di-
astereomer to the trans one.
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    CH2Cl2 (0.1M), rt
(1R,2S) -(1S,2S) -
(1R,2R) -
t1 : er 90:10
t2 : er 85:15
t1 : er 72:28
t2 : er 83:17
t1 : dr 1:1
t2 : dr 1:9
 (5 mol%)





Entry Time [h] Yield [%] dr
(cis/trans)
ee – cis[%] ee –
trans[%]
1 2 62i 55:45 80 43
2 23 64 11:89 70 66
mL out of 28.7 mL of the reaction mixture was transferred in to a separate flask and
the reaction was reduced in situ with NaBH4 at 0 °C to afford 226 in 62% yield, 1:1
dr, 80% ee for the cis diastereomer and 44% ee for the trans diastereomer. The rest
of the reaction mixture was left stirring at rt for 23 hours and then reduced in situ to
achieve 226 in 64% yield. Diastereoselectivity degradation to 1:9 dr in favour of the
trans was then observed. Enantioselectivity diminished to 70% ee for the cis-226
and raised to 66% ee for the trans-226. Examining the ratio of the four enantiomers
during and after the reaction, one can notice a redistribution driven by thermody-
namics converting both cis-products to their respective C1-epimeric trans-products
(Figure 3.10). The normalised concentration to 100 of each enantiomer was calcu-
lated at two different times (2 h and 23 h from beginning of the reaction) and it was
possible to observe that the major (1S,2R)-cis-enantiomer concentration decreased
as much as the major (1R,2R)-trans-enantiomer increased. In a similar manner
the minor (1R,2S)-cis-enantiomer decreased in concentration as much as the mi-
nor (1S,2S)-trans-enantiomer increased (Figure 3.10). Change of stereochemistry of
only one chiral centre led to an increase of enantioselectivity of the trans-product
and a decrease of enantioselectivity of the cis-product. As a consequence, the over-
all impression given is that the trans-adduct becomes increasingly enantioenriched
as more of the corresponding cis-adduct epimerises to it. On the other hand, the



























cis = 80% ee
trans = 60% ee
cis = 44% ee
trans = 66% ee
Figure 3.10: Concentration of the four enantiomers normalised to 100 at 2 and 23 h in
order to exhibit the corresponding change of concentration of enantiomer
(1R,2S)-cis-173 to (1S,2S)-trans-173 and of enantiomer (1S,2R)-cis-173 to
(1R,2R)-trans-173.
decrease of enantioselectivity of the cis-enantiomer can be explained by the fact that
the high difference of concentration of the two enantiomers leads to the epimerisa-
tion in greater quantities of the major (1S,2R)-cis enantiomer, likely via 1st order
kinetics, and ultimately adversely effecting the er of that system. Theoretically, a
retro-Michael reaction could also lead to the conversion of cis-enantiomers to the
more thermodynamically favoured trans-enantiomers (Scheme 3.20). Interestingly,
however, this study shows that the enantiomeric ratio of the trans-product is not
maintained as one would expect if this were the case, but instead undergoes an
enantioenrichment (Figure 3.10).
To conclude, epimerisation at C2 could be considered the major cause for the di-
astereoselectivity degradation, however we cannot exclude a scenario where epimeri-
sation and, at a less significant level, retro-Michael reaction are both occurring.
3.3.4.4 Mechanistic Proposal Assisted by a Computational Study
The 5-exo-trig cyclisation under investigation was also analysed from a mechanistic
point of view. Different enantioselectivity and reaction rates for the synthesis of
cis and trans diastereomers suggest that the two diastereomers might be formed
from two different intermediates following two different organocatalytic cycles. A
mechanistic proposal is outlined in Scheme 3.21. First, the secondary amine catalyst
29 could condense into the aldehyde 214 forming the iminium ion 214a. Then,
following path A, the tautomerisation of the iminium ion to the enamine would
form transition state 214b, followed by the CC bond formation step to form the
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CB intermediate 214d. The protonation step would be the next following step that
allows the opening of the oxazine oxide ring (OO) leading to the 5-membered ring
iminium intermediate 214f and the release of the cis-173 product regenerating the
free catalyst 29. Path B would go via a similar mechanism, however the iminium
ion 214a would tautomerise to the different CC bond transition state 214b. The
following formation of an oxazine oxide intermediate OO 214e instead of the CB
would be expected because of trans conformers would lead to a twisted and unstable
four membered ring. The protonation step would then allow the opening of the






















































































































Scheme 3.21: Proposed organocatalytic cycle for the synthesis of cis- and trans-173.
The double cycle could explain the different enantioselectivity of the two di-
astereomers, therefore, in collaboration with Rosta and co-workers, a computational
study was performed to investigate further the proposed mechanism of the 5-exo-trig
cyclisation.150–152 Calculated energies and Gibbs free energies were obtained at the
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ω-B97X-D/6-311G(d,p) level of theory.
The study focused on the CC bond formation and on the protonation step
in view of the fact that condensation of the catalyst into the aldehyde and final
hydrolysis of the catalytic intermediate have already been extensively studied and
























Figure 3.11: Possible intermediates after the CC bond formation.
bach, Hayashi,34 Blackmond,27,28,35,36 Wennemers,38 Pihko and Papái37,40 in studies
performed with the Hayashi-Jørgensen catalyst (chapter 1), there are three interme-
diates the addition step can result in (Figure 3.11). In a moderately polar solvent
such as DCE, the zwitterionic structure 214c is thermodynamically unfavoured.
The formation of a four-membered ring (214d) in a trans-configuration is rendered
impossible due to extreme ring strain, while it is found to be rather stable in the cis-
path, (although the applied level of theory might overestimate its stability). Thus
the oxazine oxide (OO) 214e intermediate is left the sole option in the trans-path,
as shown in Scheme 3.21. A free energy profile at -20 °C was obtained (Figure 3.12).
The CC bond forming step favoured the major (1S,2R)-cis-enantiomer with high
enantioselectivity, whereas the protonation step favoured the major (1S,2S)-trans-
enantiomer with low enantioselectivity. The free energy profile at -20 °C shows that
the transition states for the CC bond forming step and the protonation step have
similar energies, suggesting that the stereochemistry of the reaction is determined
by both states. Experimental observations suggest that the computational model
overestimates the barrier of the protonation step, which is likely to be due to the
thermochemical correction and different molecularity. Thus, we assume that the
initial selectivity is determined in the CC bond forming step and altered by the
epimerisationdiscussed before. The obtained results suggest that the relative value
of the two TS is heavily influenced by the entropy correction, thus uncertain, there-






































148214 214b 173214d 214e 214e
‡214b‡
Figure 3.12: Free energy profile at -20 °C.
fore computation might overestimate the energy barrier height of the protonation
step. In contrast with the free energy profile, electronic energy and solvent corrected
electronic energy profiles at -20 °C were performed and it was found that the free
energy of the transition states of the protonation step were much lower than those
found in the free energy profile, exhibiting results that are in line with the experi-
mental data as the major (1S,2R)-cis-173 is the favoured enantiomer at -20 °C. The
significant difference in free energy for the TS of the protonation step confirms that
the computational experiments might overestimate the free energy of the TS of the
protonation step (Figure 3.13(a)).
TS for the CC bond forming step were then determined showing that the tetra-
zole moiety is always involved in the reaction thus confirming the bifunctionality
of the catalyst (Figure 3.14). The energy of CB 214d and OO 214e intermediates
for each enantiomer were then calculated. The CB trans configuration results in a
high energy twisted 4-membered ring rendering this unavailable in the trans paths,
whereas the OO intermediate is possible for all diastereomers, although less stable
than the CB in the cis structures. The formation of CB and OO intermediates is
then followed by the protonation step. TSs for this final step were also identified.






































































148214 214b 173214 214e 214e‡214b
‡
(b)
Figure 3.13: (a) Electronic energy profile at -20 °C; (b) Solvent corrected electronic energy
profile at -20 °C.
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Figure 3.14: Transition states for the CC bond forming step.
The protonation step to form the hemiaminal product 214g can occur in two ways.
Either the oxygen of the water molecule undergoes a nucleophilic attack on the
iminium carbon, which is unlikely since in abundant intermediates the centre does
not bear a positive charge, or the water protonates the nitronate moiety ultimately
breaking the oxazine oxide ring 214e formed as intermediate. The latter scenario is
favoured by the assistance of the tetrazole ring acting as a Brønsted acid to stabilise
the transiently forming hydroxide anion. Interestingly, the protonation step favours
the trans products, because the ring configuration enables a more concerted set of
bonds forming and breaking as depicted in Figure 3.15. The relative free energies
of the transition states of the aforementioned steps are close to each other. Due
to the involvement of the water in the second step, the thermodynamic corrections,
Figure 3.15: Transition states for the protonation step.
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introduced as Grimme’s qRRHO,153 increase the uncertainty of the comparison of
these steps, possible overestimating the barrier of the protonation step (chapter 6).
The free energy profile was also obtained at rt and it was observed that changing
the temperature, results in a change to the energy barrier of the protonation step
(Figure 3.16). Nevertheless, the temperature dependence of the qRRHO term of
the protonation transition state is considerably higher than the that of the first step






































148214 214 173214d 214e 214e‡214b
‡
Figure 3.16: Free energy profile at 25 °C.
3.4 Conclusion
An initial catalyst screen at rt led to the understanding that the diastereoselectivity
could be temperature controlled and a more detailed optimisation at lower temper-
ature followed by an in situ reduction, guided the study to the isolation of the more
unstable and more difficult to achieve cis-γ-amino acid precursor 226. The reaction
was then scaled up to 7 mmol and using only 5 mol% of the catalyst the targeted
asymmetric product 226 was achieved in 74% yield with 9:1 cis/trans ratio and
92% ee. A substrate scope was carried out to prove the generality of the reaction.
However, α-substituted nitro olefin substrates were unable to perform the intended
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5-exo-trig cyclisation under the optimised conditions probably because of their sub-
stitution in α-position to the nitro group (Scheme 3.9). Different types of ketones
were tested as alternative substrates, but only the methyl ketone 250a presented
significant results which confirmed that the bifunctional function of the catalyst is
essential for the efficiency of the reaction (Scheme 3.11). Synthesis and cyclisation
of nitrogen containing substrate 255 afforded 256 in 46% yield (Scheme 3.13). Fi-
nally, an indane derivative was also obtained in good yield (73%), 1:1 dr and good
ee (-70% ee) for the cis diastereomer (Scheme 3.16). The project then focused on
the understanding of the mechanism of the 5-exo-trig reaction. A kinetic study was
performed and it was possible to see that the highest concentration of cis-173 can
be isolated before the complete consumption of starting material as the diastereose-
lective degradation is accelerated when the concentration of starting material is low.
The kinetic profile of the reaction catalysed by tetrazole catalyst 29 was compared
with the kinetic profile of reactions catalysed by the Macmillan catalyst 85 and
the Hayashi-Jørgensen catalyst 53. All studied reactions exhibited higher concen-
tration of cis than trans diastereomer at the beginning of the reaction which then
decreased with associated increased concentration of the trans diastereomer. This
observation suggested that the control of diastereoselectivity degradation is crucial
to efficiently isolate the cis product. An enantioselective study was also performed
to gain a deeper understanding of the observed diastereoselectivity degradation and
the agreement between the different changes in concentration of the four enantiomers
proves that retro-Michael reaction is less likely compared to the epimerisation pro-
cess. A computational study then confirmed a proposed double catalytic cycle and
it was found that the rate determining step of the reaction might be able to change
with temperature, which is extremely interesting in order to control the selectivity
in the synthesis of different enantiomers.
3.5 Future work
This chapter describes a new methodology developed for the synthesis of cis-
enantioselective γ-amino acid precursors. In the future the reaction could be per-
formed in flow to develop an even more efficient isolation of the cis product. Proline
and indane derivatives were synthesised using the developed methodology. The next
steps would be the final synthesis of their respective γ-amino acids, 274 and 275
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The selection of constrained residues can lead to specific secondary structures, which
might affect the biological function. More recently, research has focused on the syn-
thesis of foldamers based on constrained cyclic-γ-residues to achieve a higher control
of the secondary structure. Gellman and co-workers presented several studies where
α/γ-peptides based on cyclic γ-residues were synthesised.126,154–157 In 2009, they
presented a synthesis of γ-amino acid residues containing a cyclohexyl constraint
on the Cβ-Cγ and a variable side chain at Cα. The enantio- and diastereoselective
γ-residue was coupled with d-α-amino acid residues to achieve the heterogeneous
tetramer 276 and hexamer 277 (Figure 4.1). The X-ray crystal structure of the
synthesised foldamers showed a 12-helical secondary structure, which was also con-








































Figure 4.1: α/γ-Peptides 276 and 277 synthesised by Gellman and co-workers.
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Figure 4.2: From left to right, X-ray crystal structure of tetramer 276 and hexamer
277.154
In 2012, Gellman and co-workers built foldamers based on 6-membered ring γ-
residues constraint on the Cα-Cβ. Heterogeneous foldamers were generated by the
combination of γ-residues with d-Ala or l-Ala respectively for the oligomers based
on trans or cis residues (Figure 4.3).157 They compared α/γ-peptides based on
cis- and trans-γ-residues, interestingly the peptide based on cis-residues revealed a
strong helix-propensity forming 12-helices (278 and 279), whereas peptides based on


































Figure 4.3: α/γ-peptides based on the cis- and trans-6-membered ring moieties synthesised























Figure 4.4: α/γ-peptide based on trans-6-membered ring residues and d-Ala synthesised
by Giuliano and co-workers.156
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In 2014, Gellman and co-workers proved that the introduction of a substituent in
the γ-position can give higher control of the secondary structure leading to helical
conformations even in peptides based on trans-6-membered ring γ-residues (Fig-
ure 4.4).156 α/γ-Peptide 282 was found to fold into 12/10-helices.156
They then synthesised heterogeneous foldamers based on trans-γ-residues
(1R,2R)-2-aminomethyl-1-cyclopentane carboxylic acid (AMCP, 227) and d-Ala.126
Enantio- and diastereoselective synthesis of trans-5-membered ring residues was un-
dertaken via an organocatalysed Michael addition which produced trans-227 in high
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trans- trans-283 226 227
Scheme 4.1: Synthesis of the trans-227 performed by Gellman and co-workers.126
With this study, they concluded that α/γ-peptides 285 and 286 moderately
populate 12/10-helical conformations as well as other conformations, suggesting that
this type of peptide do not display a tendency to adopt a specific secondary structure
(Scheme 4.2).126 In spite of the previous studies demonstrating that different residue
isomers can lead to different conformational structures,156,157 they only focused on






























Scheme 4.2: α/γ-peptides based on trans-5-membered ring residues and d-Ala achieved
by Gellman and co-workers.126
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4.2 Aims and Objectives
Owing to difficulties found in the isolation of the enantioselective (1S,2R)-2-
(nitromethyl)cyclopentane-1-carboxylic acid (cis-AMCP 287),125,126 syntheses of
foldamers based on cis-5-membered ring γ-amino acid building blocks have not been
previously explored (Figure 4.5). After the development of the enantio- and diastere-
oselective synthesis of the 5-membered ring cis-γ-amino acid precursor 226 described
in chapter 3, the aim of this chapter was the synthesis of foldamers based on cis-
AMCP 287 residues. Herein a discussion of synthesis and structural characterisation




Figure 4.5: Cis-AMCP-γ-residue subject of this study.
4.3 Results and Discussion
4.3.1 Synthetic procedure
Nitroalcohol cis-226 synthesised using the organocatalytic procedure described in
chapter 3 was oxidized to carboxylic acid 288 in 92% yield. Alanine was chosen
as α-residue to couple with γ-units to synthesise heterogeneous γ/α-peptides in a
similar manner to those presented by Gellman and co-workers for the synthesis of
oligomers based on trans-AMCP-residues.126
Both nitro-dimers with d-Ala (289) and with l-Ala (290) were synthesised






















92% yield226 288 289
Scheme 4.3: Synthesis of the nitro-dimer 289.
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The carboxylic acid 288 was coupled with d-Alanine benzyl ester to afford
the nitro-dimer 289 in 34% yield (Scheme 4.3), and with l-Alanine benzyl ester
p-toluenesulfonate salt to achieve the nitro-dimer 290 in 43% yield (Scheme 4.4).
OHO2N
HH
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Scheme 4.4: Synthetic procedure for the synthesis of α/γ-peptides 292, 294 and 295.
However, comparing the oligomer based on the 5-membered ring with oligomers
based on a cis-6-membered ring unit157 and performing preliminary structural pre-
dictions using ChemDraw 3D software, l-Ala was considered more suitable for the
synthesis of oligomers with a well defined secondary structure, therefore only the
synthesis of these types of foldamers were pursued.156 The nitro group of the nitro-
dimer 290 was reduced to the amine and then protected to afford the dimer 292 in
58% yield.
Instead of generating α/γ-peptides, γ/α-peptides were synthesised.126 This syn-
thetic choice was carried out taking into account that cis-AMCP moieties are prone
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to epimerisation at the C-terminus as previously shown in chapter 3. It is reported
that α-amino acids tend to epimerise at the C-terminus under peptide coupling
conditions and for this reason Gellman and co-workers deprotected the acid moiety
on the γ-residue. The hypothesised intermediate that leads to the epimerisation is
an oxazolone formed after the activation of the carboxylic acid. Activations of the
carboxylic acids for the synthesis of the α/γ-peptide 298 and the γ/α-peptide 302























































292 296 297 298
299 300 301 302
Scheme 4.5: (i) activation, (ii) cyclisation. (a) Possible epimerisation mechanism for the
activation of the α-residue. (b) Possible epimerisation mechanism for the
activation of the γ-residue.
The activation of the carboxylic acid on the γ-residue might lead to the forma-
tion of a 7-membered ring which is enabled by Baldwin rules in a similar manner to
the formation of the 5-membered ring and therefore it might lead to the epimerisa-
tion of AMCP residues (Scheme 4.5).158,159 As a result the coupling was performed
by deprotecting the acid moiety of the α-residue. This was believed to create less
epimerisation in comparison to the deprotection of the γ-unit. The minimal amount
of opposite diastereomer formed by the epimerisation of l-Ala residue was easily
separated by flash chromatography. Furthermore, HOBt and EDCI were chosen as
coupling reagents in order to minimise the epimerisation process.
Following the coupling with l-Ala, a reduction of the nitro group of 290 pro-
duced amine 291 in quantitative yield which was then protected to achieve dimer
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292 in a 58% yield (Scheme 4.4). γ/α-Peptide 292 was then deprotected on the acid
moiety to give 293 and then coupled with the free amine 291 to obtain tetramer
294 in 25% yield over the last three steps. Finally, the amine of tetramer 294 was
also deprotected and coupled with the free acid 293 to achieve hexamer 295 in 20%
yield (Scheme 4.4). The decreased yield of coupling with increased chain length can
be accounted for the epimerisation on the C-terminus of l-Ala yielding to different
diastereomers of the oligomer.
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4.3.2 Structural characterisation of the synthesised γ/α-peptides
4.3.2.1 X-ray Crystallography
The stereochemistry of the dimer precursor 290 was confirmed by X-ray crystallog-
raphy (Figure 4.6). The single crystal was obtained after slow evaporation at 4 °C











Figure 4.6: X-ray crystal structure of compound 290.
Dimer 292 was also crystallised with slow evaporation at 4 °C in a mixture
of CHCl3 and heptane (v/v 1:3). The length of the crystallised γ/α-oligomer 292
was still too short to observe any H-bonds, therefore the crystal structure’s dihedral
angles were compared to those obtained from the computational study, which will










Figure 4.7: X-ray crystal structure of α/γ-peptide 292 (CCDC: 1947227).
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4.3.2.2 γ/α-Peptides NMR characterisation
Structural characterisation of γ/α-oligomers 294 and 295 was performed using 1D
and 2D NMR spectroscopy (COSY, TOCSY, ROESY, HSQC and HMBC), however
chemical shift overlap prevented the assignment of ring protons of 295.
NOEs cross peaks of γ/α-peptide 294 were poor. This may be related to the
short length of the peptide which prevents it from folding. However, 294 based on
cis-γ-residues exhibits a higher number of H-bond interactions than the correspond-
Table 4.1: 1H NMR spectra and δ (ppm) for the characterisation of α/γ peptide 294
































AMCP(1) 2.73 2.54 3.33 2.69 6.10 -
l-Ala(2) 4.19 1.41 - - 6.08 -
AMCP(3) 2.71 2.87 3.62 2.79 8.31 -
l-Ala(4) 4.52 1.45 - - 8.11 -
Benzyl - - - - - 5.23
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ing oligomer based on trans-γ-residues (Table 4.1 and Figure 4.8).160 γ/α-Peptide
294 showed two downfield amide peaks (δ > 7 ppm) in contrast with same length
oligomer based on trans-γ-residues reported by Gellman and co-workers, which pre-
sented only one amide peak just above 7 ppm (Scheme 4.2).126 The different outcome
for the two different oligomers may be accounted for the different stereochemistry
of the γ-residues influencing the oligomers conformation.
Figure 4.8: Overlap of TOCSY (red) and ROESY (blue) 2D NMR spectra for the assign-
ment of the sequential residues of γ/α-peptide 294. The spectra were recorded
at rt, in a 0.2 mm solution in CDCl3 (600 MHz).
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The residues of γ/α-oligomer 295 were also identified via 2D NMR spectroscopy.
First, l-Ala (6) was identified via HMBC NMR: the benzylic carbonyl was assigned
via a cross peak with the benzylic methylene; the carbonyl then would also dis-
play another cross peak with the HC[α] (6) confirming the assignment of l-Ala (6)
residue. The rest of the consecutive assignments were done via ROESY cross peaks
of the HC[α](i) with the NH (i+1) of the following residue (Table 4.2 and Figure 4.9).
Table 4.2: 1H NMR spectra and δ (ppm) for the characterisation of α/γ peptide 295





































AMCP(1) 2.73 2.6 3.38 2.61 6.38 -
l-Ala(2) 4.29 1.44 - - 6.01 -
AMCP(3) 2.74 2.95 3.60 2.48 8.90 -
l-Ala(4) 4.03 1.39 - - 8.54 -
AMCP(5) 2.82 2.95 3.61 2.80 8.51 -
l-Ala(6) 4.48 1.41 - - 8.64 -
Benzyl - - - - - 5.24
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It is possible to observe that four out of the six amide peaks are displayed at chemical
shifts > 7.0 ppm, characteristic sign of H-bonded protons (Figure 4.9).160
Figure 4.9: Overlap of TOCSY (red) and ROESY (blue) 2D NMR spectra for the assign-
ment of sequential residues of the γ/α-peptide 295. The spectra were recorded
at rt, in a 0.2 mm solution in CDCl3 (600 MHz).
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4.3.2.3 Aggregation control experiment
An aggregation control experiment was conducted on hexamer 295 to prove there
was no self-association and confirm that the downfield detected amide peaks are due
to intramolecular interactions rather than intermolecular interactions. 1H NMR of
γ/α-peptide 295 was measured in CDCl3 at different concentrations (0.04mm – 4
mm). This experiment displays the amide peaks at the same chemical shifts for all
different concentrations, which confirms the fact that the downfield NH peaks are due
to intramolecular H-bonds, rather than intermolecular H-bonds (Figure 4.10).126,160
The experiment was conducted on the longest oligomer that was synthesised (295),
which is also the one that presents a more defined secondary structure.
Figure 4.10: 1H NMR spectra (400 MHz) in CDCl3 of the γ/α-peptide 295 at 0.4, 0.1, 1,
2 and 4mm concentration for an aggregation control experiment.
4.3. Results and Discussion 123
4.3.2.4 NOEs cross peaks for secondary structure designation
Structural NMR characterisation was performed using ROESY NMR analysis. Ro-
tating frame nuclear Overhauser Effect Spectroscopy (ROESY) is a spectroscopic
technique employed to study the stereochemistry of molecules in solution. ROESY
technique was utilised instead of NOESY because of the nature of the synthesised
peptides. ROESY is preferred to NOESY for medium size molecules (MW range
700-1200 Da) whose rotational correlation time falls in a range where the nuclear
overhauser effect is too weak to be detectable. NOE signals are positive for small
molecules (MW < 600 Da), negative for large molecules (MW > 1200 Da) and zero
for medium sized molecules.161,162 This technique has been used to identify the dis-
tance between atoms that couples to each other in the same molecule. The average
distance between Hγ1 and Hγ2 of the AMCP residues was known from literature
and used as reference. Then, the distance of all the other identified cross peaks were
defined (Table 4.3) and then compared with cross peaks of 12/10-helices reported in
the literature by Sharma, Kunwar, Gellman and co-workers, which are listed below
together with the strength of the observed cross peaks:101,126,156
I HC[α] of [α]-residue (i) to NH of [α]-residue (i + 2) strong and medium
II NH of [γ]-residue (i) to NH of [α]-residue (i+ 1) medium and weak
III HC[γ] of [γ]-residue (i) to NH of [α]-residue (i +1)
IV HC[α] of [α] residue (i) to HC[α] of [γ]-residue (i +1) weak
V NH of [γ]-residue (i) to HC[α] of [α]-residue (i +1)
The observed cross peaks for γ/α-peptide 295 are shown in Table 4.3. Char-
acteristic peaks of 12/10-helical structures for α/γ-peptides101,126,156 (relative posi-
tions of interacting amino acids γ1→α2/γ1← α4)100 I, II and IV were identified and
highlighted in bold (Table 4.3) suggesting that the proposed 10/12-helical structure
for γ/α-peptides(α1 → γ2/α1← γ4)100 is the most populated conformation for the
γ/α-oligomer.101,126,156 Like Gellman, interaction III was not observed,126 however
the observation of interaction IV might be one reason why we do see a more ordered
structure. In addition, the different sequencing might have led to different NOE
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NOE cross peak NMR distance Å Designation
NH (1) - HCα (2) 4.95 weak
α (1) - NH (2) 2.38 strong
HCα (1) - HCα (2) 4.28 weak
HCβ (1) - NH (2) 3.42 medium
HCβ (1) - HCα (2) 4.68 weak
NH (1) - Hβ (3) 3.90 weak
NH (1) - Hγ''(3) 4.20 weak
HC1'(1) - HCγ''(3) 3.91 weak
HCα (2) - HCα (3) 4.28 weak (IV)
HCα (2) - HCβ (3) 4.27 weak
HCα (2) - HCγ''(3) 5.33 weak
HCα (2) - NH (4) 3.47 medium (I)
HCα (2) - HCβ (4) 2.99 strong
HCβ (3) - NH (3) 4.09 weak
NH (3) - NH (4) 3.46 medium (II)
HCα (3) - NH (4) 2.68 strong
HCα (3) - HCα (4) 4.30 weak
HCγ'(3) - HCα (4) 5.1 weak
HC1'(3) - HCα (4) 5.03 weak
HCβ (3) - HCα (5) 3.27 medium
HCγ''(3) - HCα (5) 2.62 strong
HC3''(3) - HCα (5) 3.25 medium
HCα (4) - NH (5) 2.48 strong
HCα (4) - HCβ (5) 2.96 strong
HCβ (4) - HCγ'(5) 4.27 weak
HCα (4) - NH (6) 3.47 medium (I)
HCα (4) - HCα (5) 3.96 weak (IV)
NH (5) - NH (6) 3.79 weak (II)
HCα (5) - NH (6) 2.58 strong
HCβ (5) - NH (6) 4.40 weak
HCα (5) - HCα (6) 4.73 weak
HC1'(5) - HCα (6) 4.73 weak
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patterns such as strong interactions between HCα of α residues with HCβ of i +1
α-residues and HCγ of γ-residues with HCα of the i+2 γ-residues (Table 4.3).
4.3.2.5 Computational study
Unambiguous NOEs cross peaks were used as molecular constraints for the origi-
nal Monte-Carlo conformational search. Fifty five conformers were identified and
optimised with DFT optimisation without any molecular constraint to define more
accurate energies and confirm the validity of the obtained conformers. The five
most populated conformers with the lowest energy have residues (2) to (6) of 295
that overlap in a similar conformation, which can be identified as a 10/12-helical
structure (Figure 4.11).
(a) (b)
Figure 4.11: Overlap of the 9 lowest energy structures of 295 obtained with a compu-
tational study. Residue AMCP (1) and the protecting groups have been
omitted for clarity. (a) Side view. (b) Top view.
The conformation of the 9 lowest energy structures is a right handed helix and
is in agreement with the conformation prediction given by the previously described
analyses. The dihedral angles of 295 have been calculated from the 9 lowest energy
structures (Table 4.4). They display the same sign between ψ of residue i and φ of the
following residue i+1 and this was found to be an essential characteristic for helices
to form.163,164 Subsequent pairs of ψ(i)/φ(i+1) alternate in sign which implies that
amide/amide H-bonds alternate in their directionality, which is a typical feature of
12/10-helices of α/γ-oligomers and therefore 10/12-helices for γ/α-oligomers.156,163
By comparing the dihedral angles of the α- and γ-residues of the nine lowest
energy structures with the theoretical model for a 12/10-helix, it is possible to
observe that the dihedral angles of residues (2) to (6) have similar values with
an opposite sign to the theoretical dihedral angles.100 Different sequencing of the
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Residue φ θ ζ ψ
Hexamer
295
AMCP (1) 26.0±75 9.7±50 35.3±23 -103.0±8
l-Ala (2) -72.8±8 - - 128.7±34
AMCP (3) 61.0±3 43.5±3 41.9±1 -119.0±4
l-Ala (4) -72.8±4 - - 141.7±2
AMCP (5) 59.0±1 46.2±2 28.4±1 -119.7±3







-96.3 176.7 29.4 -100.1




γ-residue -64±1 -32±1 -48±1 132±5
α-residue 68±2 - - -148±1
residues caused the opposite sign of the dihedral angles, however the values similarity
is a further confirmation that 295 populates a 10/12-helical conformation. The
characteristic small ζ dihedral angle of the γ-residue of the γ/α-oligomer 295 (ζ
= 25 - 45°) highlights a similar feature to α/γ-vinylogous peptides. However, the
hexamer 295 did not display the main NOEs interactions reported by Ganesh Kumar
and co-workers for their α/γ-Z -vinylogous peptides (HCγ(i) - NH(i + 2) and HCγ(i)
- NH(i +1)) as they observed a 12-helical conformation.102
To date, only Balaram and co-workers presented a stable α/γ helix with a con-
strained ζ-torsion angle (φ = -135°, θ =38°, ζ = 45°, ψ =-108°) using gabapentin
as γ-residue.165 These small values corresponds to the requirements of a helix for-
mation for a cis-cyclopentane ring configuration confirming that the γ/α-peptide
295 populates a 10/12-helix. The situation is completely different in the case of
the corresponding trans-configuration presented by Gellman and co-workers.126 A
much larger range of possible ζ-angles values can be covered and therefore a greater
number of helical structures can populate a single ordered structure.
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4.3.2.6 DMSO titration experiment
A DMSO titration experiment was performed to identify protons that are not en-
gaged in intramolecular H-bonds, discriminating free NH from H-bonded NH and
giving support to the proposed H-bonded 10/12-helical structure. 1H NMR spectra
of a 2mm solution of hexamer 295 in CDCl3 were measured, followed by the addition
of aliquots of DMSO. Amides that are already engaged in intramolecular hydrogen
bonding, should not form any hydrogen bonds with DMSO as DMSO cannot dis-
place pre-existing secondary interactions. Therefore consistent deshielding of amide
peaks can be observed only for free amides. This experiment showed that only l-
Ala (2) amide peak, which is circled in red, is strongly shifted downfield after the
addition of DMSO. Amides that are solvent inaccessible do not shift considerably
either and this can be the case for the NH of AMCP(1) since the chemical shift of
the NH is below 7 ppm. Therefore, it is believed that the only two residues that are
not intramolecularly H-bonded, whereas all the other amide protons are involved in
intramolecular secondary interactions (Figure 4.12). Figure 4.12(c) shows shift in
chemical shift (∆ δ) of each residue after the addition of DMSO (5, 10, 15, 25, 50,
100 µL). The obtained results confirm H-bonding within the γ/α-hexamer 295.













































Figure 4.12: DMSO titration experiment: (a) H-bonding and solvent exposed amide pro-
tons in the proposed γ/α-peptide 10/12-helical structure. The amide proton
circled in red is expected to exhibit the largest chemical shift change upon
DMSO addition. (b) Amide peak region of 1H NMR spectra collected with
addition of 0, 10, 25, 50 and 100 µL of DMSO added to a 2 mm solution of




In summary, successful synthesis and in depth structural characterisation of γ/α-
peptides 292, 294 and 295 were performed. A self-aggregation control was carried
out confirming that the observed H-bonding are due to intramolecular rather than in-
termolecular interactions. Crystal structures of nitro-dimer 290 and of γ/α-oligomer
292 were obtained to confirm the stereochemistry and as additional information re-
quired for the computational study. NOEs analyses were performed and compared
to previously reported characteristic NOE cross peaks of 12/10-helical conforma-
tions, of which a large proportion was identified. NOEs cross peaks were used as
constraints to calculate the 9 lowest energy structures. Their overlap presented a
right handed helical structure confirming the conformational hypothesis of a 10/12-
helical structure. A DMSO titration in CDCl3 was accomplished which confirmed
that γ/α-hexamer 295 populates a helical conformation.
As a result, cis-γ-residues have properties that other peptides synthesised to
date do not have. Their specific small ζ dihedral angles of cis-CC bond led the
γ/α-oligomer 295 to populate a 10/12-helical structure. Owing to their unique
properties they can pave the way to a new foldamer family.
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4.5 Future Work
In chapter 3, the synthesis of asymmetric proline and indane derivatives (317 and
266) was described. γ-Amino acids can be derived from these substrates and coupled
with α-amino acids in a similar manner to the method used to synthesise the γ/α-

















Figure 4.13: α/γ-Oligomers based on substrates synthesised with the optimised reaction
conditions described in chapter 2.
Synthesis of foldamers based on these substrates could prove to be very inter-
esting as it is still unexplored. In particular, the study of foldamers based on indane
derivatives could investigate how side chains might influence the secondary struc-
ture of the main backbone. π-Interactions might play an important role for this
type of peptide as Bornhof and Maity have recently reported.166,167 The presence
of aromatic groups as side chains of the γ-amino acid might lead to more stable
and more complex secondary structures such as double helical conformations due to
the formation of additional non-covalent bonds with the aromatic groups. There-
fore, additional studies of constrained aromatic γ-amino acid based foldamers are
valuable for further understanding and use of these novel biomaterials.167,168
Chapter 5
General Conclusions
In the past 20 years, the progress made on synthesis and characterisation of foldamers
has been remarkable. The current study shows that the field of foldamers holds great
potential to be explored and a more in depth understanding of this field could lead
to the development of new materials.
In summary, a 1,2-nitro shift was identified during an intramolecular Michael
addition assisted by organocatalysts for the synthesis of a 6-membered-ring γ-amino
acid precursor. The envisioned rearrangment produced a 5-membered ring γ-amino
acid precursor that proved to be an interesting molecular target. An enantio- and di-
astereoselective organocatalytic synthesis of cis-5-membered-ring-γ-amino acid pre-
cursor was presented. The corresponding γ-amino acid was then used as monomeric
unit for the synthesis of γ/α-peptides. Synthesis and characterisation of heteroge-
neous oligomers established that the synthesised hexamer presented a 10/12-helical
conformation. The novel peptide, with its distinctive backbone dihedral angles,




All reactions were carried out at room temperature and magnetically stirred unless
otherwise stated. Anhydrous CH2Cl2, THF, MeOH, DMF and toluene solvents were
obtained from a dry solvent system all other solvents were supplied as Sureseal®
bottles by Sigma Aldrich. All reagents were supplied by Sigma Aldrich, Alfa-Aesar,
Fisher and VWR unless otherwise stated.
NMR data: Nuclear Magnetic Resonance (NMR) spectra were recorded using
a Bruker Ascend 400 (400 MHz) or a Bruker NEO 600 (600 MHz) spectrometer
using TMS as an internal standard. Chemical shifts (δ) are quoted in parts per
million (ppm) using the abbreviations: s, singlet; d, doublet; dd, double of doublets;
t, triplet; dt, doublet of triplets; ddt, doublet of doublet of triplets; td, triplet of
doublets; q, quartet. Resonances that could not be easily interpreted were desig-
nated multiplets (m) or broad (br). Coupling constants J are quoted in Hz. 13C
NMR spectra were recorded at 100 MHz on a Bruker Ascend 400 (400 MHz) or a
Bruker NEO 600 (600 MHz) spectrometer. Two-dimensional spectroscopy (COSY,
HSQC, HMBC, TOCSY, ROESY) was used to confirm the assignments where nec-
essary. NMRs taken on the Bruker NEO 600 (600 MHz) were carried out at the
NMR facility of the Centre for Biomolecular Spectroscopy at King’s College London.
Crosspeaks were integrated manually within Topspin 3.5. The average of the inten-
sities of AMCP Hγ1-Hγ2 cross peaks was used as a reference, I0, set to correspond
to a distance, r0, of 1.763 Å. All other upper limits for distance constraints were
calculated using: r1 = [(I0/I1)(r60)]
1/6. Lower limits for all distance constraints were
set to 1.8 Å.
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IR data: IR spectra were recorded on a Shimadzu IRAffinity-1S FTIR Spec-
trophotometer as a thin film. The selected absorptions are quoted in wavenumbers
(cm−1).
MS data: High-resolution mass spectra were recorded on either Waters LCT
Premier (ES-Tof), Thermo Scientific Q-Exactive (APCI) and Micromass Autospec
Premier (EI) using the Imperial College London, Department of Chemistry Mass
Spectrometry Service.
Optical Rotation: Optical rotation readings were recorded using an Anton
Parr MCP100 Polarimeter. Specific rotations ([α]20D) were recorded at the sodium
D line (589 nm) in methanol or CH2Cl2 and are quoted in: deg cm2 g−1. Solution
concentrations (c) are given in units of 10−2 g mL−1. Temperatures are in degrees
Celsius (°C). The prefixes (+) and (-) indicate the sign of the optical rotation.
Correct units: deg cm2 g−1
Melting point: Melting points were determined on a Stuart SMP30 melting
point apparatus and are uncorrected.
HPLC Profiles: HPLC analysis was determined on Agilent Technologies 1200
Series HPLC, using a ratio of HPLC grade hexanes and propan-1-ol as the eluent,
using a Chiralpak AD-H, OD or AS column (0.46 cm x 25 cm) and detection by
UV at 210 nm. Peaks were assigned by spiking the enantioselective sample with the
racemate.
Chromatography: Reactions were monitored by thin layer chromatography
on silica gel precoated aluminium sheets (TLC Silica Gel 60 F254, Merck). Visualisa-
tion was accomplished by irradiation by UV light at 254 nm and/or ninhydrin stain,
potassium permanganate stain, p-anisaldehyde, dinitrophenylhydrazine or vanilline.
Column chromatography was performed on Merck silica gel (60 Å, 230 - 400 mesh,
40 - 63 µm) or on a CombiflashRF+ system.
Single Crystal X-ray: X-ray data was collected on an Oxford Gemini S-ultra
diffractometer using Kalpha (λ = 1.54180 Å) radiation at the University of Reading.
Circular Dichroism: All CD spectra were measured in an Aviv Circular
Dichroism Spectrophotometer, Model 410 (Biomedical Inc., Lakewood, NJ, USA),
with specially adapted sample detection to eliminate scattering artefacts, or at the
Karlsruhe synchrotron. A final oligomer concentration 1.6 mgmL−1 for 292, 1.2
6.1. General 134
mgmL−1 for 294 and 1.6 mgmL−1 for 295 was used in quartz rectangular Suprasil
demountable cells of pathlength 0.2 mm (Hellma or 0.5 mm Analytics). Each sam-
ple was scanned two to four times from 270 to 185 nm, at 1-nm intervals with an
averaging time of 0.5 s. The same cell containing buffer only was also measured
for background subtraction during data analysis. All CD spectra were processed
using CDTool.169 First, the multiple scans were averaged and the buffer background
was subtracted. These subtracted spectra were zeroed and smoothed, which set the
baseline at zero between 255 and 270 nm. Computational methods: Conforma-
tional sampling was carried out using mixed low-mode Monte-Carlo search150–152
as implemented in Schrodinger 2017-1170 based on the OPLS 2005 all atom force
field,171–173 followed by conformational clustering.
Kohn-Sham DFT calculations were done for the mechanistic studies using Gaus-
sian09 Rev.E.174 The presented result were obtained employing the ω-B97X-D range
separated hybrid functional,175 with the basis 6-311G(d,p) for optimization, fre-
quency and solvent calculations and the 6-311++G(3df,3pd) basis for electronic
energies.176–178 Thermochemical corrections were calculated according to Grimme’s
quasi-RRHO153 approximation as implemented in goodvibes.179 Solvent corrections
are determined for DCE using PCM solvent model with Truhlar’s SMD parametriza-
tion.180,181
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To a solution of ethyl 6-bromohexanoate (19.9 mL, 112.1 mmol) in DMF (1
L) was added NaNO2 (11.6 g, 69.0 mmol) and tert-butyl ammonium iodide (8.28
g, 22.4 mmol). After 4.5 hours the reaction was quenched with the addition of
H2O (600 mL) and the mixture was extracted with diethyl ether (400 mLx 3).
The organic layers were washed twice with brine, and then dried over MgSO4 and
concentrated in vacuo. The crude of the reaction was purified via an automated
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flash chromatography (gradient mobile phase 6%– 40% diethyl ether in hexane)
giving compound 186 as a pale yellow liquid (53% yield, 11.350 g). IR (neat, cm−1)
2938, 1728, 1549, 1435, 1374, 1351, 1182, 1156, 1096, 1030; 1H NMR (CDCl3, 400
MHz) δ 4.39 (2H, t, J = 7.0 Hz, H-6), 4.13 (2H, q, J = 7.1 Hz, H-7), 2.32 (2H, t, J
= 7.4 Hz, H-2), 2.18 - 2.00 (2H, m, H-5), 1.73 - 1.65 (2H, m, H-3), 1.47 - 1.39 (2H,
m, H-4), 1.26 (3H, t, J = 7.1 Hz, H-8); 13C NMR (CDCl3, 400 MHz) δ 173.2 (C-1),
75.4 (C-6), 60.4 (C-7), 33.8 (C-2), 27.0 (C-5), 25.7 (C-3), 24.1 (C-4), 14.2 (C-8);












To a solution of ethyl-6-nitronate 186 (15.0 g, 79.3 mmol) in anhydrous CH2Cl2
(450 mL) at -78 °C was added a solution of DIBAL-H 1m in hexane (111 mL, 111
mmol) dropwise over 45 minutes. After 6 hours the reaction was quenched with 1m
aqueous hydrochloric acid (260 mL) and it was left stirring overnight at 3 °C. The
aqueous phase was then extracted with CH2Cl2 (3 x 150 mL) dried over MgSO4,
filtered and concentrated in vacuo. The product 187 was obtained as an oil and
it did not require further purification (72% yield, 8.259 g). IR (neat, cm−1) 3393,
2933, 1547, 1463, 1434, 1382, 1125; 1H NMR (CDCl3, 400 MHz) δ 9.78 (1H, s, H-1),
4.40 (2H, t, J = 6.9 Hz, H-6), 2.48 (2H, t, J = 7.2 Hz, H-2), 2.16 - 1.86 (2H, m, H-5),
1.80 - 1.56 (2H, m, H-3), 1.43 (2H, tt, J = 10.0, 6.7 Hz, H-4); 13C NMR (CDCl3,














To a solution of 187 (8.30 g, 56.9 mmol) in anhydrous methanol (70 mL) was
added trimethyl orthoformate (7.5 mL, 68.3 mmol) followed by p-toluene sulfonic
acid monohydride (2.71 g, 14.2 mmol) dissolved in 15 mLof methanol. The reaction
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was left stirring for 14 hours and then, the reaction was quenched adding triethy-
lamine (3.3 mL). The methanol was evaporated under high pressure and then H2O
(30 mL) was and extracted with CH2Cl2 (3 x 30 mL), dried over MgSO4, filtered and
concentrated in vacuo. Compound 188 was obtained pure enough to carry out the
next step (93% yield, 10.107 g). IR (neat, cm−1) 3418, 2936, 2862, 1548, 1434, 1383,
1190; 1H NMR (CDCl3, 400 MHz) δ 4.52 - 4.26 (3H, m, H-1 and H-6), 3.32 (6H,
s, H-7), 2.13 - 1.88 (2H, m, H-5), 1.69 - 1.52 (2H, m, H-2), 1.49 - 1.32 (4H, m, H-3
and H-4); 13C NMR (CDCl3, 400 MHz) δ 104.3 (C-1), 75.6 (C-6), 52.8 (C-7), 32.2




















An aqueous 3n solution of NaOH (6 mL, 1.2 mL/mmol) was added to compound
188 (0.96 g, 5.0 mmol) at 0 °C. After 2 hours, a 37% w/v solution of formaldehyde
(0.21 mL, 7.5 mmol) was added and the mixture was stirred for 5 hours at ice-cold
condition. Then, acetic acid (0.57 mL, 10 mmol) was added and stirred at rt for 68
hours. H2O (15 mL) was added and the reaction mixture was then extracted with
ethyl acetate (3x 15 mL). The combined organic layers were dried over MgSO4 and
concentrated under reduced pressure. The product achieved (189) did not require
further purification and it was obtained as a colourless oil (46% yield, 0.505 g). IR
(neat, cm−1) 3405, 2943, 1540, 1463, 1353, 1192, 1126, 1050; 1H NMR (CDCl3, 400
MHz) δ 4.60 (1H, tdd, J = 8.5, 5.5, 3.2 Hz, H-6), 4.34 (1H, t, J = 5.6 Hz, H-1),
3.90 – 4.02 (2H, m, H-7), 3.31 (6H, s, H-9), 2.29 (1H, bs, H-8), 1.98 (1H, dtd, J =
17.1, 8.6, 4.2 Hz, H-5), 1.89 – 1.69 (1H, m, H-5), 1.69 – 1.51 (2H, m, H-2), 1.51 –
1.30 (4H, m, H-3 and H-4); 13C NMR (CDCl3, 400 MHz) δ 104.2 (C-1), 89.2 (C-6),
63.2 (C-7), 52.8 (C-9), 32.1 (C-2), 29.7 (C-5), 25.5 (C-4), 24.0 (C-3).
















To a solution of 189 (5.91 g, 26.7 mmol) in anhydrous CH2Cl2 (110 mL) at ice-
cold condition was added mesyl chloride (2.7 mL, 34.6 mmol) and TEA (14.8 mL,
106 mmol). After 2 hours stirring at 0 °C, the reaction was quenched with aqueous
hydrochloric acid (0.1n, 14.3 mL). H2O (50 mL) was added, and the mixture was
extracted with CH2Cl2 (3 x 70 mL). The organic layers were dried over Na2SO4
and concentrated under reduced pressure. The crude of the product was purified
via flash chromatography (20% of ethyl acetate in hexane) achieving the nitro olefin
306 as a colourless oil (66% yield, 3.58 g). IR (neat, cm−1) 2939, 1718, 1553, 1462,
1349, 1173; 1H NMR (CDCl3, 400 MHz) δ 6.43 (1H, d, J = 1.8 Hz, H-7'), 5.55 (1H,
d, J = 2.0, H-7''), 4.37 (1H, t, J = 5.6, H-1), 3.32 (6H, s, H-8), 2.61 (2H, t, J =
7.5 Hz, H-5), 1.71 – 1.51 (4H, m, H-2 and H-4), 1.51 – 1.35 (2H, m, H-3); 13C NMR
(CDCl3, 400 MHz) δ 158.0 (C-6), 117.1 (C-7), 104.2 (C-1), 52.8 (C-8), 32.2 (C-2),












To compound 306 (0.019g, 0.089 mmol) at ice-cold condition was added acetic
acid (89 µl). After the solution started to freeze HCl (1n, 29 µl) was added and
the mixture was left stirring at rt for 24 hours. CH2Cl2 (15 mL) was added and
washed with H2O (2 x 1 mL) and saturated aqueous NaHCO3 (1 mL). The organic
phase was then dried over MgSO4, filtered, concentrated under reduced pressure to
afford the nitro olefin 171 as a colourless oil (64% yield, 0.009 g). 1H NMR (CDCl3,
400 MHz) δ 9.79 (1 H, t, J = 1.5, H-1), 6.45 (1 H, d, J = 1.9, H-7'), 5.58 (1 H, s,
H-7''), 2.63 (2 H, t, J 7.5, H-5), 2.51 (2 H, td, J 7.0, 1.4, H-2), 1.77 – 1.65 (2 H, m,
H-3), 1.65 – 1.53 (2H, m, H-4). 13C NMR (CDCl3, 400 MHz) δ 201.7 (C-1), 157.6
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(C-6), 117.4 (C-7), 43.4 (C-2), 30.0 (C-5), 26.6 (C-4), 21.2 (C-3). HRMS required
for C7H10NO3 [M-H]− 156.0661, found 156.0657.








































Scheme 6.1: Synthetic procedure for the synthesis of the nitroolefin 171.










To a solution of 191 (5.3 mL, 33.5 mmol) in anhydrous CH2Cl2 (184 mL) was
added DIBAL-H (1m in hexane, 46.9 mL, 46.9 mmol) dropwise over 25 minutes.
After 2 hours and 40 minutes the reaction was quenched with aqueous hydrochloric
acid (1m, 108 mL) and it was left stirring at rt for 2 hours. H2O (100 mL) was added
to the mixture and the aqueous phase was extracted in CH2Cl2 (3 x 90 mL).The
combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo.
The product 192 was then obtained as a colourless oil (97% yield, 5.317 g) and it
did not require further purification. IR (neat, cm−1) 3425, 2940, 2866, 2725, 1721,
1433, 1409, 1391, 1252, 1202, 1113,1050; 1H NMR (CDCl3, 400 MHz) δ 9.79 (1H,
t, J = 1.5 Hz H-1), 3.43(2H, td, J = 6.7, 2.1 Hz, H-5), 2.50 (2H, td, J = 7.1, 1.4
Hz, H-2), 1.95 - 1.85 (2H, m, H-3), 1.85 - 1.74 (2H, m, H-4); 13C NMR (CDCl3, 400
MHz) δ 201.8 (C-1), 42.9 (C-2), 33.0 (C-5), 31.8 (C-3), 20.6 (C-4). HRMS required













To a solution of 192 (5.300 g, 31.9 mmol) in anhydrous methanol (40 mL) was
added trimethyl orthoformate (4.2 mL, 38.3 mmol) followed by p-toluene sulfonic
acid monohydride (1.518 g, 8.0 mmol) dissolved in 10 mL of methanol. The reaction
was left stirring for 18 hours and then, the reaction was quenched adding TEA (1.9
mL). The methanol was evaporated under high pressure and then H2O (50 mL) was
added and extracted with CH2Cl2 (3 x 40 mL), dried over Na2SO4, filtered and
concentrated in vacuo. Compound 193 was obtained as an oil and did not require
further purification (93% yield, 6.26 g). IR (neat, cm−1) 2944, 2829, 1455, 1385,
1287, 1243, 1191, 1101, 1051; 1H NMR (CDCl3, 400 MHz) δ 4.37 (1H, t, 5.6 Hz,
H-1), 3.41 (2H, t, J = 6.8 Hz, H-5), 3.32 (6H, s, H-6), 1.95 - 1.82 (2H, m, H-4), 1.68
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- 1.56 (2H, m, H-2), 1.56 - 1.43 (2H, m, H-3); 13C NMR (CDCl3, 400 MHz) δ 104.3
(C-1), 52.8 (C-6), 32.1 (c-5), 31.6 (C-4), 23.3 (C-3); HRMS required for C5H10Br







A 1.6 m solution of n-BuLi (10.0 mL, 16.0 mmol) in hexane was added dropwise
to a solution of nitroethane (1.2 mL, 16.4 mmol) in anhydrous THF (145 mL) under
inert atmosphere at -78 °C. After 1 hour stirring at -78 °C, a solution of phenylselenyl
bromide (1.80 g, 7.6 mmol) in THF (24 mL) was added rapidly in one portion. The
mixture was left stirring at -78 °C for 3.5 hours and a saturated aqueous solution of
ammonium chloride (24 mL) was added and left stirring at rt for 15 min. H2O (100
mL) was then added and extracted with ethyl acetate (3x 50 mL). Brine was also
used to eliminate the emulsions experienced during the last extraction. The organic
phase was dried over Na2SO4, filtered and concentrated in vacuo. The nitroselenide
194 was achieved as a yellow solid (90% yield, 1.58 g) and there was no need of
any further purification. IR (neat, cm−1) 2931, 1550, 1476, 1438, 1381, 1352; 1H
NMR (CDCl3, 400 MHz) δ 7.75 - 7.53 (2H, m, Ar-H), 7.49 - 7.40 (1H, m, Ar-H),
7.40 - 7.33 (2H, m, Ar-H), 5.68 (1H, q, J = 6.9 Hz, H-1), 1.83 (3H, d, J = 6.9 Hz,
H-2); 13C NMR (CDCl3, 400 MHz) δ 136.3 (C-Ar), 129.9 (C-Ar), 129.5 (C-Ar), 78.7
(C-1), 19.7 (C-2).
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To a solution of ethyl 4-bromo butyrate (18.34 mL, 128 mmol) in DMF (1 L)
was added sodium nitrite (13.248 g, 192 mmol) and tert-butyl ammonium iodide
(9.456, 25.6 mmol). The reaction was left stirring at rt for 4 hours and then it was
quenched with the addition of water (500 mL). The mixture was extracted in diethyl
ether (3 x 1L), it was washed twice with a solution of saturated LiCl and twice with
brine, dried over MgSO4 and concentrated in vacuo. Flash chromatography (30%
ethyl acetate in hexane) was required to obtain the purified product 199 (49% yield,
10.001 g) as an oil. IR (neat, cm−1) 2984, 1728, 1550, 1435, 1375, 1176; 1H NMR
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(CDCl3, 400 MHz) δ 4.49 (2H, t, J = 6.7 Hz, H-4), 4.16 (2H, q, J = 7.1 Hz, H-5),
2.54 - 2.39 (2H, m, H-2), 2.42 - 2.22 (2H, m, H-3), 1.27 (3H, t, J = 7.1 Hz, H-
6); 13C NMR (CDCl3, 400 MHz) δ 171.9 (C-1), 74.4 (C-4), 50.9 (C-5), 30.5 (C-2),










To a solution of 199 (0.400 g, 2.48 mmol) in anhydrous CH2Cl2 (14 mL) was
added DIBAL-H (1m in hexane, 3.47 mL, 3.47 mmol) dropwise over 2 minutes. After
4 hours the reaction was quenched with aqueous hydrochloric acid (1m, 8 mL) and
it was left stirring at rt for an hour. Water (15 mL) was added and it was extracted
in CH2Cl2 (3 x 15 mL) and through the help of brine to reduce emulsions. The
combined organic layers were dried over MgSO4, filtered and concentrated in vacuo.
Product 200 was achieved (93% yield, 0.270 g) as a colourless oil and it did not
require further purification. 1H NMR (CDCl3, 400 MHz) δ 9.81 (1H, s, H-1), 4.46
(2H, t, J = 6.3 Hz, H-4), 2.68 (2H, t, J = 6.8 Hz, H-2), 2.32 (2H, p, J = 6.8 Hz,










Sodium borohydride (3.1 g, 81.6 mmol) was added to a solution of diphenyl
diselenide (25 g, 80.1 mmol) in EtOH (250 mL) dried over activated molecular
sieves (4Å) in ice-cold condition. Ethyl 2-chloropropionate (9.7 mL, 75.6 mmol)
dissolved in EtOH (126 mL) was then added to the reaction mixture. After 3 hours
stirring at 0 °C, H2O (500 mL) was added and the aqueous phase was extracted
with diethyl ether (1.2 L). The organic phase was then washed with H2O again (2 x
500 mL), dried over Na2SO4, filtered and concentrated under reduced pressure. A
purification via flash chromatography (6% ethyl acetate in hexane) was required to
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achieve product 201 as a yellow solid (13.99 g, 54.4 mmol, 72% yield). IR (neat,
cm−1) 2980, 1726, 1578, 1477, 1438, 1368, 1326, 1256, 1207, 1146, 1057, 1021; 1H
NMR (CDCl3, 400 MHz) δ 7.75 -7.49 (2H, m, Ar-H), 7.44 - 7.12 (3H, m, Ar-H), 4.09
(2H, q, J = 7.1 Hz, H-4), 3.77 (1H, q, J = 7.1 Hz, H-2), 1.54 (3H, d, J = 7.1 Hz, H-
3), 1.17 (3H, t, J = 7.1 Hz, H-5); 13C NMR (CDCl3, 400 MHz) δ 173.5 (C-1), 135.7
(Ar-C), 129.0 (Ar-C), 128.5 (Ar-C), 127.9 (Ar-C), 61.0 (C-4), 37.4 (C-2), 17.7 (C-3),

















n-BuLi (1.6 m in hexane, 1.83 mL, 2.93 mmol) was added dropwise to a cooled
(-78 °C) solution of isopropyl amine (0.41 mL, 2.93 mmol) in anhydrous THF (14
mL). The mixture was left stirring at -78 °C for 1 hour and then a solution of 201
(0.753 g, 2.93 mmol) in 1.8 mL of THF was added dropwise. After 90 minutes a
solution of 200 (0.264 g, 2.25 mmol) in 2 mL of THF was added dropwise to the
cooled mixture (-78 °C). After 40 minutes, the mixture was then quenched with
saturated aqueous solution of NH4Cl (17.5 mL). The cold bath was then removed
and stirring at rt was continued for 15 minutes. The mixture was then diluted
with water (50 mL) and the aqueous phase was extracted with ethyl acetate (3 x
35 mL). The combined organic layers were washed with brine, dried (MgSO4) and
concentrated in vacuo. Flash chromatography (10% ethyl acetate in hexane) over
silica gel was then required to separate the two diastereoisomers. The less polar
diastereoisomer 202a was achieved as an colourless oil (19% yield, 0.158 g) and the
more polar 202b was obtained along with the other diasteroisomer as an colourless
oil (32% yield, 0.268 g). Diastereomer 202a had: 1H NMR (CDCl3, 400 MHz) δ
7.62 – 7.52 (2H, m, Ar-H), 7.49 – 7.39 (1H, m, Ar-H), 7.39 – 7.29 (2H, m, Ar-H),
4.54 – 4.34 (1H, m, H-6), 4.20 – 3.93 (1H, m, H-9), 3.87 (1H, dt, J = 10.1, 2.0 Hz,
H-3), 3.20 (1H, t, J = 2.3 Hz, H-7), 2.36 – 2.21 (1H, m, H-5'), 2.19 – 2.06 (1H,
m, H-5''), 1.72 – 1.58 (1H, m, H-4'), 1.54 – 1.43 (1H, m, H-4''), 1.37 (3H, s, H-8),
1.16 (3H, t, J = 7.1 Hz, H-10); 13C NMR (CDCl3, 400 MHz) δ 173.2 (C-1), 138.1
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(Ar-C), 129.7 (Ar-C), 129.0 (Ar-C), 126.0 (Ar-C), 75.3 (C-6), 72.2 (C-3), 61.3 (C-9),
56.9 (C-2), 28.1 (C-4), 24.8 (C-5), 17.1 (C-8), 13.8 (C-10). Diastereomer 202b had:
IR (neat, cm−1) 3501, 2934, 1704, 1548, 1476, 1437; 1H NMR (CDCl3, 400 MHz) δ
7.65 – 7.50 (1H, m, Ar-H), 7.49 – 7.38 (2H, m, Ar-H), 7.38 – 7.28 (2H, m, Ar-H),
4.58 – 4.34 (2H, m, H-6), 4.13 (2H, qd, J = 7.2, 1.3 Hz, H-9), 3.86 (1H, ddd, J =
10.8, 6.4, 1.6 Hz, H-3), 2.94 (1H, d, J = 6.5 Hz, H-7), 2.38 – 2.20 (1H, m, H-5'),
2.20 – 1.97 (1H, m, H-5''), 1.50 (2H, ddd, J = 10.7, 8.2, 5.0 Hz, H-4), 1.41 (3H, s,
H-8), 1.22 (3H, t, J = 7.1 Hz, H-10); 13C NMR (CDCl3, 400 MHz) δ 174.0 (C-1),
138.0 (Ar-C), 129.6 (Ar-C), 129.0 (Ar-C), 126.2 (Ar-C), 75.4 (C-6), 74.6 (C-3), 61.5
(C-9), 54.0 (C-2), 27.9 (C-4), 24.9 (C-5),17.9 (C-8), 14.0 (C-10); HRMS required for


















To a stirred and cooled (-10 °C , ice-acetone bath) solution of 202b (0.260 g,
0.69 mmol) and DMAP (0.0084 g, 0.069 mmol), pyridine (0.334 mL, 4.14 mmol) and
acetyl chloride (0.150 mL, 2.1 mmol) were added sequentially dropwise. The cold
bath was left in place but not recharged and stirring was continued for 18 hours by
which the time the temperature has risen to rt. The mixture was then diluted with
water (8.6 mL), acidified with aqueous hydrochloric acid (1m, 3.5 mL) and extracted
with CH2Cl2 (3 x 5 mL). The combined organic extracts were washed with brine,
dried over MgSO4, filtered and concentrated in vacuo. Flash chromatography of the
crude over silica gel (19:50, Ethyl Acetate – Hexane) gave the product 203 (67%
yield, 0.192 g) as an colourless oil. IR (neat, cm−1) 2982, 1741, 1723, 1476, 1438,
1371, 1224; 1H NMR (CDCl3, 400 MHz) δ 7.66 - 7.52 (2H, m, Ar-H), 7.52 -7.39 (1H,
m, Ar-H), 7.37 - 7.29 (3H, m, Ar-H), 5.41 (1H, dd, J = 10.5, 1.3 Hz, H-3), 4.44 (2H,
t, J = 6.6 Hz, H-6), 4.12 - 3.77 (2H, m , H-10), 2.38 - 2.19 (1H, m, H-4'), 2.17 -
1.99 (2H, m, H-5), 1.97 (3H, s, H-8), 1.69 (1H, dddd, J = 14.1, 10.6, 9.2, 4.9 Hz,
H-4''), 1.50 (3H, s, H-9), 1.10 (3H, t, J = 7.1 Hz, H-11); 13C NMR (CDCl3, 400
MHz) δ 171.9 (C-1), 170.0 (C-7), 137.9 (Ar-C), 129.8 (Ar-C), 129.0 (Ar-C), 126.0
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(Ar-C), 74.9 (C-6), 74.6 (C-3), 61.3 (C-10), 52.4 (C-2), 27.3 (C-4), 24.1 (C-5), 20.8




















A solution of 30%w/v hydrogen peroxide (0.6 mL, 5.28 mmol) was added drop-
wise to a stirred and cooled (0 °C) solution of 203 (0.188 g, 0.45 mmol) in CH2Cl2
(4.5 mL). After 1 hour and 15 minutes the reaction was quenched with saturated
aqueous Na2S2O3 (3 mL). The mixture was stirred at 0 °C for 5 minutes and then
the ice-bath was removed, stirring was continued for 30 minutes and water (15 mL)
was added. The aqueous phase was extracted with CH2Cl2 (3x 15 mL) and the
combined organic layers were washed with brine, dried (MgSO4) and concentrated
in vacuo. The crude of the reaction was purified via flash chromatography (7 : 20,
ethyl acetate-hexane) to give product 204 (81% yield, 0.095 g) as a viscous oil. IR
(neat, cm−1) 2984, 2363, 1741, 1713, 1633, 1551, 1435, 1370, 1267, 1228; 1H NMR
(CDCl3, 400 MHz) δ 6.33 (1H, s, H-9'), 5.78 (1H, s, H-9''), 5.66 (1H, dd, J = 7.6,
4.1 Hz, H-3), 4.41 (2H, t, J = 6.9 Hz, H-6), 4.29 – 4.19 (2H, m, H-10), 2.11 (3H, s,
H-8), 2.10 - 1.98 (2H, m, H-5), 1.98 - 1.73 (2H, m, H-4), 1.31 (3H, t, J = 7.1 Hz,
H-11); 13C NMR (CDCl3, 400 MHz) δ 169.8 (C-7), 165.0 (C-1), 139.4 (C-2), 125.4
(C-9), 74.9 (C-6), 70.6 (C-3), 61.1 (C-10), 30.8 (C-4), 23.2 (C-5), 21.0 (C-8), 14.1
(C-11); HRMS required for C11H17NO6NH4 [M+H]+ 277.1394, found 277.1396.














Caesium carbonate (0.229 g, 0.702 mmol) was added to a stirred solution of
204 (91 mg, 0.351 mmol) in THF (3.5 mL). The mixture was left stirring at rt for
6 hours, the solvent was evaporated and flash chromatography of the residue over
silica gel (1:2, ethyl acetate-hexane) was then followed to give the product 205 (57%
yield, 0.041 g) as a colourless oil. IR (neat, cm−1) 2980, 1707, 1652, 1544, 1429,
1372, 1243; 1H NMR (CDCl3, 400 MHz) δ 7.00 (1H, dd, J = 4.6, 2.9 Hz, H-3), 4.63
-4.73 (1H, m, H-6), 4.17 – 4.27 (2H, q, J = 6.8 Hz, H-8), 2.83 – 3.01 (2H, m, H-7),
2.30 – 2.53 (2H, m, H-4), 2.13 – 2.30 (2H, m , H-5), 1.30 (3H, t, J = 7.2 Hz, H-9);
13C NMR (CDCl3, 400 MHz) δ 165.9 (C-1), 137.8 (c-3), 126.9 (C-2), 80.5 (C-6), 60.8
(C-8), 28.2 (C-7), 25.8 (C-5), 23.6 (C-4), 14.2 (C-9); HRMS required for C9H14NO4














Pd/C (10 wt%, 0.010 g) was added to a stirred solution of compound 205 (0.100
g, 0.50 mmol) in MeOH (2 mL) under inert atmosphere (N2). H2 (1 atm) was then
added and the mixture was left stirring at rt for 3 hours. The mixture was filtered
through a pad of celite and it was washed again with MeOH. The crude product
was purified via flash chromatography (1:2 ethyl acetate-hexane) giving two different
inseparable diastereoisomers of the ester 206 as a colourless oil (37% yield, 0.037
g). Mixture of the two diastereomers a and b in a 1:1.5 ratio: 1H NMR (CDCl3,
400 MHz) δ 4.73 (0.4H, tt, J 7.4, 4.6, H-6a), 4.40 (0.6H, tt, J 12.1, 4.0, H-6b), 4.16
(2H, qd, J 7.1, 3.6, H-8), 2.82 (0.4H, p, J = 5.9, H-2a), 2.57 (0.6 H, ddq, J = 12.2,
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3.7, 1.9, H-7b), 2.46 – 2.22 (2 H, m, H-2b, H-5b and H-7a), 2.20-2.05 (0.4 H, m,
H-5a), 2.07 – 1.89 (2 H, m, H-3b, H-4b, H-7b, H-5a), 1.86 – 1.72 (1 H, m, H-5b and
H-3a), 1.72 – 1.51 (1 H, m, H-4a), 1.49 – 1.34 (1 H, m, H-3b and H-4b), 1.27 (3 H,
td, J 7.1, 3.4, H-9); 13C NMR (CDCl3, 400 MHz) δ 174.2 (C-1a), 173.5 (C-1b), 83.7
(C-6b), 81.1 (C-6a), 60.9 (C-8a), 60.8 (C-8b), 41.5 (C-2b), 38.4 (C-2a), 32.6 (C-7b),
30.5 (C-7a), 30.4 (C-5b), 29.6 (C-5a), 27.6 (C-3b), 27.2 (C-3a), 23.4 (C-4b), 20.7
(C-4a), 14.2 (C-9b), 14.2 (C-9a); HRMS required for C9H16NO4 [M+H]+ 202.1079,
found 202.1085.






















































A 1.6m solution of n-BuLi (2.75 mL, 4.4 mmol) in hexane was added dropwise
over 2 minutes to a solution of isopropyl amine (0.68 mL, 4.8 mmol) in anhydrous
THF (8 mL) at -78 °C. The reaction mixture was left stirring at this temperature
for 45 minutes when a solution of compound 201 (1.03 g, 4.0 mmol) in THF (3 mL
+ 1 mL to rinse the vial) was added dropwise over 5 min. After 1.5 hours stirring
at -78 °C, 1,4-dibromobutane (0.96 mL, 8 mmol) in THF (3 mL) and HMPA (1
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mL) was added dropwise over 5 min. The reaction mixture was stirred at -78 °C
for additional 2 hours and then the cooling bath was removed and stirring at rt was
continued for 2 h. At 0 °C, H2O (1 mL) and saturated aqueous NH4Cl (5 mL) were
used to quech the reaction, stirring was continued at rt for 10 minutes and then the
mixture was diluted with water (50 mL) and extracted with ethyl acetate (3 x 20
mL). The organic layers were dried (Na2SO4), filtered and concentrated in vacuo.
Flash chromatography of the crude was required to achieve compound 211 (19%
yield, 0.297g) as a viscous oil. IR (neat, cm−1) 2931, 1717, 1578, 1475, 1437, 1377,
1301, 1260, 1238, 1152, 1099, 1066, 1022, 1000; 1H NMR (CDCl3, 400 MHz) δ 7.74
– 7.48 (2 H, m, Ar-H), 7.44 – 7.35 (1 H, m, Ar-H), 7.35 – 7.20 (2 H, m, Ar-H), 4.18
– 3.99 (2 H, m, H-8), 3.39 (2 H, t, J = 6.7, H-6), 1.95 (1 H, ddd, J = 13.5, 11.9,
4.5, H-3'), 1.89 – 1.79 (2 H, m, H-5), 1.75 (1 H, ddd, J = 13.5, 12.0, 4.4, H-3''),
1.69 – 1.58 (1 H, m, H-4'),1.51 (3 H, s, H-7), 1.38 (1 H, dddd, J 17.2, 8.5, 7.2, 4.4,
H-4''), 1.19 (3 H, t, J 7.1, H-9); 13C NMR (CDCl3, 400 MHz) δ 173.8 138.1 (Ar-C),
129.2 (Ar-C), 128.7 (Ar-C), 61.0 (C-8), 37.5 (C-3), 33.4 (C-6), 32.7 (C-5), 24.1 (C-















Hydrogen peroxide (30% w/v, 36.3 mL, 0.32 mol) was added dropwise to a
solution of compound 211 (12.2 g, 0.31 mol) in CH2Cl2 (650 mL) at -10 °C (ice-
acetone cooling bath 1:1). After 1.5 hours the reaction was quenched dropwise
with saturated aqueous NaHCO3 (1.9 L) and then with saturated aqueous solution
of Na2S2O3 (430 mL). Stirring was continued for 10 minutes at -10 °C, then the
cooling bath was removed. The reaction mixture was left stirring for additional 10
minutes at rt, it was diluted with water (850 mL), extracted with CH2Cl2 (3 x 450
mL) , dried (Na2SO4), filtered and concentrated in vacuo. The crude product was
purified via flash chromatography to afford the title product 212 as an oil (57%
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yield, 4.04 g). IR (neat, cm−1) 2937, 1701, 1631, 1444, 1409, 1368, 1300, 1282, 1254,
1179, 1028; 1H NMR (CDCl3, 400 MHz) δ 6.17 (1H, d, J = 1.4 Hz, H-7'), 5.55 (1H,
d, J = 1.4 Hz, H-7''), 4.21 (2H, q, J = 7.1 Hz, H-8), 3.43 (2H, t, J = 6.8 Hz, H-6),
2.38 - 2.29 (2H, t, J = 7.6 Hz, H-3), 1.96 - 1.83 (2H, m, H-5), 1.73 - 1.53 (2H, m,
H-4), 1.31 (3H, t, J = 7.1 Hz, H-9); 13C NMR (CDCl3, 400 MHz) δ 167.1 (C-1),
140.3 (C-5), 124.8 (C-7), 60.7 (C-8), 33.5 (C-6), 32.2 (C-5), 31.0 (C-3), 27.0 (C-4),














Sodium nitrite (1.77 g, 25.7 mmol) and TBAI (1.26 g, 3.4 mmol) were added
to a solution of compound 212 (4.0 g, 17.1 mmol) and DMF (170 mL). Stirring at
rt was continued for 6 hours. H2O (170 mL) was then added and the organic phase
was extracted with diethyl ether (3 x 300 mL). The organic layers were washed with
a saturated aqueous solution of LiCl (150 mL x2) and then brine (150 mL x 2).
The combined organic layers were then dried (Na2SO4), filtered and concentrated
in vacuo. Purification via flash chromatography was required (15% ethyl acetate in
hexane) . The title product was obtained as a yellow oil (57% yield, 1.953 g). IR
(neat, cm−1) 2932, 1713, 1632, 1552, 1436, 1382, 1302, 1259, 1185, 1146, 1026; 1H
NMR (CDCl3, 400 MHz) δ 6.19 (1H, d, J = 1.3 Hz, H-7'), 5.55 (1H, d, J = 1.4 Hz,
H-7''), 4.41 (2H, t, J = 7.0 Hz, H-6), 4.21 (2H, q, J =7.1 Hz, H-8), 2.37 (2H, td,
J = 7.5, 1.3 Hz, H-3), 2.15 - 1.92 (2H, m, H-5), 1.66 - 1.49 (2H, m, H-4), 1.31 (3H,
t, J = 7.1 Hz, H-9); 13C NMR (CDCl3, 400 MHz) δ 166.9 (C-1), 139.7 (C-2), 125.3
(C-7), 75.4 (C-6), 60.8 (C-8), 31.1 (C-3), 26.8 (C-5), 25.2 (C-4), 14.2 (C-9);














To a solution of 213 (1.50 g, 7.4 mmol) in THF (75 mL) was added CsF (2.26
g, 14.9 mmol) and the reaction mixture was then left stirring at rt for 24 h. The
reaction mixture was then concentrated under reduced pressure and the residue was
purified via flash chromatography on silica gel (25% ethyl acetate in hexane) to
afford the title compound as a colourless oil (0.831 g, 56% yield). Characterisation
















To a solution of 206 (1.00 g, 5.0 mmol) in anhydrous CH2Cl2 (28 mL) at -78°C
was added dropwise DIBAL-H (1m in hexane, 7 mL). The reaction was left stirring
at -78°C for 2 hours and then it was quenched with 1m aq. solution of HCl (16 mL).
The reaction mixture was left stirring at rt overnight, then H2O (16 mL) was added
and the organic phase was extracted with CH2Cl2 (3 x 30 mL). The product was
obtained as a colourless oil as a mixture of diastereoisomers and it was used without
further purification for the following step (0.753 g, 96% yield). cis 151: IR (neat,
cm−1) 2944, 1725, 1539, 1378, 1019, 749; 1H NMR (CDCl3, 400 MHz) δ 9.68 (1H, s,
H-8), 4.62 (1H, t, J = 7.6, 4.8 Hz, H-6), 2.80 (1H, p, J = 5.7 Hz, H-2), 2.39 – 2.23
(2H, m, H-7), 2.09 (2H, ttt, J = 17.3, 9.2, 3.9 Hz, H-3), 1.94 – 1.65 (3H, m, H-4 and
H-5), 1.57 – 1.41 (1H, m, H-4). 13C NMR (CDCl3, 101 MHz) δ 202.6 (C-1), 80.7
(C-6), 45.6 (C-2), 29.7 (C-3), 27.9 (C-7), 24.0 (C-5), 20.8 (C-4). HRMS required for
C7H11NO3 [M+H]+ 158.0817, found m/z 158.0814. trans 151: 1H NMR (CDCl3,
400 MHz) δ 9.66 (1H, d, J = 1.1 Hz, H-8), 4.43 (1H, tt, J = 12.0, 4.0 Hz, H-6), 2.64
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– 2.53 (1H, m, H-7), 2.48 – 2.31 (2H, m, H-2 and H-5), 2.16 – 1.98 (2H, m, H-4 and
H-3), 1.95 – 1.68 (2H, m, H-7 and H-5), 1.52 – 1.37 (1H, m, H-4), 1.33 – 1.16 (1H,
m, H-3). 13C NMR (CDCl3, 101 MHz) δ 201.1 (C-1), 83.6 (C-6), 48.2 (C-2), 30.7
(C-5), 30.0 (C-7), 24.8 (C-3), 23.3 (C-4).
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To a solution of 205 (0.300 g, 1.51 mmol) in anhydrous CH2Cl2 (8.5 mL) at -78
°C was added DIBAL-H (1m in Hex, 2.1 mL, 2.11 mmol) dropwise over 2 minutes.
After 5.5 hours the reaction mixture still displayed starting material via TLC, so
supplementary DIBAL-H was added (1M in Hex, 1 mL, 1 mmol). After 1 more
hour the reaction was quenched with aqueous hydrochloric acid (1m, 7.5 mL) and
it was left stirring at rt overnight. Water (15 mL) was added and it was extracted
in CH2Cl2 (3 x 15 mL). The combined organic layers were dried(Na2SO4), filtered
and concentrated in vacuo. The product 207 was obtained as a colourless oil (89%
yield, 0.211 g) and it did not require further purification. IR (neat, cm−1) 3347,
2923, 2360, 1359, 1438, 1378, 1286, 1221, 1142, 1063, 1008; 1H NMR (CDCl3, 400
MHz) δ 5.85 – 5.62 (1H, m, H-3), 4.83 – 4.51 (1H, m, H-6), 4.06 (2H, s, H-1), 2.84 –
2.50 (2H, m, H-7), 2.46 – 2.08 (4H, m, H-4 and H-5); 13C NMR (CDCl3, 400 MHz)
δ 133.8 (C-2), 122.2 (C-3), 81.3 (C-6), 66.5 (C-1), 29.7 (C-7), 26.7 (C-5), 23.0 (C-4).













In a dry flask containing activated 4Å molecular sieves (0.085 g), compound
207 (0.200 g, 1.27 mmol) was dissolved in an anhydrous mixture of CH2Cl2 (17 mL)
and acetonitrile (3.4 mL) in a ratio of 40:8. N -Methylmorpholine N-oxide (0.373 g,
3.2 mmol) was added to the solution at 0 °C. Once dissolved, TPAP (0.067 g, 0.19
mmol) was then added and it was left stirring at rt for 1.5 h. The reaction mixture
was then filtered through a short pad of celite and silica and washed with 10% ethyl
acetate-hexane (1.5 L). Compound 208 was obtained as an oil (79% yield, 0.156 g)
and it did not require any further purification. IR (neat, cm−1) 2922, 2850, 2361,
1765, 1695, 1647, 1545, 1430, 1385, 1301, 1279, 1172, 1117, 1070, 1001; 1H NMR
(CDCl3, 400 MHz) δ 9.49 (s, 1H), 6.85 (1H, tt, J = 3.7, 1.7 Hz, H-3), 4.85 - 4.62
(1H, m, H-6), 3.01 - 2.76 (2H, m, H-7), 2.74 - 2.41 (2H, m, H-4), 2.41 - 2.16 (2H,
m, H-5); 13C NMR (CDCl3, 400 MHz) δ 192.3 (C-1), 148.2 (C-3), 137.5 (C-2), 79.7
(C-6), 26.2 (C-5), 25.5 (C-7), 24.0 (C-4).
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Figure 6.1: Synthesis of substrate 214 according to the synthetic procedure described in
method E.














To an oven-dried quick-fit cap test tube charged with magnetic stir-bar was
added activated 4Å molecular sieves (1.5 g), AgNO2 (21.7 g, 128 mmol) and TEMPO
(2.0 g, 12.8 mmol). Ethyl-6-heptenoate (5.6 mL, 32.0 mmol) and anhydrous DCE
(100 mL) were added. The tube was then placed in a preheated oil bath at 70 °C and
the reaction mixture was left stirring vigorously for 18 hours. The progress of the
reaction was monitored by TLC and then the reaction mixture was left to cool down
to rt. The reaction mixture was then filtered through a short pad of celite washed
with ethyl acetate (500 mL) and concentrated in vacuum. The crude product was
then purified via combiflash using silica gel columns and a gradient solution of ethyl
acetate and hexane up to 20% ethyl acetate in hexane to afford the title compound
307 as a colourless oil (2.96 g, 14.7 mmol, 46%). IR (neat, cm−1) 2936, 1728, 1650,
1522, 1462, 1349, 1179, 1152, 1097, 1030; 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.21
(1H, m, H-7), 7.01 (1H, dt, J = 13.4, 1.6 Hz, H-6), 4.15 (2H, q, J = 7.1 Hz, H-8),
2.43 – 2.23 (4H, m, H-2 and H-5), 1.74 – 1.56 (2H, m, H-4), 1.64 – 1.50 (2H, m,
H-3), 1.28 (3H, t, J = 7.1 Hz, H-9). 13C NMR (CDCl3, 101 MHz) δ 173.1 (C-1),
141.9 (C-6), 139.8 (C-7), 60.4 (C-8), 33.8 (C-2), 28.1 (C-5), 27.2 (C-3), 24.3 (C-4),












To a solution of ethyl 307 (2.95 g, 14.7 mmol) and anhydrous CH2Cl2 (80 mL)
at -78 °C was added DIBAL-H (1M in hexane, 16.9 mL, 16.9 mmol) dropwise in
15 minutes. The progress of the reaction was monitored by TLC and the reaction
went to completion in 4 hours. An aqueous solution of HCl (1m, 50 mL) was added
and the reaction mixture was left to stir overnight at rt. Then, H2O (80 mL) was
added and the organic phase was extracted with CH2Cl2 (3 x 80 mL). The combined
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organic phase was dried (Na2SO4), filtered and concentrated in vacuo. Purification
by combiflash (silica gel, gradient up to 40% diethyl ether in hexane) afforded the
title compound 214 as a colourless oil (0.864 g, 5.5 mmol, 37% yield). IR (neat,
cm−1) 2937 , 1719, 1648, 1517, 1347; 1H NMR (400 MHz, CDCl3) δ 9.78 (1H, t,
J = 1.4 Hz, H-1), 7.33 - 7.13 (1H, m, H-6), 6.99 (1H, dt, J = 13.4, 1.6 Hz, H-7),
2.50 (2H, td, J = 7.1, 1.4 Hz, H-2), 2.30 (2H, td, J = 7.4, 1.6 Hz, H-5), 1.92 -
1.60 (2H, m, H-3), 1.62 - 1.37 (2H, m, H-4). 13C NMR (101 MHz, CDCl3) δ 201.6
(C-1), 141.78 (C-6), 139.90 (C-7), 43.41 (C-2), 28.26 (C-5), 27.19 (C-4), 21.42(C-3).
HRMS required for C7H12NO3 [M+H]+ is 158.0817, found 158.0821.













































A three neck round bottom flask was heat dried and each neck was respectively
occupied by a drying tube loaded with CaCl as outlet, a glass stopper and the
ozoniser inlet. Cyclohexene (7.6 mL, 75 mmol) was dissolved in a solution of CH2Cl2
(250 mL) and MeOH (50 mL) and it was then cooled to -78 °C. O3 was then bubbled
through the solution until a light blue colour developed. Excess of O3 was removed
by bubbling through the reaction mixture N2 until the blue colour was discharged.
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The reaction mixture was then left to warm up to rt and the drying tube and the
ozone inlet were replaced with rubber septums. p-Tosylic acid monohydride (10%
w/w, 1.22 g) was added to the solution and then it was left stirring at rt under N2
for 90 min. NaHCO3 (4mol-eq, 2.15 g) was added followed by dimethyl sulphide (12
mL, 163.4 mmol) after 15 minutes. The reaction mixture was left stirring overnight
and then concentrated up to 50 mL of solution. Then, it was diluted with CH2Cl2
(100 mL) and washed with H2O (75 mL). The aqueous phase was extracted with
CH2Cl2 (2 x 100 mL). The combined organic layers were washed with H2O (100
mL) and the aqueous phase was extracted with a final portion of CH2Cl2 (100 mL).
The organic layers were dried over Na2SO4, filtered and concentrated in vacuo. The
product 308 was obtained as a colourless oil (12.6 g, 12 mmol, quantitative yield)
and it was used for the following reaction without further purification. IR (neat,
cm−1) 2946, 2830, 1724, 1460, 1387, 1191, 1126, 1071, 1050; 1H NMR (400 MHz,
CDCl3) δ 9.75 (1 H, s, H-6), 4.34 (1 H, t, J 5.7, H-1), 3.30 (6 H, s, H-7), 2.43 (2
H, td, J 7.3, 1.7, H-5), 1.82 – 1.51 (4 H, m, H-4, H-2), 1.45 – 1.31 (2 H, m, H-3).
13C NMR (101 MHz, CDCl3) δ 202.5 (C-6), 104.3 (C-1), 52.8 (C-7), 43.8 (C-5), 32.3














To a suspension solution of MePPh3Br (53.6 g, 150 mmol) in THF (180 mL)
at 0 °C was added nBuLi (2.5m in hexane, 60 mL, 150 mmol) dropwise and the
reaction mixture was left stirring at 0 °C for 30 minutes. A solution of 308 in THF
(48 mL) was then added dropwise in 15 minutes. The reaction mixture was then
left stirring at rt for 46 hours. A saturated aqueous solution of NH4Cl (420 mL)
was added. The organic phase was extracted with diethyl ether (3 x 300 mL) and
then washed with brine (250 mL). The combined organic phases were dried over
Na2SO4, filtered and then concentrated in vacuo keeping the water bath at a max
temperature of 30 °C and a pressure of 100 mbar to avoid any evaporation of the
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targeted product. The concentrated organic phase was then filtered through a short
pad of silica and washed with a mixture of diethyl ether and pentane (1:1, 1.2 L).
The organic solvent was concentrated again in vacuo to afford a colourless oil as
pure product 232 (9.5 g, 60.0 mmol, 80% yield). 1H NMR (400 MHz, CDCl3) δ
5.80 (1 H, ddt, J = 16.9, 10.2, 6.7, H-6), 5.05 – 4.87 (1 H, m, H-7), 4.36 (1 H, t, J
= 5.8, H-1), 3.31 (6 H, s, H-8), 2.19 – 1.94 (2 H, m, H-5), 1.73 – 1.47 (2 H, m, H-2),
1.49 – 1.25 (4 H, m, H-4, H-3). 13C NMR (101 MHz, CDCl3) δ 138.8 (C-6), 114.4















To a heat dried two-neck round bottomed flask charged with magnetic stir-bar
was added activated 4Å molecular sieves (2 g), AgNO2 (40.4 g, 238 mmol) and
TEMPO (3.7 g, 23.8 mmol). Olefin 232 (9.4 g, 59.6 mmol) and anhydrous DCE
(186 mL) were added. The round bottomed flask was then placed in a preheated oil
bath at 70 °C and the reaction mixture was left stirring vigorously. The progress
of the reaction was monitored by TLC and after 17 hours the reaction mixture was
left to cool down to rt. The reaction mixture was then filtered through a short pad
of celite washed with ethyl acetate (1 L) and concentrated in vacuum. The crude
product was then purified via combiflash using silica gel columns and a gradient
solution of ethyl acetate and hexane up to 30% diethyl ether in hexane to afford the
title compound 233 as a colourless oil (5.8, 28.5 mmol, 48%). 1H NMR (400 MHz,
CDCl3) δ 7.23 – 7.12 (1 H, m, H-6), 6.89 (1 H, dt, J = 13.4, 1.5, H-7), 4.47 – 4.03
(1 H, m, H-1), 3.22 (6 H, d, J = 3.8, H-8), 2.19 (2 H, qd, J = 7.4, 1.6, H-5), 1.72 –
1.39 (4 H, m, H-2, H-4), 1.39 – 1.22 (2 H, m, H-3). 13C NMR (101 MHz, CDCl3) δ
142.3 (C-6), 139.7 (C-7), 104.3 (C-1), 52.9 (C-8), 32.2(C-2), 28.4(C-5), 27.6 (C-4),
24.1 (C-3).












To neat acetal 233 (2.940 g, 14.5 mmol), glacial acetic acid (14.5 mL) was added
at 0 °C and, as soon as frozen, HCl (1n, 4.8 mL) was added. The reaction mixture
was left stirring at rt. The progress of the reaction was monitored by TLC and 1H
NMR and after 20 hours CH2Cl2 (30 mL) was added to the reaction mixture and
washed with H2O (2 x 50 mL) and a saturated aqueous solution of NaHCO3 (50mL).
The organic phase was back extracted with CH2Cl2 (3 x 50 mL) and then the organic
phases were combined, dried (Na2SO4), filtered and concentrated in vacuo with a
30 °C water bath temperature at a max pressure of 100 mbar. Purification by
combiflash (silica gel, gradient up to 55% diethyl ether in pentane) afforded the title
compound as a colourless oil (0.760 g, 4.8 mmol, 34% yield). The characterisation
of compound 214 was described in method E.
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Scheme 6.5: Synthetic procedure for the synthesis of bifunctional catalysts 238 and 239.
To a stirred solution of 309 in anhydrous CH2Cl2 was added the isocyanate at
rt. The reaction mixture was stirred at rt for 18 hours and then concentrated in
vacuo to afford the crude protected product as a white solid and it was used without
further purification for the following step. The N-Boc derivative was dissolved in a
mixture of trifluoroacetic acid and CH2Cl2 (40 mL, v/v = 1:1) and the solution was
stirred at rt for 3 h. The pH was then adjusted to 8 with saturated aqueous solution
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of NaHCO3 and then the organic phase was extracted with CH2Cl2 (3 x 150 mL).
Organic layers were combined and dried over MgSO4, filtered and concentrated in
vacuo. The crude product was then purified via flash chromatography on alumina
























Following general procedure G, the urea catalyst 238 was obtained from the
nucleophilic addition of the amine 309 (4.35 mmol, 0.871 g) in anhydrous CH2Cl2
(30 mL) to isothiocyanate (4.35 mmol, 0.8 mL). The obtained crude protected amine
was deprotected with trifluoroacetic acid and CH2Cl2 (40 mL, v/v = 1:1) to afford
the thiourea 239 as a white powder (0.565g, 36% yield). [α]20D + 30.0 (c = 0.1,
CH2Cl2); 1H NMR (400 MHz, CD3OD) δ 7.97 (2H, s, H-11), 7.43 (1H, s, H-13), 3.71
– 3.55 (1H, m, H-2), 3.42 (1H, d, J = 6.6 Hz, H-1), 3.32 - 3.07 (1H, m, H-5), 2.21
– 2.01 (1H, m, H-3), 2.01 – 1.84 (2H, m, H-4), 1.79 - 1.59 (1H, m, H-3).13C NMR
(101 MHz, CD3OD) δ 156.9 (C-8), 141.8 (C-10), 131.7 (q, J = 33.0 Hz, C-14), 123.4
(q, J = 271.7 Hz, C-12), 117.8 (d, J = 4.0 Hz, C-11), 114.6 – 114.1 (m, C-13), 61.3
























Following general procedure G, the thiourea catalyst 239 was obtained from the
nucleophilic addition of the amine 309 (4.35 mmol, 0.871 g) in anhydrous CH2Cl2
(30 mL) to isothiocyanate (4.35 mmol, 0.75 mL). The obtained crude protected
amine was deprotected with trifluoroacetic acid and CH2Cl2 (40 mL, v/v = 1:1) to
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afford the thiourea 239 as a white powder (0.86 g, 56% yield). [α]20D - 29.0 (c =
0.1, CH2Cl2) 1H NMR (400 MHz, CD3OD) δ 8.18 (2H, s, H-11), 7.57 (1H, s, H-13),
3.98 – 3.79 (3H, m, H-1 and H-2), 3.40 – 3.11 (2H, m, H-5), 2.18 – 2.05 (1H, m,
H-3'), 2.04 – 1.87 (2H, m, H-4), 1.76 (1H, qd, J = 8.2, 3.8 Hz, H-3''). 13C NMR (101
MHz, CD3OD) δ 184.2 (C-8), 142.9 (C-10), 133.8 – 131.6 (m, C-12), 126.1 (C-14),
124.8 – 123.5 (m, C-11), 118.8 – 117.4 (m, C-13), 61.8 (C-2), 46.6 (C-5), 45.6 (C-1),
28.7 (C-3), 24.4 (C-4).


































A solution of isothiocyanate (2 mmol) in CH2Cl2 (10 mL) was added dropwise
over 2 hours via a syringe pump to a stirred solution of (1R,2R)-1,2-diphenylethane-
1,2-diamine (4 mmol) in anhydrous CH2Cl2 (10 mL) at 0 °C. The reaction mixture
was stirred at rt for 14 hours. Then, the reaction mixture was concentrated in
vacuo and the residue was purified by flash chromatography on silica gel (eluent
phase: 10% MeOH in CH2Cl2) to afford the corresponding thiourea. White solid,
59% yield; [α]20D + 109.0 (c = 0.1, CH2Cl2); 1H NMR (CDCl3, 400 MHz) δ 7.56
(1H, br s, H-4), 7.55 – 7.37 (2H, m, H-1 and Ar-H), 7.37 - 7.05 (14H, m, Ar-H), 5.47
(1H, s, H-6), 4.35 (1H, d, J = 3.1 Hz, H-2), 1.40 (2H, br s, H-3). 13C NMR (CDCl3,
101 MHz) δ 180.7 (C-5), 141.5 (Ar-C), 140.0 (Ar-C), 136.1 (Ar-C), 130.0 (Ar-C),
128.8 (Ar-C), 128.5 (Ar-C), 128.5 (Ar-C), 127.8 (Ar-C), 127.5 (Ar-C), 126.4 (Ar-C),
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126.3 (Ar-C), 125.7 (Ar-C), 64.3 (C-1), 59.3 (C-2).





































To a solution of (S)-(-)-5-(2-pyrrolidinyl)-1H-tetrazole (5 mol%, 0.35 mmol,
0.051 g) and DCE (130 mL) previously sonicated for 30 minutes was added the nitro
olefin 214 (1.104 g, 7.0 mmol) at -20 °C dropwise in 3 minutes followed by DCE
(5 mL) to wash the syringe used and the sides of the reaction flask. The reaction
mixture was left stirring at -20 °C for 99 hours. The progress of the reaction was
monitored by TLC and 1H NMR. Once the reaction went to completion the reaction
was reduced in situ. NaBH4 (0.397 g, 10.5 mmol) was added at -20 °C followed by
MeOH (10.9 mL). The reaction went to completion in 1 hour. A saturated aqueous
solution of NH4Cl (15 mL) was added, followed by brine (50 mL) and H2O (20 mL).
The organic phase was extracted first with a mixture of chloroform and isopropanol
(3:1, 80 mL x 5), then with diethyl ether (3 x 150 mL) and finally with ethyl acetate
(3 x 100 mL) because of the high affinity of the product with the aqueous phase.
The organic phase was then dried (Na2SO4), filtered and concentrated in vacuo.
The crude product was then purified by flash chromatography on silica gel (25%
ethyl acetate in hexane) to afford separately both diastereomers, cis and trans, as a
colourless oil (0.820 g, 9:1 cis/trans ratio, 74%). Cis-226: 92% ee; HPLC analysis:
Chiralpack OD, 2% isopropanol in hexane, flow rate = 0.8 mL/min, λ = 210 nm.
6.9. Synthesis of nitroalcohol derivative 241 162
[α]20D -14 (c = 0.1, CH2Cl2). IR (neat, cm−1) 3376, 2958, 2877, 1543, 1383, 1022;
1H NMR (400 MHz, CDCl3) δ 4.55 (2H, ABX, JAX = 6.6 Hz, JBX = 9.1 Hz, JAB =
12.7, νAB = 138.5, H-7), 3.67 – 3.50 (2H, m, H-1), 2.87 – 2.71 (1H, m, H-6), 2.38 –
2.25 (1H, m, H-2), 1.91 – 1.79 (2H, m, H-5'and H-3'), 1.79 – 1.69 (1H, m, H-4'), 1.71
– 1.56 (1H, m, H-4''), 1.57 – 1.32 (2H, m, H-5'', H3''). 13C NMR (101 MHz, CDCl3)
δ C 77.2 (C-7), 63.2 (C-1), 43.1 (C-2), 40.3 (C-6), 29.3 (C-5), 28.0 (C-3), 23.1 (C-4);
HRMS required for C7H43NO3 [M+H]+ is 160.0974, found 160.0980. Trans-226:
45% ee; HPLC analysis: Chiralpack OD, 1% isopropanol in hexane, flow rate = 1
mL/min, λ = 210 nm. [α]20D - 8 (c = 0.1, CH2Cl2). 1H NMR (400 MHz, CDCl3) δ
4.44 (2 H, ABX, JAX = 5.7 Hz, JBX = 8.8 Hz,JAB = 11.8 Hz, νAB = 110.5, H-7),
3.77 - 3.50 (2 H, m, H-1), 2.54 - 2.38 (1 H, m, H-6), 2.01 - 1.88 (1 H, m, H-5'), 1.88 -
1.75 (2 H, m, H-2 and H-3'), 1.71 - 1.53 (2 H, m, H-4), 1.53 - 1.33 (1 H, m, H-5''and
H-3'').13C NMR (CDCl3, 101 MHz) δ 79.1 (C-7), 64.9 (C-1), 44.1 (C-2), 40.6 (C-6),
29.8 (C-5), 27.9 (C-3), 23.1 (C-4).























To a solution of the nitro alcohol cis-226 (0.040 g, 0.25 mmol) and imidazole
(17 µl, 0.30 mmol) in anhydrous THF (2.5 mL), (S)-(-)-camphanic chloride was
added at 0 °C. The reaction mixture was refluxed for 4 hours and then left stirring
at rt for 20 more hours as the reaction was not gone to completion yet. Then, H2O
(5 mL) was added and the organic phase was extracted with diethyl ether (3 x 10
mL), then dried (Na2SO4), filtered and concentrated in vacuo. The crude product
was then recrystallised in a solvent mixture of methanol, ethyl acetate and hexane
(2:1:4) to obtain the X-ray crystal of the title compound 241 as a white solid. mp
= 71.5 - 73.6 °C; [α]20D - 12.0 (c = 0.1, CH2Cl2); IR (neat, cm−1) 2969, 1778, 1743,
1546, 1449, 1398, 1381, 1315, 1266, 1225, 1173, 1154, 1113, 1063, 1034, 1020; 1H
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NMR (400 MHz, CDCl3) δ 4.36 (2H, ABX, JAX = 6.7 Hz, JBX = 8.9 Hz, JAB =
12.6 Hz, νAB = 96,4 Hz, H-7), 4.10 (2H, qd, J = 11.5, 6.7, H-1), 2.85 - 2.70 (1H,
m, H-6), 2.51 - 2.42 (1H, m, H-2), 2.42 - 2.29 (1H, m, H-10'), 2.06 - 1.92 (1H, m,
H-10''), 1.92 - 1.77 (3H, m, H-5'and H-4', H-11'), 1.72 (2H, m, H-3), 1.68 - 1.51 (1H,
m, H-11''), 1.51 - 1.31 (3H, m, H-4''and H-5'') 1.05 (3H, s, H-14), 1.00 (3H, s, H-16),
0.90 (3H, s, H-17). 13C NMR (101 MHz, CDCl3) δ 178.0 (C-13), 167.5 (C-8), 91.0
(C-9), 76.5 (C-7), 65.3 (C-1), 54.8 (C-12), 54.3 (C-15), 40.2 (C-6), 39.9 (C-2), 30.7
(C-10), 29.0 (C-11), 28.9 (C-5), 28.1 (C-4), 22.6 (C-3), 16.8 (C-16), 16.8 (C-17), 9.7
(C-14). HRMS required for C17H26NO6 [M+H]+ is 340.1760, found 340.1762.
Figure 6.4: X-ray crystal structure of the nitro alcohol derivative 241 (CCDC : 1947228).
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Crystal size/mm3 0.09 × 0.07 × 0.05
Radiation CuKα (λ = 1.54184)
2Θ range for data collection/° 7.95 to 119.994
Index ranges -7 ≤ h ≤ 6, -13 ≤ k ≤ 13, -12 ≤ l ≤ 12
Reflections collected 6574
Independent reflections 2431 [Rint = 0.0266, Rsigma = 0.0283]
Data/restraints/parameters 2431/1/220
Goodness-of-fit on F2 1.097
Final R indexes [I>=2σ (I)] R1 = 0.0292, wR2 = 0.0719
Final R indexes [all data] R1 = 0.0310, wR2 = 0.0737
Largest diff. peak/hole / e Å−3 0.15/-0.17
Flack parameter -0.10(9)
6.10. Synthetic procedure for the synthesis of α-substituted nitroolefins 165
































Scheme 6.7: Synthesis of α-substituted nitro olefin substrates.
General procedure H for the synthesis of nitro alcohols 242.
Potassium tert-butoxide (0.2 eq.) was added to a solution of 231 (1 eq.) (obtained
as described in Method F), nitroalkane (3 eq.) in a mixture of t-BuOH and THF (v/v
= 1:1) and it was left stirring for 3 h. The reaction mixture was then diluted with
ethyl acetate and the organic phase was washed with H2O and brine. The aqueous
phase was back extracted with ethyl acetate and the combined organic layers were
then dried (Na2SO4), filtered and concentrated in vacuo. The crude product was

















Following the general procedure H, potassium tert-butoxide (0.140 g, 1.3 mmol)
was added to a solution of 231 (1.0 g, 6.2 mmol), 1-nitroethane (1.3 mL, 18.7 mmol)
in a mixture of t-BuOH and THF (12.4 mL, v/v = 1:1) to afford two diastereomers
of the nitro alcohol 242a as a colourless oil (0.73 g, 50% yield). Mixture of diastere-
omers (1:1 syn/anti): IR (neat, cm−1) 2945, 1546, 1454, 1390, 1126, 1022, 984; 1H
NMR (CDCl3, 400 MHz) δ 4.53 – 4.37 (2H, m, H-7), 4.29 (2H, td, J = 5.7, 0.7 Hz,
H-1), 4.12 (1H, ddd, J = 8.6, 4.0, 2.9 Hz, H-6), 3.84 (1H, ddd, J = 9.7, 4.7, 2.2 Hz,
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H-6), 3.42 and 3.25 (12H, d, J = 0.9 Hz, H-9), 1.60 – 1.51 (4H, m, H-2 and H-3), 1.49
(3H, J = 1.5 Hz, H-8), 1.48 (3H, d, J = 1.5 Hz, H-8), 1.43 – 1.25 (12H, m, H-2, H-3,
H-4 and H-5). 13C NMR (CDCl3, 101 MHz) δ 104.4 (C-1), 87.7 (C-7), 86.4 (C-7),
72.7 (C-6), 71.9 (C-6), 52.7 (C-9), 50.9 (C-9), 32.9 (C-5), 32.9 (C-2), 32.3 (C-2), 25.6
(C-5), 25.0 (C-3), 24.7 (C-3), 24.3 (C-4), 24.3 (C-4), 16.3 (C-8), 12.4 (C-8). HRMS




















Following the general procedure H, potassium tert-butoxide (0.140 g, 1.3 mmol)
was added to a solution of 231 (1.0 g, 6.2 mmol), 1-nitropropane (1.7 mL, 18.7 mmol)
in a mixture of t-BuOH and THF (12.4 mL, v/v = 1:1) to afford two diastereomers
of the nitro alcohol 242b as a colourless oil (0.83 g, 54% yield). Mixture of diastere-
omers (1:1 syn/anti): IR (neat, cm−1) 3429, 2944, 1545, 1460, 1375, 1126, 1049,
954, 808; 1H NMR (CDCl3, 400 MHz) δ 4.36 – 4.21 (4H, m, H-7 and H-1), 3.95
(1H, dt, J = 8.3, 4.1 Hz, H-6), 3.89 – 3.77 (1H, m, H-6), 3.41 and 3.25 (12H, s,
H-10), 2.58 – 2.19 (2H, m, H-11), 2.14 - 1.89 (2H, m, H-8), 1.88 – 1.69 (2H, m, H-8),
1.61 – 1.20 (16H, m, H-2, H-3, H-4 and H-5), 0.92 (6H, td, J = 7.4, 3.5 Hz, H-9).
13C NMR (CDCl3, 101 MHz) δ 104.3 (C-1), 94.4 (C-7), 93.9 (C-7), 72.1 (C-6), 71.6
(C-6), 52.8 (C-10), 52.7 (C-10), 33.7 (C-5), 33.4 (C-5), 33.1 (C-2), 32.3 (C-2), 25.5
(C-4), 25.1 (C-4), 24.3 (C-3), 24.3 (C-3), 23.9 (C-8), 21.5 (C-8). , 21.5, 10.6 (C-9),
10.2 (C-9). HRMS required for C11H23NO5 [M+Na]+ 272.1474, found 272.1470.






















Following the general procedure H, potassium tert-butoxide (0.13 g, 1.1 mmol)
was added to a solution of 231 (0.91 g, 5.7 mmol), 1-nitropentane (2.1 mL, 17.1
mmol) in a mixture of t-BuOH and THF (11.4 mL, v/v = 1:1) to afford two di-
astereomers of the nitro alcohol 242c as a colourless oil (1.0 g, 64% yield). Mixture
of diastereomers (1:1 syn/anti): IR (neat, cm−1) 3429, 2938, 1547, 1460, 1382, 1127,
1049; 1H NMR (CDCl3, 400 MHz) δ 4.37 (1H, ddt, J = 12.6, 6.2, 3.9 Hz, H-7), 4.29
(1H, td, J = 5.7, 1.3 Hz, H-1), 3.94 (0.4H dq, J = 8.4, 4.1 Hz, H-6), 3.82 (0.6H, dd,
J = 9.4, 6.3 Hz, H-6), 3.25 (6H, s, H-12), 2.33 (0.4H, d, J = 4.7 Hz, H-13), 2.19
(0.6H, d, J = 7.9 Hz, H-13), 2.12 – 1.89 (1H, m, H-8), 1.72 (1H, dddd, J = 15.6,
14.2, 5.9, 3.7 Hz, H-8), 1.64 – 1.15 (12H, m, H-2, H-3, H-4, H-5, H-9 and H-10),
0.90 – 0.75 (3H, m, H-11). 13C NMR (CDCl3, 101 MHz) δ 104.4 (C-1), 92.9 (C-7),
92.3 (C-7), 72.2 (C-6), 71.9 (C-6), 52.8 (C-12), 52.7 (C-12), 33.5 (C-5), 33.1 (C-5),
32.3 (C-2), 32.3 (C-2), 30.2 (C-8), 28.1 (C-8), 27.8 (C-9), 27.7 (C-9), 25.5 (C-10),
25.1 (C-10), 24.3 (C-3), 24.3 (C-3), 22.2 (C-4), 22.1 (C-4), 13.7 (C-11), 13.7 (C-11).






To a solution of sodium nitrite (3.59 g, 52 mmol) in anhydrous DMF (230 mL)
at -78 °C was added 2-bromo ethyl benzene (5.5 mL, 40 mmol) and it was left stirring
overnight leaving the cooling bath to warm up to rt. The reaction was monitored by
TLC, and after 20 hours the reaction mixture was concentrated in vacuo to reduce
the amount of DMF. The reaction mixture was then diluted with ethyl acetate (50
mL) and the organic phase was washed with H2O (3 x 50 mL). The combined organic
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layers were dried (Na2SO4), filtered and concentrated in vacuo. The crude product
was purified via flash chromatography on silica gel (10% ethyl acetate in hexane) to
afford the title product as a yellow liquid (2.32 g, 38% yield). 1H NMR (CDCl3, 400
MHz) δ 7.41 – 7.33 (2 H, m, Ar-H), 7.33 – 7.26 (1 H, m, Ar-H), 7.28 – 7.17 (2 H,
m, Ar-H), 4.64 (2 H, t, J = 7.4 Hz, H-1), 3.35 (2 H, t, J = 7.4 Hz, H-2); 13C NMR





















Following the general procedure H, potassium tert-butoxide (0.140 g, 1.3 mmol)
was added to a solution of 231 (1.0 g, 6.2 mmol), (2-nitroethyl)benzene 312 (2.83
g, 18.7 mmol) in a mixture of t-BuOH and THF (12.4 mL, v/v = 1:1) to afford two
diastereomers of the nitro alcohol 242d as a yellow oil (1.51 g, 78% yield). Mixture
of diastereomers (1:1 syn/anti): IR (neat, cm−1) 3431, 2942, 1723, 1547, 1497, 1456,
1371, 1128, 1051, 858, 749, 699; 1H NMR (CDCl3, 400 MHz) δ 7.32 – 7.17 (3H, m,
Ar-H), 7.16 – 7.03 (2H, m, Ar-H), 4.68 – 4.56 (1H, m, H-7), 4.28 (1H, t, J = 5.6 Hz,
H-1), 4.13 – 3.98 (0.3H, m, H-6), 3.78 (0.7H, tt, J = 8.7, 4.5 Hz, H-6), 3.39 - 3.00
(8H, m, H-8 and H-9), 2.40 – 2.35 (0.3H, m, H-5), 2.30 – 2.23 (1H, m, H-5), 1.60
– 1.25 (6H, m, H-2, H-3, H-4). 13C NMR (CDCl3, 101 MHz) δ 135.7 (Ar-C), 135.1
(Ar-C), 128.9 (Ar-C), 128.9 (Ar-C), 128.9 (Ar-C), 128.8 (Ar-C), 127.6 (Ar-C), 127.4
(Ar-C), 104.4 (C-1), 104.3 (C-1), 93.5 (C-7), 93.4 (C-7), 72.2 (C-6), 71.2 (C-6), 52.8
(C-9), 52.8 (C-9), 36.6 (C-8), 34.4 (C-8), 33.8 (C-5), 33.2 (C-5), 32.3 (C-2), 25.4
(C-3), 25.3 (C-3), 24.3 (C-4), 24.2 (C-4). HRMS required for C16H25NO5 [M+Na]+
334.1630, found 334.1629.
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quant. yield 53% yield313 314 315













To a solution of ǫ-caprolactone 313 (9.7 mL, 87.6 mmol) in anhydrous methanol
(175 mL), potassium carbonate (1.21 g, 8.8 mmol) was added and the reaction
mixture was stirred vigorously for 20 minutes. H2O (200 mL) was then added and
the organic phase was extracted with CH2Cl2 (5 x 200 mL). The combined organic
layers were dried (Na2SO4), filtered and concentrated at 25 °C in vacuo. The alcohol
314 was achieved as a colourless oil (12.8 g, quantitative yield) and it did not need
any further purification. 1H NMR (CDCl3, 400 MHz) δ 3.62 – 3.53 (5 H, m, H-8
and H-6), 2.26 (2 H, t, J = 7.5 Hz, H-2), 1.65 – 1.55 (2 H, m, H-3), 1.55 – 1.47 (2
H, m, H-5), 1.45 (1 H, s, H-7), 1.39 – 1.28 (2 H, m, H-4). 13C NMR (CDCl3, 101













To a solution of the alcohol 314 (6.60 g, 45.1 mmol) in a mixture of CH2Cl2
and DMSO (v/v, 1:1, 90.2 mL), anhydrous triethylamine (37.7 mL, 270.8 mmol) was
added at -5 °C, followed by the addition of the SO3·pyridine complex (8.97 g, 56.4
mmol) in a single portion. CH2Cl2 (5 mL) was added dropwise to clean the neck of
the round bottom flask. The reaction mixture was stirred at -5 °C for 2 hours and
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then another portion of SO3·pyridine complex (8.97 g, 56.4 mmol) was added. After
2 extra hours, a saturated aqueous solution of NH4Cl (100 mL). Diethyl ether (100
mL) was added to dilute the solution and then the organic phase was washed with
NH4Cl (3 x 50 mL), followed by a saturated solution of CuSO4 (2 x 50 mL), then
with brine (50 mL) and finally with NaHCO3 (50 mL). The organic layer was then
dried (Na2SO4), filtered and concentrated in vacuo. The product 315 was achieved
as a colourless oil (3.48 g, 53% yield) and did not need any further purification. 1H
NMR (CDCl3, 400 MHz) δ 9.70 (1 H, t, J = 1.6 Hz, H-7), 3.61 (3 H, s, H-7), 2.40
(2 H, ddq, J = 5.8 Hz, 4.4 Hz, 1.4 Hz, H-5), 2.33 – 2.20 (2 H, m, H-2), 1.68 – 1.46
(4 H, m, H-3 and H-4). 13C NMR (CDCl3, 101 MHz) δ 202.0 (C-6), 173.7 (C-1),
















To a solution of 315 (0.80 g, 5.6 mmol) and nitrotoluene (2.28 g, 16.7 mmol)
in a mixture of t-BuOH and THF (11.2 mL, v/v = 1:1) was added potassium tert-
butoxide (0.125 g, 1.1 mmol) at 0 °C. The reaction mixture was left stirring at
rt for 4 hours and then it was diluted with ethyl acetate (30 mL). The organic
phase was washed with H2O (30 mL) and with brine (30 mL). The organic phase
was back extracted from the aqueous phase with ethyl acetate (3 x 50 mL). The
combined organic layers were dried (Na2SO4), filtered and concentrated in vacuo.
The crude product was purified via flash chromatography on silica gel (25% ethyl
acetate in hexane) to afford the nitro alcohol 242e as a yellow solid (0.81 g, 52%
yield). Mixture of two diastereomers syn/anti: mp = 58.6 - 60.0 °C; IR (neat,
cm−1) 3424, 3381, 2952, 2924, 1724, 1562, 1456, 1436, 1366, 1250, 1228, 1195, 1177,
1115, 962, 725, 695, 622; 1H NMR (CDCl3, 400 MHz) δ 7.47 – 7.35 (5H, m, Ar-H),
5.32 (1H, d, J = 9.7 Hz, H-7), 4.66 – 4.48 (1H, m, H-6), 3.64 (3H, s, H-8), 2.85 -
2.69 (1H, m, H-9), 2.39 - 2.20 (2H, m, H-2), 1.74 – 1.10 (6H, m, H-3 and H-4 and
H-5). 13C NMR (CDCl3, 101 MHz) δ 174.1 (C-1), 132.0 (Ar-C), 131.3 (Ar-C), 130.3
(Ar-C), 130.2 (Ar-C), 129.3 (Ar-C), 129.1 (Ar-C), 129.1 (Ar-C), 128.0 (Ar-C), 96.7
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(C-7), 94.0 (C-7), 72.2 (C-6), 71.7 (C-6), 51.6 (C-8), 33.8 (C-2), 33.7 (C-2), 32.9
(C-5), 31.8 (C-5), 24.9 (C-3), 24.5 (C-3), 24.4 (C-4), 24.3 (C-4). HRMS required for
C16H22N2O5 [M+Na]+ 345.1426, found 345.1430.
General procedure I for the synthesis of nitro olefins 243.
To a solution of the nitro alcohol 242 in anhydrous CH2Cl2, trifluoroacetic anhydride
(1.05 eq) followed by triethylamine (2.1 eq.) were added dropwise at 0 °C. The
reaction mixture was left stirring at 0 °C for 3.5 hours and then an aqueous saturated
solution of NH4Cl was added, followed by H2O. The organic phase was extracted
with CH2Cl2 and then dried over Na2SO4 and filtered through a short plug of celite
and concentrated in vacuo. Purification of the crude product was performed by














Following the general procedure I, the nitro alcohol 242a (0.70 g, 3.0 mmol)
was reacted with trifluoroacetic anhydride (0.43 mL, 3.1 mmol) and anhydrous tri-
ethylamine (0.9 mL, 6.3 mmol) to afford the nitro olefin 243a as colourless oil (0.49
g, 75% yield). IR (neat, cm−1) 2944, 1517, 1437, 1390, 1331, 1123, 1072, 1049, 963,
912, 722; 1H NMR (CDCl3, 400 MHz) δ 7.06 (1H, tq, J = 7.9, 1.1 Hz, H-6), 4.29
(1H, t, J = 5.6 Hz, H-1), 3.25 (6H, s, H-9), 2.24 – 2.12 (2H, m, H-5), 2.09 (3H, d, J
= 1.0 Hz, H-8), 1.62 – 1.52 (2H, m, H-2), 1.52 – 1.41 (2H, m, H-4), 1.41 – 1.24 (2H,
m, H-3). 13C NMR (CDCl3, 101 MHz) δ 147.7 (C-7), 136.0 (C-6), 104.3 (C-1), 52.9
(C-9), 32.3 (C-2), 28.2 (C-4), 28.1 (C-5), 24.3 (C-3), 12.5 (C-8). HRMS required for
C10H18NO4 [M-H]− 216.1230, found 216.1228.

















Following the general procedure I, the nitro alcohol 242b (0.80 g, 3.2 mmol)
was reacted with trifluoroacetic anhydride (0.47 mL, 3.4 mmol) and anhydrous tri-
ethylamine (0.94 mL, 6.7 mmol) to afford the nitro olefin 243b as a colourless oil
(0.34 g, 46% yield). IR (neat, cm−1) 2940, 1517, 1460, 1337, 1124, 1072, 1051; 1H
NMR (CDCl3, 400 MHz) δ 6.99 (1H, t, J = 7.9 Hz, H-6), 4.29 (1H, t, J = 5.7 Hz,
H-1), 3.25 (6H, s, H-10), 2.53 (2H, q, J = 7.4 Hz, H-8), 2.17 (2H, q, J = 7.6 Hz,
H-5), 1.62 – 1.50 (3H, m, H-2 and ), 1.50 – 1.42 (2H, m, H-4), 1.41 – 1.27 (2H, m,
H-3), 1.04 (3H, t, J = 7.4 Hz, H-9). 13C NMR (CDCl3, 101 MHz) δ 153.3 (C-7),
135.6 (C-6), 104.3 (C-1), 52.9 (C-10), 32.3 (C-2), 28.4 (C-4), 27.8 (C-5), 24.4 (C-3),




















Following the general procedure I, the nitro alcohol 242c (0.96 g, 3.4 mmol)
was reacted with trifluoroacetic anhydride (0.50 mL, 3.6 mmol) and anhydrous tri-
ethylamine (1.0 mL, 7.1 mmol) to afford the nitro olefin 243a as colourless oil (0.49
g, 55% yield). IR (neat, cm−1) 2933, 1517, 1456, 1336, 1125, 1072, 1051, 957; 1H
NMR (CDCl3, 400 MHz) δ 7.00 (1H, t, J = 7.9 Hz, H-6), 4.29 (1H, t, J = 5.6 Hz,
H-1), 3.26 (6H, s, H-12), 2.60 – 2.44 (2H, m, H-8), 2.17 (2H, q, J = 7.6 Hz, H-5),
1.61 – 1.51 (3H, m, H-2 and), 1.51 – 1.21 (8H, m, H-3, H-4, H-9 and H-10), 0.86 (3H,
t, J = 7.2 Hz, H-11). 13C NMR (CDCl3, 101 MHz) δ 152.0 (C-7), 136.0 (C-6), 104.3
(C-1), 52.9 (C-12), 32.3 (C-2), 30.0 (C-9), 28.4 (C-4), 28.0 (C-5), 26.1 (C-8), 24.4
(C-3), 22.4 (C-10), 13.8 (C-11). HRMS required for C15H28N2O4 [M+CH3CN+Na]+


















Following the general procedure I, the nitro alcohol 242d (1.75 g, 5.6 mmol)
was reacted with trifluoroacetic anhydride (0.82 mL, 5.9 mmol) and anhydrous tri-
ethylamine (1.6 mL, 11.8 mmol) to afford the nitro olefin 243d as a colourless oil
(0.51 g, 31% yield). 1H NMR (CDCl3, 400 MHz) δ 7.26 – 7.08 (7H, m, Ar-H and
H-6), 4.28 (1H, t, J = 5.6 Hz, H-1), 3.90 (2H, s, H-8), 3.25 (6H, s, H-9), 2.29 (2H, q,
J = 7.6 Hz, H-5), 1.62 – 1.42 (4H, m, H-2 and H-4), 1.42 – 1.29 (2H, m, H-3). 13C
NMR (CDCl3, 101 MHz) δ 150.4 (C-7), 137.6 (Ar-C), 136.5 (Ar-C), 128.7 (Ar-C),
128.0 (C-6), 126.9 (Ar-C), 104.3 (C-1), 52.9 (C-9), 32.3 (C-2), 32.0 (C-8), 28.3 (C-4),














Following the general procedure I, the nitro alcohol 242e (0.81 g, 2.9 mmol)
was reacted with trifluoroacetic anhydride (0.42 mL, 3.0 mmol) and anhydrous tri-
ethylamine (0.84 mL, 6.0 mmol) to afford the nitro olefin 243e as a yellow oil (0.51
g, 67% yield). IR (neat, cm−1) 2952, 2862, 1733, 1635, 1521, 1495, 1437, 1332, 1277,
1196, 1173, 772, 701; 1H NMR (CDCl3, 400 MHz) δ 7.54 – 7.42 (3H, m, Ar-H), 7.39
(1H, t, J = 8.0 Hz, H-6), 7.34 – 7.21 (2H, m, Ar-H), 3.68 (3H, s, H-8), 2.29 (2H,
t, J = 7.2 Hz, H-2), 2.17 (2H, dt, J = 8.0, 7.2 Hz, H-5), 1.70 – 1.58 (2H, m, H-3),
1.58 – 1.47 (2H, m, H-4). 13C NMR (CDCl3, 101 MHz) δ 173.6 (C-1), 151.6 (C-7),
137.9 (C-6), 130.3 (Ar-C), 129.7 (Ar-C), 129.5 (Ar-C), 128.6 (Ar-C), 51.6 (C-8), 33.6
(C-2), 28.2 (C-5), 27.9 (C-4), 24.4 (C-3). HRMS required for C14H18N2O4 [M+H]+
264.1230, found 264.1222.
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General procedure L for the synthesis of aldehydes 244.
To neat nitro olefin 243 glacial acetic acid (1 mL/mmol) was added at 0 °C. Once
frozen, 1n aqueous HCl solution (0.33 mL/mmol) was added and the reaction mix-
ture was left stirring at rt for 17 hours. CH2Cl2 was added to the reaction mixture,
and the organic phase was washed with H2O and then with NaHCO3. The aqueous
phase was back extracted with CH2Cl2 and then the combined organic layers were
dried (Na2SO4), filtered and concetrated in vacuo. The crude product was then pu-
rified via combiflash on silica gel (gradient 0-30% diethyl ether in hexane) to afford













Following the general procedure L, glacial acetic acid (2.2 mL, 1 mL/mmol) and
1n aqueous HCl solution (0.73 mL) were added to the neat nitro olefin 243a (0.476
g, 2.2 mmol) to afford the aldehyde 244a as a pale yellow oil (0.20 g, 54% yield). IR
(neat, cm−1) 2936, 2862, 1721, 1671, 1460, 1437, 1390, 1329, 1090, 1058, 1036, 966,
907, 855, 722, 669, 659; 1H NMR (CDCl3, 400 MHz) δ 9.72 (1H, t, J = 1.4 Hz, H-1),
7.04 (1H, t, J = 7.9 Hz, H-6), 2.43 (2H, td, J = 7.1, 1.5 Hz, H-2), 2.28 – 2.14 (2H,
m, H-5), 2.10 (3H, s, H-8), 1.71 – 1.57 (2H, m, H-3), 1.57 – 1.41 (2H, m, H-4). 13C
NMR (CDCl3, 101 MHz) δ 201.8 (C-1), 147.9 (C-7), 135.4 (C-6), 43.5 (C-2), 27.9















Following the general procedure L, glacial acetic acid (8.9 mL, 1 mL/mmol) and
1n aqueous HCl solution (2.9 mL) were added to the neat nitro olefin 243b (2.1 g,
8.9 mmol) to afford the aldehyde 244b as a pale yellow oil (0.46 g, 28% yield). 1H
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NMR (CDCl3, 400 MHz) δ 9.80 (1H, t, J = 1.5 Hz, H-1), 7.06 (1H, t, J = 7.9 Hz,
H-6), 2.63 (2H, q, J = 7.4 Hz, H-8), 2.52 (2H, td, J = 7.1, 1.5 Hz, H-2), 2.28 (2H,
q, J = 7.6 Hz, H-5), 1.79 – 1.65 (2H, m, H-3), 1.65 – 1.49 (2H, m, H-4), 1.14 (3H,
t, J = 7.4 Hz, H-9). 13C NMR (CDCl3, 101 MHz) δ 201.7 (C-1), 153.5 (C-7), 134.9

















Following the general procedure L, glacial acetic acid (1.8 mL, 1 mL/mmol) and
1n aqueous HCl solution (0.6 mL) were added to the neat nitroolefin 243c (0.48 g,
1.8 mmol) to afford the aldehyde 244c as a pale yellow oil (0.22 g, 57% yield). IR
(neat, cm−1) 2957, 2933, 2864, 2327, 2321, 1723, 1700, 1685, 1670, 1636, 1517, 1437,
1335, 1126, 731, 668, 639; 1H NMR (CDCl3, 400 MHz) δ 9.72 (1H, t, J = 1.5 Hz,
H-1), 6.99 (1H, t, J = 7.8 Hz, H-6), 2.56 – 2.47 (2H, m, H-8), 2.43 (2H, td, J = 7.1,
1.5 Hz, H-2), 2.19 (2H, q, J = 7.5 Hz, H-5), 1.70 – 1.57 (2H, m, H-3), 1.54 – 1.43
(3H, m, H-4), 1.43 – 1.34 (2H, m, H-9), 1.35 – 1.22 (2H, m, H-10), 0.86 (3H, t, J =
7.2 Hz, H-11). 13C NMR (CDCl3, 101 MHz) δ 201.8 (C-1), 152.3 (C-7), 135.3 (C-6),
43.5 (C-2), 30.0 (C-9), 28.0 (C-4), 27.8 (C-5), 26.2 (C-8), 22.4 (C-10), 21.7 (C-3),













Following the general procedure L, glacial acetic acid (1.5 mL, 1 mL/mmol) and
1n aqueous HCl solution (0.5 mL) were added to the neat nitro olefin 243a (0.43
g, 1.5 mmol) to afford the aldehyde 244d as a pale yellow oil (0.21 g, 58% yield).
IR (neat, cm−1) 1721, 1515, 1330, 697; 1H NMR (CDCl3, 400 MHz) δ 9.69 (1H, t,
J = 1.4 Hz, H-1), 7.27 – 7.13 (5H, m, Ar-H and H-6), 7.13 - 7.05 (2H,m, Ar-H),
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3.90 (2H, d, J = 7.8 Hz, H-8), 2.40 (2H, td, J = 7.1, 1.4 Hz, H-2), 2.31 (2H, dd,
J = 15.0, 7.6 Hz, H-5), 1.68 – 1.56 (2H, m, H-3), 1.56 – 1.44 (2H, m, H-4). 13C
NMR (CDCl3, 101 MHz) δ 201.7 (C-1), 150.6 (C-7), 137.0 (C-6), 136.4 (Ar-C), 128.8
(Ar-C), 128.0 (Ar-C), 127.0 (Ar-C), 43.4 (C-2), 32.1 (C-8), 28.1 (C-5), 27.9 (C-4),












To a solution of the nitro olefin 243e (0.49 g, 1.9 mmol) in CH2Cl2 (10 mL),
DIBAL-H (2.0 mL, 1M in cyclohexane) was added dropwise at -78 °C. The reaction
was stopped after 7 hours adding an aqueous solution of 1N HCl (5.7 mL) and the
reaction mixture was then left stirring at rt overnight. H2O (5 mL) was then added
and the organic phase was extracted with CH2Cl2 (10 mL x 3). The combined
organic layers were dried (Na2SO4), filtered and concentrated in vacuo. Purification
of the crude product was performed by combiflash on silica gel (gradient diethyl
ether in hexane) to afford the title aldehyde as pale yellow oil (0.17 g, 38% yield).
IR (neat, cm−1) 2939, 2863, 1720, 1495, 1331, 1235, 1074, 1050, 1028, 1001, 803, 772,
700, 668; 1H NMR (CDCl3, 400 MHz) δ 9.66 (1H, t, J = 1.5 Hz, H-1), 7.43 – 7.35
(3H, m, Ar-H), 7.29 (1H, t, J = 8.0 Hz, H-6), 7.23 – 7.14 (2H, m, Ar-H), 2.33 (2H,
td, J = 7.0, 1.5 Hz, H-2), 2.09 (2H, dt, J = 8.1, 7.3 Hz, H-5), 1.62 – 1.50 (2H, m,
H-3), 1.50 – 1.40 (2H, m, H-4). 13C NMR (CDCl3, 101 MHz) δ 201.7 (C-1), 151.7
(C-7), 137.6 (C-6), 130.3 (Ar-C), 129.7 (Ar-C), 129.5 (Ar-C), 128.6 (Ar-C), 43.4
(C-2), 28.3 (C-5), 27.9 (C-4), 21.5 (C-3). HRMS required for C13H16NO3 [M+H]+
234.1125, found 234.1126.
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a R=Me 33% yield
b R=Et 28% yield
c R=Pro 27% yield







Scheme 6.9: Synthesis of ketones 249a, 249b and 249c.













To a solution of N,O-dimethylhydroxylamine hydrochloride (4.84 g, 49.6 mmol)
in anhydrous THF (50 mL) was added a solution of ethyl-6-heptenoate in anhydrous
THF (14 mL). The reaction mixture was then cooled to -15 °C and iPrMgCl (2.0m
in THF, 48 mL) was added steadily dropwise in 30 min. The reaction mixture was
stirred at -10° for 2 hours and then a saturated aqueous solution of NH4Cl (50 mL).
The organic phase was extracted with diethyl ether (3 x 50 mL) and then washed
with brine (50 mL). The combined organic layers were then dried (MgSO4), filtered
and concentrated in vacuo. The crude product was purified via flash chromatography
on silica gel (30% ethyl acetate in hexane) to afford the title product in quantitative
yield as a colourless oil. IR (neat, cm−1) 2938, 1664, 1652, 1414, 1384, 1177, 993,
909; 1H NMR (CDCl3, 400 MHz) δ 5.74 (1H, ddt, J = 16.9, 10.2, 6.7 Hz, H-6), 5.02
– 4.75 (2H, m, H-7), 3.61 (3H, s, H-9), 3.11 (3H, s, H-8), 2.36 (2H, t, J = 7.6 Hz,
H-2), 2.13 – 1.93 (2H, m, H-5), 1.68 – 1.51 (2H, m, H-3), 1.46 – 1.27 (2H, m, H-4).
13C NMR (CDCl3, 101 MHz) δ 138.7 (C-6), 114.6 (C-7), 61.2 (C-9), 33.6 (C-5), 32.2
(C-8), 31.7 (C-2) 28.7 (C-4), 24.2 (C-3). HRMS required for C9H17NO2 [M+H]+
172.1332, found 172.1333.
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6.10.3 General procedure M for the synthesis of the olefins 248
To a solution of 247 (1 eq.) in anhydrous THF at 0 °C, the Grignard reagent (4 eq.)
was added dropwise in 15 min. The reaction was left stirring at 0 °C for 30 minutes
and then a saturated aqueous solution of NH4Cl was slowly added. The orgnic
phase was extracted with diethyl ether and then washed with brine. The combined
organic layers were dried (MgSO4), filtered and concentrated at a maximum pressure
of 100 mbar keeping the water bath at 25 °C to avoid any evaporation of the volatile












Following the general procedure M, methylmagnesium bromide (3.0m in THF,
10.7 mL) was added dropwise in 15 minutes to a solution of 247 (1.37 g, 8.0 mmol)
in anhydrous THF (80 mL) at 0 °C. The reaction was left stirring at 0 °C for 30
minutes and then a saturated aqueous solution of NH4Cl (50 mL) was slowly added
to finally achieve the desired product 248a as a colourless oil (0.90 g, 89% yield).
IR (neat, cm−1) 2933, 1715, 1642, 1413, 1359, 1164, 995, 910; 1H NMR (CDCl3, 400
MHz) δ 5.72 (1H, ddt, J = 16.9, 10.2, 6.7 Hz, H-6), 5.06 – 4.82 (2H, m, H-7), 2.38
(1H, d, J = 7.4 Hz, H-2), 2.07 (3H, s, H-8), 2.04 – 1.92 (2H, m, H-5), 1.64 – 1.49
(1H, m, H-3), 1.45 – 1.25 (2H, m, H-4). 13C NMR (CDCl3, 101 MHz) δ 209.2 (C-1),
138.5 (C-6), 114.7 (C-7), 43.6 (C-2), 33.5 (C-5), 29.9 (C-8), 28.4 (C-4), 23.3 (C-3).













Following the general procedure M, ethylmagnesium bromide (3.0m in THF,
32 mL) was added dropwise in 10 minutes to a solution of 247 (1.37 g, 8.0 mmol)
in anhydrous THF (80 mL) at 0 °C. The reaction was left stirring at 0 °C for 50
minutes and then a saturated aqueous solution of NH4Cl (50 mL) was slowly added
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to finally achieve the desired product 248b as a colourless oil (1.1 g, 99% yield). IR
(neat, cm−1) 2937, 1713, 1641, 1460, 1414, 1376, 1111, 992, 910; 1H NMR (CDCl3,
400 MHz) δ 5.78 (1H, ddt, J = 16.9, 10.2, 6.7 Hz, H-6), 5.07 – 4.87 (m,2H, H-7),
2.40 (4H, m, H-2 and H-8), 2.11 – 2.00 (2H, m, H-5), 1.68 – 1.52 (2H, m, H-3),
1.47 – 1.32 (2H, m, H-4), 1.04 (3H, t, J = 7.3 Hz, H-9). 13C NMR (CDCl3, 101
MHz) δ 211.8 (C-1), 138.5 (C-6) 114.6 (C-7), 42.2 (C-2), 35.9 (C-8), 33.5 (C-5), 28.5















Following the general procedure M, n-propylmagnesium bromide (1.0m in THF,
25 mL) was added dropwise in 10 minutes to a solution of 247 (1.07 g, 6.3 mmol)
in anhydrous THF (60 mL) at 0 °C. The reaction was left stirring at 0 °C for 1
hour and then a saturated aqueous solution of NH4Cl (40 mL) was slowly added
to finally achieve the desired product 248c as a colourless oil (1.04 g, quantitative
yield). IR (neat, cm−1) 2934, 1711, 1456, 1412, 1371, 1128, 992, 910; 1H NMR
(CDCl3, 400 MHz) δ 5.72 (1H, ddt, J = 16.9, 10.2, 6.7 Hz, H-6), 5.03 – 4.79 (2H,
m, H-7), 2.44 – 2.25 (4H, m, H-2 and H-8), 2.09 – 1.88 (2H, m, H-5), 1.70 – 1.43
(4H, m, H-3 and H-9), 1.43 – 1.24 (2H, m, H-4), 0.84 (3H, t, J = 7.4 Hz, H-10). 13C
NMR (CDCl3, 101 MHz) δ 211.4 (C-1), 138.5 (C-6), 114.6 (C-7), 44.7 (C-2), 42.6
(C-8), 33.5 (C-5), 28.5 (C-4), 23.3 (C-3), 17.3 (C-9), 13.8 (C-10). HRMS required
for C10H19O [M+H]+ 155.1436, found 155.1429.
General procedure N for the synthesis of 249
To a solution of AgNO2 (4 eq.), TEMPO (0.4 eq.), 4Å molecular sieves in anhydrous
DCE, 248 was added and the reaction mixture was left stirring in a close reaction
tube at 70 °C for 16 hours. The reaction mixture was then left to cool down to
rt and then filtered over a short pad of celite and washed with ethyl acetate. The
crude product was then purified via combiflash on silica gel (gradient 0-20% ethyl
acetate in hexane).












Following the general procedure N, the olefin 248a (1.05 g, 8 mmol) was added
to a solution of AgNO2 (4.49 g, 26.4 mmol), TEMPO (0.625 g, 4.0 mmol), 4Å
molecular sieves (2 g) in anhydrous DCE (32 mL) to afford the title product as a
colourless oil (0.45 g, 33% yield). 1H NMR (CDCl3, 400 MHz) δ 7.29 – 7.12 (1H,
m, H-6), 6.93 (1H. dt, J = 13.5, 1.6 Hz, H-7), 2.41 (2H, t, J = 7.0 Hz, H-2), 2.23
(2H, qd, J = 7.3, 1.6 Hz, H-5), 2.08 (3H, s, H-8), 1.65 – 1.52 (2H, m, H-3), 1.52 –
1.40 (2H, m, H-4). 13C NMR (CDCl3, 101 MHz) δ 208.2 (C-1), 142.1 (C-6), 139.8
(C-7), 43.0 (C-2), 30.0 (C-8), 28.4 (C-5), 27.2 (C-4), 23.0 (C-3). HRMS required for














Following the general procedure N, the olefin 248b (1.050 g, 7.5 mmol) was
added to a solution of AgNO2 (5.09 g, 30 mmol), TEMPO (0.47 g, 3.0 mmol), 4Å
molecular sieves (2 g) in anhydrous DCE (30 mL) to afford the title product as a
colourless oil (0.39 g, 28% yield). IR (neat, cm−1) 2937, 1711, 1700, 1648, 1521,
1460, 1351, 1115, 959, 732; 1H NMR (CDCl3, 400 MHz) δ 7.35 – 7.16 (1H, m, H-6),
7.01 (1H, dt, J = 13.4, 1.6 Hz, H-7), 2.54 – 2.38 (4H, m, H-2 and H-8), 2.30 (2H, qd,
J = 7.3, 1.6 Hz, H-5), 1.73 – 1.61 (2H, m, H-3), 1.61 – 1.45 (2H, m, H-4), 1.07 (3H,
t, J = 7.4 Hz, H-9). 13C NMR (CDCl3, 101 MHz) δ 210.9 (C-1), 142.1 (C-6), 139.8
(C-7), 41.9 (C-2), 41.7 (C-8), 36.0 (C-5), 28.4, 27.3 (C-4), 23.1 (C-3), 7.8 (C-9).
HRMS required for C9H16NO3 [M+H]+ 186.1125, found 186.1127.














Following the general procedure N, the olefin 248c (1.020 g, 6.6 mmol) was
added to a solution of AgNO2 (4.49 g, 26.5 mmol), TEMPO (0.41 g, 2.6 mmol),
4Å molecular sieves (2 g) in anhydrous DCE (26 mL) to afford the title product as
a colourless oil (0.36 g, 27% yield). IR (neat, cm−1) 2936, 1709, 1700, 1648, 1521,
1458, 1412, 1350, 1127, 961, 732; 1H NMR (CDCl3, 400 MHz) δ 7.35 – 7.21 (1H,
m, H-6), 7.01 (1H, dt, J = 13.4, 1.6 Hz, H-7), 2.45 (2H, t, J = 7.0 Hz, H-8), 2.39
(2H, t, J = 7.3 Hz, H-2), 2.30 (2H, qd, J = 7.3, 1.6 Hz, H-5), 1.71 – 1.56 (4H,
m, H-3 and H-9), 1.60 – 1.47 (2H, m, H-4), 0.93 (3H, t, J = 7.4 Hz, H-10). 13C
NMR (CDCl3, 101 MHz) δ 210.5 (C-1), 142.1 (C-6), 139.8 (C-7), 44.8 (C-2), 42.1
(C-8), 28.4 (C-5), 27.3 (C-4), 23.1 (C-3), 17.3 (C-9), 13.8 (C-10). HRMS required
for C10H16NO3 [M-H]− 198.1125, found 198.1127.
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Scheme 6.10: Synthesis of substrate 255















To a solution of aminoacetaldehyde diethyl acetal (11.6 mL, 80 mmol) in ace-
tonitrile (200 mL), K2CO3 (8.29 g, 60 mmol) and a solution of 4-bromobutene (4
mL, 40 mmol) in acetonitrile (80 mL) were added and left stirring at 65°C for 18
hours. The reaction mixture was then concentrated in vacuo and the residue was
diluted with ethyl acetate (100 mL) and washed with first with H2O (100 mL) and
then with brine (100 mL). The organic phase was dried over Na2SO4, filtered and
concentrated in vacuo. The crude product was purified via combiflash on silica gel
(gradient hexane/ethyl acetate) to afford the title compound as a oil (5.05 g, 68%
yield). IR (neat, cm−1) 2976, 2901, 1457, 1373, 1123, 1059, 994, 913; 1H NMR
(CDCl3, 400 MHz) δ 5.80 (1H, ddt, J = 17.1, 10.2, 6.9 Hz, H-3), 5.17 – 4.97 (2H,
m, H-4), 4.62 (1H, t, J = 5.6 Hz, H-7), 3.64 (4H, ddq, J = 64.2, 9.4, 7.0 Hz, H-8),
2.75 (2H, d, J = 5.7 Hz, H-6), 2.71 (2H, t, J = 6.9 Hz, H-1) 2.27 (2H, qt, J = 6.9,
1.3 Hz, H-2), 1.23 (6H, t, J = 7.1 Hz, H-9).13C NMR (CDCl3, 101 MHz) δ 136.3
(C-3), 116.3 (C-4), 102.2 (C-7), 62.4 (C-8), 52.1 (C-6), 48.9 (C-1), 34.3 (C-2), 15.4

















To a solution of 252 (5.0 g, 26.7 mmol) in THF (108 mL) was added Na2CO3
(8.2 g, 77.4 mmol) and benzyl chloroformate (4.6 mL, 32 mmol) and the reaction
mixture was left vigorously stirring at rt for 19 hours. H2O (50 mL) was added and
the organic phase was extracted with ethyl acetate (3 x 70 mL). The organic layers
were then washed with brine (50 mL), dried over Na2SO4, filtered and concentrated
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in vacuo. The crude product was then purified via combiflash on silica gel (gradient
to 15% ethyl acetate in hexane) to afford the 253 as a yellow oil (6.985 g, 21.8
mmol, 81% yield). IR (neat, cm−1) 2976, 1697, 1474, 1416, 1374, 1284, 1238, 1159,
1121, 1058, 1029, 913, 770, 752, 734, 697; 1H NMR (CDCl3, 400 MHz) δ 7.46 –
7.30 (5H, m, Ar-H), 5.76 (1H, dddt, J = 24.1, 17.1, 10.1, 7.0 Hz, H-3), 5.16 (2H, s,
H-10), 5.08 – 4.94 (2H, m, H-4), 4.66 and 4.51 (split because of N-CBZ rotamers,
1H, t, J = 5.4 Hz, H-6), 3.65 and 3.53 (2H, ddq, J = 78.7, 9.5, 7.1 Hz, H-7), 3.49
– 3.40 (2H, m, H-5), 3.34 (2H, dd, J = 10.6, 5.4 Hz, H-1), 2.32 (2H, dq, J = 14.8,
7.2 Hz, H-2), 1.19 (6H, dt, J = 20.5, 7.0 Hz, H-8). 13C NMR (CDCl3, 101 MHz,
rotamers) δ 156.4 and 156.0 (C-9), 136.8 and 135.4 (C-3), 135.3 (Ar-C) 128.5 and
128.0 (Ar-C), 127.9 and 127.7 (Ar-C), 116.7 and 116.6 (C-4), 102.2 and 101.7 (C-6),
67.1 and 67.0 (C-10), 63.5 and 63.4 (C-7), 50.9 and 50.3 (C-5), 48.4 and 48.1 (C-1),



















To an oven-dried two-neck round bottom flask charged with magnetic stir-bar
was added activated 4Å molecular sieves (0.6 g), AgNO2 (17.61 g, 103.7 mmol) and
TEMPO (2.03 g, 13.0 mmol), 253 (6.95 g, 21.6 mmol) and anhydrous DCE (67
mL) were added. The tube was then placed in a preheated oil bath at 70 °C and
the reaction mixture was left stirring vigorously for 41 hours. The progress of the
reaction was monitored by TLC and then the reaction mixture was left to cool down
to rt. The reaction mixture was then filtered through a short pad of celite washed
with ethyl acetate (500 mL) and concentrated in vacuo. The crude product was
then purified via combiflash using silica gel columns (gradient up to 50% diethyl
ether in hexane) to afford the title compound 254 as a colourless oil (4.29 g, 11.7
mmol, 54%). IR (neat, cm−1) 2976, 2885, 1700, 1523, 1454, 1416, 1350, 1238, 1191,
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935, 770, 733, 697; 1H NMR (CDCl3, 400 MHz) δ 7.45 – 7.32 (5H, m, Ar-H), 7.32
– 7.13 (1H, m, H-3), 7.01 and 6.96 (1H, d, J = 13.5 Hz, H-4), 5.16 (2H, s, H-10),
4.66 and 4.49 (1H, t, J = 5.2 Hz, H-6), 3.82 -3.39 (6H, m, H-7 and H-1), 3.35 and
3.32 (2H, d, J = 5.1 Hz, H-5), 2.64 – 2.47 (2H, m, H-2), 1.22 and 1.17 (t, J = 7.0
Hz, 6H). 13C NMR (CDCl3, 101 MHz) δ 156.1 and 156.0 (C-9), 140.5 (C-4) 139.3
and 139.1 (C-3), 136.3 and 136.2 (Ar-C), 128.6 and 128.6 (Ar-C), 128.3 and 128.1
(Ar-C), 102.0 and 101.5 (C-6), 67.6 and 67.5 (C-10), 63.7 and 63.5 (C-7), 51.3 and
50.9 (C-1), 47.5 and 47.0 (C-5), 27.9 and 27.4 (C-2), 15.4 and 15.3 (C-8). HRMS














To the protected nitro olefin 254 (1.47 g, 4.0 mmol) at ice-cold condition was
added acetic acid (4 mL). After the solution started to freeze HCl (1N, 1.3 mL)
was added and the mixture was left stirring at rt for 28 hours. CH2Cl2 (15 mL)
was added and the organic phase was washed with H2O (2 x 15 mL) and saturated
aqueous NaHCO3 (35 mL). The aqueous phase was back extracted with CH2Cl2 (3
x 30 mL) and then the combined organic layers were dried over MgSO4, filtered and
concentrated under reduced pressure. The crude product was purified via combiflash
on silica gel (gradient up to 55% ethyl acetate in hexane) to afford compound 255
as a colourless oil (33% yield, 0.389 g). IR (neat, cm−1) 1697, 1521, 1454, 1351,
1235, 1134, 1028, 771, 734, 699; 1H NMR (CDCl3, 400 MHz) δ 9.64 and 9.59 (1H, s,
H-1), 7.48 – 7.25 (5H, m, Ar-H), 7.25 – 7.13 (1H, m, H-5), 7.04 and 6.97 (1H, d, J =
13.4 Hz, H-6), 5.18 and 5.13 (1H, s, H-8), 4.15 and 4.09 (1H, s, H-2), 3.53 (2H, dt, J
= 10.4, 6.9 Hz, H-3), 2.54 (2H, dq, J = 25.7, 7.3 Hz, H-4). 13C NMR (CDCl3, 101
MHz) δ 197.0 and 196.9 (C-1), 156.0 and 155.6 (C-7), 140.9 (C-6), 138.4 and 138.3
(c-5), 135.8 (Ar-C), 128.7 and 128.6 (Ar-C), 128.5 and 128.4 (Ar-C), 128.2 and 128.0
(Ar-C), 68.2 and 68.0 (C-8), 58.2 and 58.0 (C-2), 47.8 and 47.1 (C-3), 28.1 and 27.6
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(C-4). HRMS required for C14H17N2O5 [M+H]+ 293.1137, found 293.1140.
6.12 Synthesis of nitro olefin 265














72% yield 63% yield64 % yield
























1,2-dihydronaphtalene (3.0 g, 23 mmol) was dissolved in a mixture of CH2Cl2
and MeOH (V/V 1:1, 120 mL) and the mixture was cooled to -78°C. O3 was then
bubbled through until a blue colour developed. Excess of O3 was removed bubbling
through N2 until the blue colour was discharged. NaBH4 (1.74 g, 46.0 mmol) was
added slowly and then the reaction mixture was stirred at rt for 1 h. The reaction
was quenched with saturated aq. NH4Cl solution (100 mL) and then the organic
phase was extracted with CH2Cl2 (3 x 100 mL). The combined organic layers were
dried over Na2SO4, filtered and concentrated in vacuo to afford compound 261 as
a dense colourless liquid. To a solution of 261 (3.30 g, 19.9 mmol) in toluene (81
mL) was added activated MnO2 powder (8.63 g, 99.3 mmol) every hour for the first
three hours for a total of 15 eq. added. The reaction mixture was left stirring at rt
for further 18 h. MnO2 was filtered through a short pad of celite, washed with ethyl
acetate (250 mL) and concentrated in vacuo. Compound 262 was used for Wittig
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olefination without further purification. To a suspension of MePPh3Br (10.7 g, 30.0
mmol) in THF (36 mL) was added n-BuLi (2.5m in hexane, 12 mL) dropwise at 0°C.
The reaction mixture was stirred at 0°C for 30 minutes and then a solution of 262
(2.46 g, 15.0 mmol) in THF (9.5 mL) was added dropwise. The reaction mixture
was left stirring at rt for 20 hours and then it was quenched with a saturated aq.
solution of NH4Cl (85 mL) at 0°C. The organic phase was extracted with diethyl
ether (3 x 90 mL) and then combined organic layers were then dried over Na2SO4,
filtered and concentrated in vacuo. The residue was purified via combiflash on silica
gel (gradient from 20 to 30% ethyl acetate in hexane) to afford the title product
263 as a colourless oil (2.03 g, 64% yield for three steps). 1H NMR (CDCl3, 400
MHz) δ 7.60 – 7.44 (1H, m, Ar-H), 7.26 – 7.14 (3H, m, Ar-H), 7.04 (1H, dd, J =
17.3, 10.9 Hz, H-7), 5.68 (1H, dd, J = 17.3, 1.4 Hz, H-8), 5.33 (1H, dd, J = 11.0,
1.4 Hz, H-8), 3.70 (2H, t, J = 6.3 Hz, H-2), 2.91 – 2.74 (2H, m, H-4), 1.97 – 1.79
(2H, m, H-3), 1.45 (1H, s, H-1). 13C NMR (CDCl3, 101 MHz) δ 139.2 (C-6), 136.5
(C-5), 134.6 (C-7), 129.5 (Ar-C), 127.9 (Ar-C), 126.4 (Ar-C), 125.9 (Ar-C), 115.6











To a solution of 263 (0.487 g, 3.0 mmol) in CH2Cl2 (17 mL) was added a
solution of PCC (1.29 g, 6.0 mmol) in CH2Cl2 (3 mL) and the reaction mixture was
left stirring at rt for 3 h. Silica gel was added and the crude product was purified
via combiflash on silica gel (gradient up to 10% ethyl acetate in hexane) to afford
compound 264 as a colourless oil (0.346 g, 72% yield). 1H NMR (CDCl3, 400 MHz)
δ 9.84 (1H, t, J = 1.4 Hz, H-1), 7.64 – 7.47 (1H, m, Ar-H), 7.40 – 7.12 (3H, m, Ar-H),
6.97 (1H, dd, J = 17.3, 11.0 Hz, H-6), 5.68 (1H, dd, J = 17.3, 1.4 Hz, H-7), 5.36
(1H, dd, J = 11.0, 1.4 Hz, H-7), 3.04 (2H, dd, J = 8.4, 7.1 Hz, H-3), 2.76 (2H, ddd,
J = 8.7, 7.1, 1.4 Hz, H-2). 13C NMR (CDCl3, 101 MHz) δ 201.4 (C-1), 137.6 (C-5),
136.6 (C-4), 134.2 (C-6), 129.3 (Ar-C), 128.0 (Ar-C), 126.8 (Ar-C), 126.2 (Ar-C),
116.3 (C-7), 44.8 (C-2), 25.6 (C-3). HRMS required for C11H13O [M+H]+ 161.0966,












To an oven-dried quick-fit cap test tube charged with magnetic stir-bar was
added activated 4Å molecular sieves (0.15 g), AgNO2 (1.00 g, 5.9 mmol) and
TEMPO (0.125 g, 0.8 mmol). Compound 264 (0.314 g, 2.0 mmol) and anhydrous
DCE (8 mL) were added. The tube was then placed in a preheated oil bath at 70 °C
and the reaction mixture was left stirring vigorously for 17 hours. The progress of
the reaction was monitored by TLC and then the reaction mixture was left to cool
down to rt. The reaction mixture was then filtered through a short pad of celite
washed with ethyl acetate (250 mL) and concentrated in vacuum. The crude prod-
uct was then purified via combiflash using silica gel columns (gradient up to 20%
ethyl acetate in hexane) to afford the title compound 265 as a yellow solid (0.257 g,
63% yield). mp = 63.0 - 64.8 °C IR (neat, cm−1)2841, 1713, 1700, 1627, 1597, 1500,
1331, 1299, 1270, 1211, 966, 957, 774, 750, 606; 1H NMR (CDCl3, 400 MHz) δ 9.85
(1H, t, J = 1.1 Hz, H-1), 8.35 (1H, d, J = 13.5 Hz, H-7), 7.62 – 7.51 (2H, m, H-6
and Ar-H), 7.50 – 7.39 (1H, m, Ar-H), 7.33 (1H, d, J = 7,6 Hz, Ar-H), 7.32 - 7.29
(1H, m, Ar-H) 3.15 (2H, t, J = 7.4 Hz, H-3), 2.82 (2H, td, J = 7.5, 1.1 Hz, H-2).
13C NMR (CDCl3, 101 MHz) δ 200.0 (C-1), 141.5 (C-5), 138.3 (C-6), 136.0 (C-7),
132.1 (Ar-C), 130.4 (Ar-C), 128.6 (C-4), 127.6 (Ar-C), 127.4 (Ar-C), 44.9 (C-2), 25.3
(C-3). HRMS required for C11H10NO3 [M-H]− 204.0661, found 204.0665.
6.13 Organocatalytic products 249, 317 and 266
6.13.1 General procedure O for the organocatalytic reactions
To a solution of (S)-(-)-5-(2-pyrrolidinyl)-1H-tetrazole (5 mol%) and DCE (0.05M)
previously sonicated for 30 minutes was added the nitro olefin (1 eq.) at -20 °C
dropwise in 3 minutes followed by DCE to wash the syringe used and the sides of
the reaction flask. The reaction mixture was left stirring at -20 °C until completion of
the reaction. NaBH4 (1.5 eq.) was added at -20 °C followed by MeOH. The reaction
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went to completion in 1 hour. A saturated aqueous solution of NH4Cl was added,
followed by brine and H2O. The organic phase was extracted first with a mixture
of chloroform and isopropanol (V/V, 3:1), then with diethyl ether and finally with
ethyl acetate because of the high affinity of the product with the aqueous phase.
The organic phase was then dried (Na2SO4), filtered and concentrated in vacuo.
The crude product was then purified by flash chromatography on silica gel to afford
the target product.
6.13.2 General procedure P for the organocatalytic racemic reac-
tions
To a solution of the nitro olefin in DCE (0.2m), l-Proline (10 mol%) and d-Proline
(10 mol%) were added at -20 °C. The reaction was monitored by TLC and once
gone to completion, NaBH4 (1.5 eq.) and MeOH were added. The reaction mixture
was left stirring at -20 °C until the reduction was completed. Then, a saturated
aqueous solution of NH4Cl was added, followed by brine and H2O. The organic phase
was extracted with CH2Cl2. The combined organic layers were dried (Na2SO4),
filtered and concentrated in vacuo. The crude product was then purified by flash














Following general procedure O, the nitro olefin 248a (0.100 g, 0.58 mmol)
was added to a mixture of catalyst 29 (0.017 g, 0.12 mmol) in DCE (10.6 mL)
at 0 °C. After 5 hours, the reaction did not show any formation of the product,
therefore the reaction mixture was left stirring at rt. After 48 hours, the reaction
was monitored by 1H NMR, showing only partial formation of the product. Acetic
acid (20 mol%, 7µL) was added as co-catalyst. After 8 days from start of the
reaction, the reaction mixture was concentrated in vacuo. The crude product was
purified via flash chromatography on silica gel (20% ethyl acetate in hexane) to
afford separately cis- and trans-250a as colourless oils (0.56 g, 56% yield of both
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diastereomers combined). cis-250a: 84% ee; HPLC analysis: Chiralpack OD, 2%
isopropanol in hexane, flow rate = 0.8 mL/min, λ = 210 nm. [α]20D + 24.0 (c =
0.1, CH2Cl2); IR (neat, cm−1) 2960, 1699, 1545, 1422, 1382, 1355, 1178; 1H NMR
(CDCl3, 400 MHz) δ 4.59 (2H, ABX, JAX = 8.5 Hz, JBX = 6.9 Hz, JAB = 12.9
Hz, νAB = 92.1 Hz, H-7), 3.23 (1H, ddd, J = 8.4, 7.1, 4.8 Hz, H-2), 2.77 (1H, tq,
J = 8.9, 7.3 Hz, H-6), 2.22 (3H, s, H-8), 2.11 – 1.96 (1H, m, H-3), 1.96 – 1.76 (3H,
m, H-5, H-3 and H-4), 1.76 – 1.62 (2H, m, H-5 and H-4). 13C NMR (CDCl3, 101
MHz) δ 210.6 (C-1), 75.9 (C-7), 52.1 (C-2), 40.9 (C-6), 30.7 (C-8), 29.4 (C-3), 29.2
(C-5), 23.2 (C-4). HRMS required for C8H14NO3 [M+H]+ 172.0968, found 172.0972.
trans-250a: 38% ee; HPLC analysis: Chiralpack AD-H, 0.5% isopropanol in hexane,
flow rate = 0.5 mL/min, λ = 210 nm. [α]20D + 2.0 (c = 0.1, CH2Cl2); IR (neat,
cm−1) 2960, 1705, 1545, 1431, 1371, 1356, 1174; 1H NMR (CDCl3, 400 MHz) δ 4.31
(2H, ABX, JAX = 6.8 Hz, JBX = 7.2 Hz, JAB = 12.1 Hz, νAB = 30.2 Hz, H-7),
2.94 (1H, m, H-2), 2.79 – 2.61 (1H, m, H-6), 2.13 (3H, s, H-8), 2.10 – 1.97 (1H, m,
H-5), 1.97 – 1.85 (1H, m, H-3), 1.79 – 1.61 (3H, m, H-4 and H-5), 1.49 – 1.26 (2H,
m, H-3). 13C NMR (CDCl3, 101 MHz) δ 208.8 (C-1), 78.9 (c-7), 55.2 (C-6), 39.2
(C-2), 30.0 (C-8), 30.0 (C-5), 29.1 (C-3), 24.4 (C-4). HRMS required for C8H14NO3
















Following general procedure O, the nitro olefin 248b (0.150 g, 0.81 mmol) was
added to a mixture of catalyst 29 (0.023 g, 0.16 mmol), acetic acid (9.5 µL, 0.16
mmol) in DCE (16.2 mL) at rt. After 8 days, H2O (20 mL) was added to the
reaction mixture and the organic phase was extracted with CH2Cl2 (3 x 20 mL).
The organic phase was washed with an aqueous solution of 1N HCl (20 mL) and
then it was back-extracted with CH2Cl2 (20 mL). The combined organic layers were
dried (Na2SO4), filtered and concentrated in vacuo. The crude product was purified
by flash chromatography on silica gel (gradient 10-20% ethyl acetate in hexane) to
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afford separately cis- and trans-250b as colourless oils (0.23 g, 15% yield of both
diastereomers combined). cis-250b: IR (neat, cm−1) 2964, 1705, 1700, 1545, 1452,
1379, 1107; 1H NMR (CDCl3, 400 MHz) δ 4.47 (2H, ABX, JAX = 8.6 Hz, JBX =
6.7 Hz, JAB = 12.9 Hz, νAB = 84.1 Hz, H-7), 3.13 (1H, ddd, J = 8.0, 7.2, 5.3 Hz,
H-2), 2.80 – 2.60 (1H, m, H-6), 2.54 – 2.33 (2H, m, H-8), 2.01 – 1.87 (1H, m, H-3),
1.86 – 1.66 (3H, m, H-3, H-5 and H-4), 1.66 – 1.50 (2H, m, H-5 and H-4), 0.96 (3H,
t, J = 7.2 Hz, H-9). 13C NMR (CDCl3, 101 MHz) δ 213.4 (C-1), 76.0 (C-7), 51.1
(C-2), 41.0 (C-6), 36.7 (C-8), 29.8 (C-3), 29.5 (C-5), 23.4 (C-4), 7.6 (C-9). HRMS
required for C9H16NO3 [M+H]+ 186.1125, found 186.1126.
trans-250b: -57% ee; HPLC analysis: Chiralpack AD-H, 3% isopropanol in
hexane, flow rate = 0.3 mL/min, λ = 210 nm. [α]20D - 3.0 (c = 0.1, CH2Cl2); IR
(neat, cm−1) 2958, 1707, 1547, 1526, 1377, 1346, 1119; 1H NMR (CDCl3, 400 MHz)
δ 4.30 (2H, ABX, JAX = 7.0 Hz, JBX = 7.0 Hz, JAB = 12.1, νAB = 24.7 Hz, H-7),
3.05 - 2.86 (1H, m, H-6), 2.68 (1H, dt, J = 9.1, 7.7 Hz, H-2), 2.59 – 2.29 (2H, m,
H-8), 2.07 – 1.86 (2H, m, H-5 and H-3), 1.74 – 1.56 (3H, m, H-3 and H-4), 1.47 – 1.25
(1H, m, H-5), 1.00 (3H, t, J = 7.3 Hz, H-9). 13C NMR (CDCl3, 101 MHz) δ 211.6
(C-1), 79.0 (C-7), 54.2 (C-2), 39.5 (C-6), 35.3 (C-8), 30.3 (C-3), 30.0 (C-5), 24.4

















Following general procedure O, the nitro olefin 248c (0.150 g, 0.75 mmol) was
added to a mixture of catalyst 29 (0.021 g, 0.15 mmol), acetic acid (9 µL, 0.15
mmol) in DCE (15 mL) at rt. After 8 days, H2O (20 mL) was added to the reaction
mixture and the organic phase was extracted with CH2Cl2 (3 x 20 mL). The organic
phase was washed with an aqueous solution of 1N HCl (40 mL) and then it was
back-extracted with CH2Cl2 (2 x 30 mL). The combined organic layers were dried
(Na2SO4), filtered and concentrated in vacuo. The crude product was purified by
flash chromatography on silica gel (gradient 10-20% ethyl acetate in hexane) to
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afford separately cis- and trans-250c as colourless oils (0.14 g, dr 1:2, 9% yield of
both diastereomers combined). cis-250c: 87% ee; HPLC analysis: Chiralpack OD,
0.5% isopropanol in hexane, flow rate = 0.5 mL/min, λ = 210 nm. [α]20D + 6.0 (c
= 0.1, CH2Cl2); IR (neat, cm−1) 2960, 1704, 1547, 1451, 1381, 1123, 1047; 1H NMR
(CDCl3, 400 MHz) δ 4.57 (2H, ABX, JAX = 8.6 Hz, JBX = 6.7 Hz, JAB = 12.9 Hz,
νAB = 87.0 Hz, H-7), 3.20 (1H, ddd, J = 8.2, 7.1, 5.1 Hz, H-2), 2.87 – 2.69 (1H,
m, H-6), 2.58 – 2.36 (2H, m, H-8), 2.08 – 1.93 (1H, m, H-3), 1.93 – 1.75 (3H, m,
H-3, H-5 and H-4), 1.75 – 1.64 (2H, m, H-5 and H-4), 1.67 – 1.53 (2H, m, H-9), 0.93
(3H, t, J = 7.4 Hz, H-10). 13C NMR (CDCl3, 101 MHz) δ 212.9 (C-1), 76.0 (C-7),
51.3 (C-2), 45.4 (C-8), 41.0 (C-6), 29.6 (C-3), 29.4 (C-5), 23.4 (C-4), 16.8 (c-9), 13.7
(C-10). HRMS required for C10H18NO3 [M+H]+ 200.1281, found 200.1282.
trans-250c: -55% ee; HPLC analysis: Chiralpack AD-H, 3% isopropanol in
hexane, flow rate = 0.3 mL/min, λ = 210 nm. [α]20D + 6.0 (c = 0.1, CH2Cl2)
IR (neat, cm−1) 2963, 1705, 1547, 1452, 1431, 1379, 1129; 1H NMR (CDCl3, 400
MHz) δ 4.30 (2H, ABX, JAX = 7.0 Hz, JBX = 7.0 Hz, JAB = 12.0, νAB = 24.3
Hz, H-7), 3.04 – 2.88 (1H, m, H-6), 2.67 (1H, dt, J = 9.3, 7.6 Hz, H-2), 2.52 – 2.26
(2H, m, H-8), 2.08 – 1.83 (2H, m, H-3 and H-5), 1.72 – 1.59 (3H, m, H-3 and H-4),
1.59 – 1.44 (2H, m, H-9), 1.44 – 1.29 (1H, m, H-5), 0.85 (3H, t, J = 7.4 Hz, H-10).
13C NMR (CDCl3, 101 MHz) δ 211.1 (C-1), 79.0 (C-7), 54.4 (C-2), 44.0 (C-8), 39.3
(C-6), 30.2 (C-3), 30.0 (C-5), 24.4 (C-4), 17.1 (C-9), 13.7 (C-10). HRMS required



















Following general procedure O, the nitro olefin 255 (0.187 g, 0.64 mmol) was
added to catalyst 29 (0.019 g, 0.13 mmol) in DCE (12.8 mL) at -20 °C. The reaction
was left stirring at -20 °C for 7 days and then reduced to the alcohol. The crude
product was purified via flash chromatography to achieve both diastereomers of the
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nitro alcohol 317 (0.092 g, 1:1 cis/trans ratio, 48% yield of both diastereomers
combined) cis-317:-77% ee; HPLC analysis: Chiralpack AD-H, 10% isopropanol in
hexane, flow rate = 1.0 mL/min, λ = 210 nm. [α]20D + 7.0 (c = 0.1, CH2Cl2); IR
(neat, cm−1) 3427, 2954, 1701, 1549, 1384, 1359, 1292, 1115, 1030, 1003, 769, 698,
668; 1H NMR (CDCl3, 400 MHz) δ 7.36 – 7.21 (5H, m, Ar-H), 5.17 – 4.90 (2H, m,
H-9), 4.66 (1H, dd, J = 13,9, 7,7 Hz, H-6), 4.54 – 4.30 (1H, m, H-6), 4.14 – 3.93
(1H, m, H-2), 3.71 (1H, m, H-1), 3.59 (1H, m, H-1), 3.57 – 3.47 (1H, m, H-3), 3.43
– 3.26 (1H, m, H-3), 3.05 – 2.88 (1H, m, H-5), 2.03 – 1.74 (2H, m, H-4). 13C NMR
(CDCl3, 101 MHz) δ 155.4 (C-8), 136.4 (Ar-C), 128.6 (Ar-C), 128.2 (Ar-C), 127.9
(Ar-C), 74.9 (C-6), 67.2 (C-9), 61.3 (C-1), 61.0 (C-5), 45.4 (C-3), 38.7 (C-2), 27.0
(C-4). trans-317: [α]20D + 22.2 (c = 0.1, CH2Cl2) IR (neat, cm−1) 3418, 2953,
2887, 1697, 1547, 1416, 1384, 1357, 1213, 1113, 769, 737, 697; 1H NMR (CDCl3, 400
MHz) δ 7.42 - 7.29 (5H, m, Ar-H), 5.25 – 5.06 (2H, m, H-8), 4.60 – 4.42 (1H, m,
H-6), 4.36 (1H, dd, J = 12.7, 8.7 Hz, H-6), 3.82 – 3.63 (3H, m, H-5 and H-1 and
H-3), 3.45 (2H, dt, J = 11.2, 7.3 Hz, H-3), 2.97 – 2.70 (1H, m, H-2), 2.29 – 2.10 (1H,
m, H-4), 1.83 – 1.66 (1H, m, H-4). 13C NMR (CDCl3, 101 MHz) δ 136.2 (Ar-C),
128.6 (Ar-C), 128.3 (Ar-C), 128.1 (Ar-C), 72.0 (C-6), 67.5 (C-8), 65.1 (C-1) 45.1














Following general procedure O, the nitro olefin 265 (0.131 g, 0.64 mmol) was
added to a solution of catalyst 29 (0.019 g, 0.13 mmol) in DCE (12.8 mL). After
24 hours the reaction went to completion and it was reduced to the alcohol. The
crude product was purified by flash chromatography on silica gel (25% ethyl acetate
in hexane) to obtain a combination of cis- and trans-266 as a colourless oil (0.97 g,
1:1 cis/trans ratio, 73% yield).
Mixture of diastereomers: [α]20D - 16.0 (c = 0.1, CH2Cl2) IR (neat, cm−1)
3569, 3366, 2922, 1543, 1479, 1459, 1430, 1377, 1198, 1020, 752, 668; cis-266: 90%
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ee; HPLC analysis: Chiralpack AD-H, 5% isopropanol in hexane, flow rate = 0.6
mL/min, λ = 210 nm. 1H NMR (CDCl3, 400 MHz) δ 7.34 – 7.09 (4H, m, Ar-H),
4.71 (2H, ABX, JAX = 7.5 Hz, JBX = 7.8 Hz, JAB = 13.2 Hz, νAB = 128.3 Hz,
H-7), 4.14 (1H, q, J = 7.5 Hz, H-6), 3.94 – 3.73 (2H, m, H-1), 3.10 – 2.90 (2H, m,
H-2 and H-3), 2.83 (1H, dd, J = 14.8, 7.2 Hz, H-3). 13C NMR (CDCl3, 101 MHz)
δ 142.3 (C-5), 141.4 (C-4), 128.0 (Ar-C), 127.0 (Ar-C), 125.0 (Ar-C), 124.0 (Ar-C),
76.0 (C-7), 62.6 (C-1), 44.5 (C-6), 44.3 (C-2), 33.9 (C-3). trans-266: 52% ee; HPLC
analysis: Chiralpack AD-H, 5% isopropanol in hexane, flow rate = 0.6 mL/min, λ =
210 nm. 1H NMR (CDCl3, 400 MHz) δ 7.26 – 7.04 (4H, m, Ar-H), 4.65 – 4.42 (2H,
m, H-7), 3.80 (1H, td, J = 7.0, 4.7 Hz, H-6), 3.70 – 3.49 (2H, m, H-1), 2.91 (2H,
ABX, JAX = 8.4 Hz, JBX = 5.0 Hz, JAB = 16.5 Hz, νAB = 19.4 Hz, H-3), 2.57 –
2.38 (1H, m, H-2). 13C NMR (CDCl3, 101 MHz) δ 142.3 (C-5), 140.4 (C-4), 128.2
(Ar-C), 127.1 (Ar-C), 125.3 (Ar-C), 124.3 (Ar-C), 79.2 (C-7), 65.3 (C-1), 46.3 (C-6),
45.0 (C-2), 34.0 (C-3). HRMS required for C11H12NO3 [M-H]− 206.0812, 206.0816.
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6.14 Kinetic studies
Kinetic studies were performed at the University of Manchester under the supervi-
sion of Dr. Jordi Burés. Nuclear Magnetic Resonance (NMR) spectra were recorded

















Scheme 6.12: Reaction monitored by 1H NMR to study the kinetic profile.
(400 µL, 0.1m in CD2Cl2) was added to a stock solution of the catalyst 29 (100 µL,
1m in CD2Cl2) and CD2Cl2 (100 µL), directly in a NMR tube. The reaction was






















Scheme 6.13: Reactions monitored by 1H NMR to study the kinetic profile.
A stock solution of the nitro olefin 214 (400 µL, 0.1m in CD2Cl2) was added to
a stock solution of the catalyst 85 or 53 (100 µL, 1m in CD2Cl2) and CD2Cl2 (100
µL), directly in a NMR tube. The reaction was monitored by 1H NMR at 25 °C.
6.15 Calculated Energies
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6.16 Synthesis of γ/α-peptides
OHO2N
HH










































1) HCl (4N in dioxane)



















































To a solution of H5IO6 (2.198 g, 9.7 mmol) in anhydrous acetonitrile (19 mL)
stirred vigorously for 15 minutes at rt was added cis-226 (0.699 g, 4.4 mmol) at
0 °C in anhydrous acetonitrile (2 mL) followed by PCC (0.019 g, 0.09 mmol) in
acetonitrile (4 mL). The reaction mixture was stirred at 0 °C for 45 minutes until
the reaction went to completion. The reaction was monitored by TLC. Ethyl acetate
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(50 mL) was then added and the organic phase was washed first with brine (50 mL),
then with a saturated aqueous solution of NaHSO3 (70 mL) and brine (50 mL)
again. The organic layers were then combined and dried on Na2SO4, filtered and
concentrated in vacuo. The product obtained was a colourless oil (0.674 g, 3.9 mmol,
88%) and it did not require further purification. [α]20D +21.0 (c = 0.1, CH2Cl2);
IR (neat, cm−1) 2963, 1701 , 1547, 1383; 1H NMR (400 MHz, CDCl3) δ 4.56 (2H,
ABX, JAX = 7.2 Hz, JBX = 8.1 Hz, JAB = 13.2 Hz, νAB = 99.0 Hz, H-7), 3.07 (1
H, td, J 7.4, 6.1, H-2), 2.90 (1 H, dt, J 9.3, 7.5, H-6), 2.12 – 1.99 (2 H, m, H-3), 2.00
– 1.84 (2 H, m, H-4', H-5'), 1.82 – 1.67 (1 H, m, H-4''), 1.67 – 1.50 (1 H, m, H-5'').
13C NMR (101 MHz, CDCl3) δ 179.6 (C-1), 76.1 (C-7), 45.2 (C-2), 40.4 (C-6), 29.1





















To a solution of the carboxylic acid 288 (0.087 g, 0.5 mmol) in CH2Cl2 (3.4
mL), DIPEA (0.1 mL, 0.6 mmol), HOBt· H2O (0.081 g, 0.6 mmol) and EDCI (0.115
g, 0.6 mmol) were added and the reaction mixture was stirred for 15 minutes at rt.
d-Ala benzyl ester (0.090 g, 0.5 mmol) was then added and the reaction mixture
was left stirring at rt for 16 hours. The reaction was monitored by TLC and after
24 hours ethyl acetate (50 mL) was added. The organic phase was washed first with
an aqueous 1n solution of aqueous HCl (75 mL), then with an aqueous saturated
solution of NaHCO3 (25 mL) and finally with brine (25 mL). The acidic aqueous
phase was then extracted again with CH2Cl2 (2 x 25 mL) and the same procedure
was carried out for the basic phase (NaHCO3 and brine phases combined) too. The
organic phase was then dried over Na2SO4, filtered and concentrated in vacuo. The
crude product was purified via combiflash on 80 g silica gel columns (gradient ethyl
acetate in hexane). The product was obtained as a white solid (0.056 g, 34%). mp
= 48.8 - 50.4 °C; IR (neat, cm−1) 3315, 2932, 1733, 1638, 1538, 1450, 1385, 1334,
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1316, 1207, 1144, 958, 757, 731; 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.23 (5 H, m,
Ar-H), 6.10 (1 H, d, J = 7.4 Hz, H-3), 5.10 (2 H, ABq, JAB = 12.3 Hz, H-12), 4.58
– 4.31 (3 H, ABX unresolved, m, H-10 and H-2), 2.84 – 2.66 (2 H, m, H-5 and H-9),
1.94 - 1.78 (2 H, m, H-8 and H-7'), 1.81 - 1.70 (1 H, m, H-6'), 1.62 – 1.48 (2 H, m,
H-7''and H-6''), 1.32 (3 H, d, J = 7.2 Hz, H-11); 13C NMR (101 MHz, CDCl3) δ
173.2 (C-4), 172.8 (C-1), 135.3 (Ar-C), 128.6 (Ar-C), 128.5 (Ar-C), 128.2 (Ar-C),
76.3 (C-10), 67.2 (C-12), 48.1 (C-2), 46.7 (C-5), 41.1 (C-9), 29.9 (C-8), 29.7 (C-6),
24.0 (C-7), 18.2 (C-11). HRMS required for C17H23N2O5 [M+H]+ is 335.1607, found
335.1600.



















To a solution of the carboxylic acid 288 (0.660 g, 3.8 mmol) in CH2Cl2 (27
mL), DIPEA (0.80 mL, 4.6 mmol), HOBt· H2O (0.622 g, 4.6 mmol) and EDCI
(0.882 g, 4.6 mmol) were added and the reaction mixture was stirred for 15 minutes
at rt. l-Ala benzyl ester p-toluene sulfonate salt was then added and the reaction
mixture was left stirring at rt for 16 hours. The reaction was monitored by TLC and
once gone to completion ethyl acetate (150 mL) was added. The organic phase was
washed first with an aqueous 1n solution of NaHSO4 (75 mL), then with an aqueous
saturated solution of NaHCO3 (75 mL) and finally with brine (75 mL). The acidic
aqueous phase was then extracted again with CH2Cl2 (2 x 75 mL) and the same
procedure was carried out for the basic phase (NaHCO3 and brine phases combined)
too. The organic phase was then dried over Na2SO4, filtered and concentrated in
vacuo. The crude product was purified via combiflash on 80 g silica gel columns
(gradient ethyl acetate in hexane). The product was obtained as a white solid (0.40
g, 1.2 mmol, 31%). mp = 94.2 - 97.1 °C; [α]20D +15.0 (c = 0.1, CH2Cl2); IR (neat,
cm−1) 3316, 2959, 1744, 1640, 1550, 1527, 1456, 1389, 1376, 1188, 1168, 1153; 1H
NMR (400 MHz, CDCl3) δ 7.46 – 7.32 (3 H, m, Ar-H), 6.14 (1 H, d, J 7.3, H-3),
5.19 (2H, AB, JAB = 12.2 Hz, νAB = 27.9 Hz, H-12), 4.55 (2H, ABX, JAX = 8.2 Hz,
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JBX = 6.6 Hz, JAB = 13.5 Hz, νAB = 119.4 Hz, H-10), 4.56 (1 H, p, J 7.2, H-2),
2.91 (1 H, td, J 7.7, 4.8, H-5), 2.87 – 2.71 (1 H, m, H-9), 2.10 – 1.89 (3 H, m, H-6,
H-7'), 1.91 – 1.74 (1 H, m, H-8'), 1.74 – 1.58 (2 H, m, H-8'', H-7''), 1.43 (3 H, d, J
7.2, H-11). 13C NMR (101 MHz, CDCl3) δ 173.4 (C-4), 172.8 (C-1), 135.4 (Ar-C),
128.8 (Ar-C), 128.6 (Ar-C), 128.4 (Ar-C), 76.5 (C-10), 67.4 (C-12), 48.3 (C-2), 46.9
(C-5), 41.9 (C-9), 29.7 (C-8), 29.5 (C-6), 23.8 (C-7), 18.0 (C-11); HRMS required
for C17H23N2O5 [M+H]+ is 335.1607, found 335.1596.
Figure 6.6: Crystal structure of the nitrodimer 290.
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Crystal size/mm3 0.26 × 0.05 × 0.02
Radiation CuKα (λ = 1.54184)
2Θ range for data collection/° 9.418 to 140.84
Index ranges -11 ≤ h ≤ 11, -11 ≤ k ≤ 11, -12 ≤ l ≤
12
Reflections collected 15121
Independent reflections 3114 [Rint = 0.0432, Rsigma = 0.0291]
Data/restraints/parameters 3114/1/232
Goodness-of-fit on F2 1.046
Final R indexes [I>=2σ (I)] R1 = 0.0327, wR2 = 0.0838
Final R indexes [all data] R1 = 0.0342, wR2 = 0.0856
Largest diff. peak/hole / e Å−3 0.17/-0.18
Flack parameter 0.03(10)

























To a solution of compound 290 (0.56 g, 1.7 mmol) in anhydrous MeOH (33
mL) and anhydrous THF (33 mL), Zn powder (1.64 g, 24.9 mmol) and NH4Cl (1.33
g, 24.9 mmol) were added. The reaction mixture was stirred at rt for 1 hour and
it was worked up after monitoring it via TLC. Ehtyl acetate (500 mL) was added
and it was then filtered through a short pad of celite. The white solid obtained was
then dissolved in CH2Cl2 and filtered through cotton wool to remove any NH4Cl left
in solution. The product 291 obtained was a pale yellow paste (0.57 g, 1.8 mmol,
quantitative yield) and it did not require further purifcation. To a solution of the free
amine 291 (0.552 g, 1.81 mmol) in anhydrous CH2Cl2 (14 mL), isopropyl amine (0.63
mL, 3.6 mmol) and Boc2O (0.64 mol, 2.7 mmol) were added and the reaction mixture
was stirred at rt. The reaction was monitored by TLC and it went to completion
in 45 minutes. The reaction mixture was diluted with ethyl acetate (45 mL) and
washed with an aqueous solution of 1m NaHSO4 (30 mL) followed by brine (30 mL).
The organic layers were then combined, dried over Na2SO4, filtered and concentrated
in vacuo. The crude product was then purified via flash chromatography on silica
gel (30% ethyl acetate in hexane). The title product was obtained as a white solid
(0.270 g, 36%). mp = 131.3 - 133.9 °C; [α]20D +103.8 (c = 0.08, MeOH); IR (neat,
cm−1) 3350, 3322, 2958, 1739, 1676, 1640, 1533, 1454, 1370, 1281, 1152, 1058; 1H
NMR (400 MHz, CDCl3) δ 7.36 – 7.21 (5 H, m, Ar-H), 6.16 (1 H, d, J 6.7, H-3),
5.39 (1 H, t J 6.2, H-11)), 5.19 (1 H, ABq, JAB = 12.3 Hz, νAB = 30.5, H-16),
4.60 (1 H, p, J 7.3, H-2), 3.19 (1 H, dt, J 13.9, 5.9, H-10'), 3.11 - 2.91 (1 H, m,
H-10''), 2.73 – 2.60 (1 H, m, H-5), 2.48 - 2.29 (1 H, m, H-9), 2.00 - 1.79 (3 H, m, H-6,
H-7'), 1.79 - 1.69 (1 H, m, H-8'), 1.60 – 1.48 (2H, m H-7''and H-8''), 1.44 (9H, s,
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H-14), 1.41 (3H, m, H-15); 13C NMR (101 MHz, CDCl3) δ 174.6 (C-4), 173.4 (C-1),
156.4 (C-12), 135.3 (Ar-C), 128.7 (Ar-C), 128.5 (Ar-C), 128.3 (Ar-C), 67.3 (C-16),
48.0 (C-2), 47.4 (C-5), 44.2 (C-9), 41.8 (C-10), 29.7 (C-8), 29.2 (C-6), 28.5 (C-14),
24.1(C-7), 18.0 (C-15); HRMS required for C22H33N2O5 [M+H]+ is 405.2389, found
405.2399.
Figure 6.7: X-Ray crystal structure of the dimer 292 (CCDC : 1947227).
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Crystal size/mm3 0.14 × 0.03 × 0.03
Radiation CuKα (λ = 1.54184)
2Θ range for data collection/° 7.638 to 134.094
Index ranges -5 ≤ h ≤ 4, -22 ≤ k ≤ 22, -13 ≤ l ≤ 13
Reflections collected 16639
Independent reflections 3822 [Rint = 0.0575, Rsigma = 0.0462]
Data/restraints/parameters 3822/1/266
Goodness-of-fit on F2 1.068
Final R indexes [I>= 2σ (I)] R1 = 0.0343, wR2 = 0.0828
Final R indexes [all data] R1 = 0.0383, wR2 = 0.0848
Largest diff. peak/hole / e Å−3 0.20/−0.17
Flack parameter 0.02(11)
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6.16.1 General procedure Q for deprotection of the acid moiety
To a solution of benzyl ester in MeOH (20 mL/mmol), a spatula tip of Pd/C (10
%w/w) was added followed by 3 H2 balloons that were emptied in the reaction
mixture. The reaction was monitored by 1H NMR and TLC. The reaction mixture
was then filtered through a short pad of celite with a short pad of silica on top and
it was washed with MeOH (50 mL). The organic phase was then concentrated in
vacuo. The title product is obtained pure and did not need any further purification.
6.16.2 General procedure R for deprotection of the amine moiety
To a solution of protected amine dissolved in a minimal amount of 1,4-dioxane, a
solution of 4n HCl in 1,4-dioxane (5 mL/0.5 mmol) was added. The reaction flask
was then sealed with a septum and stirred at rt. The reaction was monitored by 1H
NMR and TLC and after 4.5 hours, the reaction mixture was then concentrated in























To a solution of the dimer acid 293 (0.063 g, 0.2 mmol) in DMF (0.5 mL),
DIPEA (0.2 mL, 1.2 mmol), HOBt· H2O (0.032 g, 0.24 mmol) and EDCI (0.046 g,
0.24 mmol) were added. The solution was stirred at rt for 15 minutes and then a
solution of dimer amine 291 (0.061 g, 0.2 mmol) in DMF (0.5 mL) was added. The
reaction mixture was stirred at rt for 24 hours. Ethyl acetate (10 mL) was then
added and the organic phase was washed with a 1m aqueous solution of NaHSO4
(2 x 5 mL), a saturated aqueous solution of NaHCO3 (2 x 5 mL) and then brine
(2 x 5 mL). Acid and basic aqueous layers were then extracted twice with CH2Cl2.
All organic layers were combined, dried over Na2SO4, filtered and concentrate in
vacuo. The crude product was then purified by flash chromatography on silica gel
(gradient hexane/ethyl acetate/methanol) to obtain the title product 294 as a white
solid (0.031 g, 0.05 mmol, 26%). [α]20D +69.2 (c = 0.12, MeOH). IR (neat, cm−1)
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3300, 2931, 1741, 1636, 1534, 1449, 1366, 1278, 1247, 1169, 1114, 1034 . 1H NMR
(600 MHz, CDCl3) δ 8.31 (1 H, m), 8.11 (1 H, d, J 7.0), 7.44 – 7.27 (5 H, m),
6.11 (1 H, d, J 4.9), 6.08 (1 H, d, J 6.7), 5.26 (1 H, d, J 12.3), 5.20 (1 H, dd, J
39.7, 12.3), 4.52 (1 H, t, J 7.3), 4.18 (1 H, q, J 6.9), 3.62 (1 H, ddd, J 13.4, 6.1,
4.7), 3.33 (1 H, dd, J 13.1, 6.3), 2.91 – 2.81 (2 H, m), 2.82 – 2.65 (3 H, m), 2.59 –
2.49 (1 H, m), 1.99 – 1.80 (6 H, m), 1.81 – 1.72 (2 H, m), 1.60 (9 H, s), 1.60-1.54
(2H, m) 1.47 - 1.43 (4 H, m), 1.42 (m, 1H), 1.41 (3 H, d, J 7.0). 13C NMR (101
MHz, CDCl3) δ 176.5 (CO AMCP(3)), 176.0 (CO l-Ala(4)), 175.7 (CO l-Ala(2)),
173.3 (CO AMCP(1)), 156.5 (CO-Boc), 135.2 (C-Ar), 128.6 (C-Ar), 128.4 (C-Ar),
128.1 (C-Ar), 67.4 (CH2-Bn), 50.0 (HCα l-Ala(2)), 48.2 (HCα l-Ala(4)), 46.6 (HCα
AMCP(1)), 45.3(HCα AMCP(3)), 44.3 (HCβ AMCP(1)), 42.0 (H2Cγ AMCP(1)),
41.9 (HCγ AMCP(1), 30.8 (C1 AMCP(3)), 30.3, 30.1 (C1-AMCP(1)), 30.0 (C3-
AMCP(3)), 29.7 (C3-AMCP(1)), 25.6 (C2 AMCP(3)), 24.5 (C2 AMCP(1)), 17.6
(HCβ l-Ala(2)), 16.8 (HCβ l-Ala(4)). HRMS required for C32H49N4O7 [M+H]+ is
601.3601, found 601.3604.



















4.19 1.41 - - 6.08 - - -
AMCP
(3)











4.52 1.45 - - 8.11 - - -
AMCP
(1)
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Figure 6.8: COSY NMR spectrum of tetramer 294 at a concentration of 0.2mm in CDCl3
(600 MHz).
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Figure 6.9: TOCSY NMR spectrum of tetramer 294 at a concentration of 0.2mm in CDCl3
(600 MHz).
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Figure 6.10: ROESY NMR spectrum of tetramer 294 at a concentration of 0.2mm in
CDCl3 (600 MHz).
























































































































Figure 6.11: HMBC NMR spectrum of tetramer 294 at a concentration of 0.2mm in CDCl3
(600 MHz).


























AMPC (1) AMPC (5)AMPC (3)L-Ala (2) L-Ala (6)L-Ala (4)
295
To a solution of of 293 (0.036 g, 0.1 mmol) in DMF (1 mL), DIPEA (0.1 mL,
0.6 mmol), HOBt· H2O (0.018 g, 0.12 mmol), EDCI (0.023 g, 0.12 mmol) were
added. The reaction mixture was stirred at rt for 15 minutes and then a solution
of the amine deprotected 294 (0.054 g, 0.1 mmol) in DMF (1 mL) was added. The
reaction mixture was sealed with a septum and it was left stirring at rt for 24 hours.
Ethyl acetate (10 mL) was then added and the organic phase was washed with a 1m
aqueous solution of NaHSO4 (2 x 5 mL), a saturated aqueous solution of NaHCO3
(2 x 5 mL) and then brine (2 x 5 mL). Acid and basic aqueous layers were then
extracted twice with CH2Cl2. All organic layers were combined, dried over Na2SO4,
filtered and concentrate in vacuo. The crude product was then purified by flash
chromatography on silica gel (gradient hexane/ethyl acetate/methanol) to obtain
the title product 295 as a white solid (0.016 g, 0.02 mmol, 20%).
[α]20D +106.0 (c = 0.05, CH2Cl2); IR (neat, cm−1) 3288, 2927, 1739, 1701,
1635, 1529, 1449, 1366, 1247, 1225, 1169; HRMS required for C42H65N6O9 [M+H]+
is 797.4813, found 797.4832. 1H NMR (600 MHz, CDCl3) δ 8.90 (1 H, s), 8.64 (1
H, d, J 6.8), 8.60 – 8.40 (2 H, m), 7.50 – 7.33 (5 H, m), 6.38 (1 H, s), 6.01 (1 H, d,
J 6.2), 5.27 (1H, d, J = 12.3 Hz), 5.19 (1H, d, J = 12.3 Hz), 4.48 (1 H, p, J 7.3),
4.29 (1 H, q, J 6.7), 4.03 (1 H, p, J 6.8), 3.66 - 3,54 (2 H, m), 3.45 – 3.31 (1 H, m),
3.04 - 2.89 (2 H, m), 2.88 – 2.77 (2 H, m), 2.77 - 2.68 (2 H, m), 2.68 – 2.55 (2 H,
m), 2.54 – 2.42 (1 H, m), 2.02 - 1.92 (2 H, m), 1.94 - 1.83 (4 H, m), 1.83 – 1.70 (3
H, m), 1.48 (10 H, s), 1.46 – 1.43 (5 H, m), 1.41 (3 H, d, J 7.5), 1.39 (3 H, d, J 7.1).
13C NMR (101 MHz, CDCl3) δ 176.9, 176.7, 176.3, 176.0, 175.4, 173.5, 156.6,
139.3, 135.2, 128.6, 128.4, 128.1, 124.8, 114.1, 78.7, 67.4, 53.4, 50.7, 50.3, 48.3, 46.3,
45.1, 44.8, 44.4, 42.5, 42.3, 41.8, 41.7, 36.5, 34.3, 33.8, 31.9, 31.0, 30.9, 30.3, 30.2,
30.1, 29.7, 29.5, 29.4, 29.2, 29.0, 28.5, 25.7, 25.7, 24.7, 22.7, 17.6, 16.9, 16.6, 14.1.
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4.287 1.438 - - 6.005 - -
AMCP(5) 2.821 2.952 3.611 2.8 8.513 -
l-
Ala(4)
4.033 1.387 - - 8.537 - -
AMCP(3) 2.739 2.954 3.6 2.483 8.901 - -
l-
Ala(6)
4.483 1.412 - - 8.642 - -
AMCP(1) 2.726 2.6 3.377 2.614 6.377 - -
Benzyl - - - - - 5.236 7.33 -
7.44
Table 6.7: 13C NMR assignment for the γ/α-peptide 295.






l-Ala(2) 50.33 17.65 - - - 173.38
AMCP(5) 45.1 41.77 42.45 - - 176.72
l-Ala(4) 50.71 16.98 - - - 175.51
AMCP(3) 44.71 41.77 42.33 - - 176.9
l-Ala(6) 48.32 16.64 - - - 176.38
AMCP(1) 46.26 44.42 42 - - 176.03
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Figure 6.12: COSY NMR spectrum of hexamer 295 at a concentration of 0.2mm in CDCl3
(600 MHz).
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Figure 6.13: ROESY NMR spectrum of hexamer 295 at a concentration of 0.2mm in
CDCl3 (600 MHz).
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The identified 55 conformers have been processed with DFT as detailed above, apart
from the electronic energy calculations with larger basis set. Apart from conformer
23 and 27, all have been optimised to a local minimum according to the vibrational
frequencies.
Table 6.8: DFT data for the foldamer conformers, energies shown in hartree, relative free
energies (∆G) are in kcal/mol.
conf E Gtherm GCDCl3 ∆G Pop%
2 -2644.68699609 -2643.728544 -2644.73530155 0.0 40.4
1 -2644.69218238 -2643.731061 -2644.73791821 0.0 38.3
3 -2644.69273043 -2643.726661 -2644.74126282 1.0 7.5
13 -2644.69179647 -2643.727440 -2644.73921455 1.2 5.3
15 -2644.68722408 -2643.725307 -2644.73569671 1.9 1.8
6 -2644.68830318 -2643.723753 -2644.73826996 2.0 1.7
4 -2644.69067077 -2643.726560 -2644.73765846 2.1 1.4
36 -2644.68999239 -2643.728052 -2644.73515110 2.3 1.0
7c -2644.68664102 -2643.726629 -2644.73320216 2.3 1.0
21 -2644.68281779 -2643.723289 -2644.73226715 2.6 0.6
5 -2644.68624683 -2643.723673 -2644.73469509 3.0 0.3
48c -2644.68554976 -2643.725689 -2644.73185672 3.0 0.3
19 -2644.68489999 -2643.724086 -2644.73242209 3.3 0.2
9 -2644.68641137 -2643.723480 -2644.73370708 3.8 0.1
29 -2644.68556255 -2643.723266 -2644.73281774 4.0 0.1
17 -2644.68664154 -2643.722931 -2644.73372975 4.3 0.0
12 -2644.68599286 -2643.724920 -2644.73098164 4.4 0.0
42 -2644.68342883 -2643.720420 -2644.73258366 4.6 0.0
8 -2644.68747109 -2643.721151 -2644.73589490 4.6 0.0
18 -2644.68213438 -2643.719856 -2644.73092248 5.1 0.0
44 -2644.68197103 -2643.716164 -2644.73423200 5.3 0.0
30 -2644.68058863 -2643.717996 -2644.73095954 5.3 0.0
16 -2644.68318582 -2643.720860 -2644.73042529 5.5 0.0
11 -2644.68317107 -2643.717081 -2644.73394925 5.6 0.0
23 -2644.68047735 -2643.719414 -2644.72891948 5.6 0.0
49 -2644.67786248 -2643.714263 -2644.73106703 5.9 0.0
33c -2644.68181786 -2643.720704 -2644.72821781 6.1 0.0
10 -2644.68840009 -2643.721717 -2644.73344859 6.3 0.0
14 -2644.6871915 -2643.721810 -2644.73188780 6.5 0.0
55 -2644.67456623 -2643.714100 -2644.72646804 6.8 0.0
38 -2644.67866302 -2643.716416 -2644.72806146 6.9 0.0
45 -2644.68465842 -2643.720296 -2644.73015004 6.9 0.0
39 -2644.67931606 -2643.718411 -2644.72658773 7.0 0.0
34 -2644.67954929 -2643.716430 -2644.72874308 7.0 0.0
51 -2644.68007288 -2643.716644 -2644.72876918 7.2 0.0
41 -2644.67989286 -2643.715497 -2644.72957564 7.3 0.0
47 -2644.66677457 -2643.708734 -2644.72214856 8.0 0.0
20 -2644.68387582 -2643.715650 -2644.73180148 8.3 0.0
22c -2644.68603818 -2643.719605 -2644.72995857 8.4 0.0
25 -2644.68093092 -2643.717417 -2644.72703656 8.4 0.0
31 -2644.6822678 -2643.717565 -2644.72820256 8.4 0.0
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53 -2644.66985637 -2643.709825 -2644.72308257 8.7 0.0
26 -2644.6848354 -2643.718215 -2644.72934691 8.9 0.0
35c -2644.67599832 -2643.715935 -2644.72274123 8.9 0.0
54 -2644.67203954 -2643.711219 -2644.72328760 9.0 0.0
40 -2644.6704656 -2643.711772 -2644.72102136 9.1 0.0
27 -2644.67571738 -2643.711273 -2644.72530966 10.0 0.0
37 -2644.67493904 -2643.710936 -2644.72473439 10.1 0.0
24 -2644.67310522 -2643.708253 -2644.72551838 10.2 0.0
43 -2644.67452023 -2643.711053 -2644.72389976 10.3 0.0
28 -2644.67252849 -2643.709870 -2644.72160322 11.2 0.0
46 -2644.66888856 -2643.706041 -2644.72114960 11.6 0.0
32 -2644.67932466 -2643.713084 -2644.72421571 11.8 0.0
50 -2644.67477119 -2643.709797 -2644.72271710 12.0 0.0
52 -2644.66830324 -2643.703964 -2644.71972771 13.5 0.0
In order to show that the computational ensemble conforms the NMR data, the
distances originally obtained from the NOESY data are plotted against the original
constrains. Note that while in the original Monte-Carlo conformational search, these
constrains were in place, but there were not during DFT optimization.
Figure 6.15: Distances for conformer 2.
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Figure 6.16: Distances for conformer 1.
Figure 6.17: Distances for conformer 3.
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